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Zusammenfassung  
 
Eine vollständige  Rückenmarksdurchtrennung führt zu einem totalen 
funktionellen Verlust  jeglicher willentlicher Kontrolle unterhalb der Läsion. Die 
Ursache für diesen Verlust ist der limitierten Zellernneuerung und der 
ausbleibenen axonalen Regeneration zu zuschreiben. Erste Hinweise deuten 
daraufhin, dass die Präsenz von Myelin-assozierten inhibitorischen 
Wachstumsfaktoren, wie zum Beispiel Nogo-A, dafür verantworlich sind. Eine 
therapeutische Massnahme um diesen inhibitorischen Effekt entgegen zu 
wirken, ist die Applikation von Antikörpern welche diese Stoffe neutralisieren. 
Am Rattenmodel wurde erfolgreich gezeigt das nach einer 
Rückenmarksverletzung und einer zweiwöchigen Applikation eines 
neutralisierendes Antikörpers gegen das Protein Nogo-A, Nervenzellen dazu 
stimulierten wieder auszuwachsen und funktionelle Verknüpfungen 
herzustellen. Diese neuen Verbindungen ermöglichten den anti-Nogo-A 
behandelten Tieren im Vergleich zu Unbehandelten  zu einer verbesserte 
Motorik.   
 
Das Ziel dieser These war es zu prüfen, ob die Translation dieser 
therapeutischen Anwendung am Primaten bevor es zur ersten klinischen 
Anwendung an querschnittsgelähmten Patienten gelangt. Der 
Translationschritt ist in sofern unumgänglich, da er zum einen erlaubt zu 
prüfen, ob die Neutralsierung und die folgliche Stimulierung von 
Nervenwachstum nicht irrtürmlicher Weise zu falschen Verbindungen führen 
könnte mit heftigen Nebenwirkung als Folge und zum anderen ob die 
Applizierung des Antikörpers am Primaten zu wessen Gruppe der Mensch 
zählt, funktioniert. 
 
Insgesamt wurden 13 adulten Makaken einer unilateralen zervikalen Läsion 
ausgesetzt. Sieben Tiere erhielten den neutralieserendem Antikörper gegen 
Nogo-A während vier Wochen und die Anderen sechs Tiere erhielten eine 
Kontrollantikörper Behandelung. Kontrollantikörper behandelte Tiere wiesen 
eine läsionsgrössen-abhängige motorische Genesung für einen 
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Dexteritätstest auf mit sehr limitertem axonalen Wachstum des 
Kortikospinalen Tractes kaudal der Läsion. Im scharfen Gegensatz wiesen 
behandelte Tiere vermehrtes axonales Wachstum und eine vollständige 
funktionelle Erholung für diesen spezifischen  Dexteritätstest auf (Kapitel 1, 2 
und 3). Desweiteren führte die Neutrilaztion von Nogo-A zu einer verstärkten 
Reorganization des Kortikospinalen Trakt rostral der Läsion (Kapitel 4).  
 
Auf dem Nivieau des Kortex und des Pons wurden retrograde degenerative 
Veränderungen gemessen anhand der Zellgrösee und Anzal von Neuronen 
im motrischen Kortex und im Rotem Nucleus. In beiden untersuchten Arealen 
kam es zu eienr deutlichen vermindureung der Zellsomagrösse auf der 
lädierten Seite. Im Gegensatzt zum motorischen Kortex wo kein signifikanter 
Unterschied von Zell Anzahl gefunden wurde gab es zudem im Roten Nucleus 
eine deutlich Reduzierung der Anzahl von Neuronen auf der lädierten Seite. 
Diese degenerativen Vorgängen wurden nicht durch die anti-Nogo-A 
Behandlung vermindert (Kapitel 5 und 6). 
 
Zusammengefasst zeigen die Resultate dieser These dass eine Neutralization 
von einem Myelin-assoziertem Protein Nogo-A nach einer 
Rückenmarksverletzung zu einer verbesserten Motorik und vermehrtem 
axonalen Wachstum auf der Höhe der Läsion im adulten Primaten fürht, in 
Abwesenheit von Nebenwirkungen. 
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1 Summary 
 
After injury to the adult central nervous system (CNS), permanent deficits 
remain to a large part due to limited cell renewal, axonal regeneration and re-
establishment of functional connectivity. Evidence indicate that the lack of 
axonal regeneration is partly due to the myelin-associated inhibitory factor 
Nogo-A. A therapeutical strategy to overcome this inhibition is to prevent the 
neurite outgrowth inhibitor Nogo-A from interacting with its neural receptors by 
using antibodies specifically binding to Nogo-A, thereby neutralizing its action. 
Experiences in the rodent model subjected to spinal cord injury have shown 
that neutralizing Nogo-A, by using specific antibodies not only promotes axonal 
regeneration but also leads to significant functional recovery. 
 
The aim of this thesis was to investigate whether this treatment strategy also 
leads to axonal regeneration and functional recovery in non-human adult 
primates subjected to a partial section of the spinal cord. This assessment is a 
crucial step towards a safe clinical application. Thirteen macaque monkeys 
were subjected to a unilateral cervical lesion at the border between the C7 
and C8 segments. A group received intrathecal injections of a control antibody 
whereas the other animals received a monoclonal antibody recognizing Nogo-
A. Functional recovery was tested using several motor tasks mainly focusing 
on manual dexterity. Control antibody treated monkeys showed a recovery 
that depends on lesion size. In contrast, anti-Nogo-A antibody treated 
monkeys recovered better and even returned to pre-lesion score levels in a 
manual dexterity task (Chapters 2 and 3). 
 
We further investigated, using light-microscopy, if the process of functional 
recovery is paralleled by an anatomical reorganization of the injured 
corticospinal tract (CST). At the spinal level, the area rostral and caudal to 
injury was analyzed for axonal regeneration. Compared to control antibody 
treated monkeys, an enhanced number of fibers presumably due to 
regenerative sprouting was observed rostral to the lesion in anti-Nogo-A 
antibody treated monkeys. Caudal to injury, a higher cumulated axonal arbor 
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length and a higher number of axonal swellings were observed in anti-Nogo-A 
treated animals (Chapters 2 and 4). 
 
We also investigated the consequences of the lesion on corticospinal (CS) 
and rubrospinal (RS) neurons and whether the anti-Nogo-A antibody 
treatment had an influence on these effects. For this purpose the number and 
size of CS and RS neurons were measured in both sides of the brain using 
light-microscopy in intact, in control antibody as well as in anti-Nogo-A 
antibody treated monkeys.  
At the level of the motor cortex the number of pyramidal neurons remains 
similar on both hemispheres, but their somata shrunk on the side opposite to 
the lesion. In this case, the neutralization of Nogo-A did not protect the cells 
from shrinkage.  
In the red nucleus, the lesion also induced shrinkage of the soma of the 
neurons detected in the contralesional magnocellular part of the red nucleus 
(RNm). In contrast to cortical level, here, the number of cells detected in the 
contralesional RNm was consistently lower to that in the ipsilesional RNm, 
suggesting either cell loss or shrinkage beyond detection. Thus, the 
neutralization of Nogo-A by antibody infusion at the lesion side did not prevent 
the phenomena of cell somata shrinkage nor cell disappearance (Chapters 5 
and 6).  
 
In summary the results reported in this thesis demonstrate that the 
neutralization of the neurite outgrowth inhibitor Nogo-A promotes axonal 
regeneration on the level of the spinal cord in adult monkeys subjected to a 
unilateral spinal cord lesion. This effect is paralleled by significant functional 
recovery. However, histological changes in the red nucleus and motor cortex 
were not prevented or attenuated by the anti-Nogo-A antibody treatment. 
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2 Introduction 
 
In patients suffering from spinal cord injury the connections linking the brain to 
the centres controlling limb movements are often interrupted. Currently no 
treatments to re-establish these lost connections are available. Patients with 
high cervical lesions present tetraplegia, a paralysis of all four limbs, whereas 
patients with thoracic and/or lower lesions present paraplegia, paralysis of the 
lower part of the body. Depending on the lesion extent and level, injuries are 
classified according to the American Spinal Injury Association (ASIA) as 
complete (ASIA A) or incomplete (ASIA B-D). Both types of injury represent 
different challenges to basic as well as clinical research. In case of complete 
lesion questions have to be addressed whether it is possible to enable injured 
axons to cross the lesion scar in order to reconnect the two stumps. As in the 
present case of incomplete injuries, injured axons may not need to regenerate 
through the lesion site, but sprout around the lesion using spared tissue as a 
bridge or onto spared pathways not affected by the lesion. 
At present, focus on treating spinal cord injured (SCI) patients remains limited 
to management of bladder dysfunction, spasticity and neuropathic pain. 
However, tetra- as well as paraplegic patients experience limited functional 
recovery that can be promoted by rehabilitative means (Dietz, 1997). For 
example it was shown that regular locomotor training, by walking on a 
treadmill under weight support conditions, can aid some incomplete patients 
to regain their capability of weight bearing and walking (Dietz, 1995; Dietz et 
al., 1998). Nevertheless, in all cases, SCI patients have to learn to make 
compensatory use of spared motor functions.  
Repair of large lesions to the spinal cord requires lesioned axons to 
regenerate across the lesion scar and/or compensatory sprouting of spared 
fibers. After a lesion, both types of neurite growth are abundant in the 
newborn CNS but not in the mature CNS. The time point at which this 
capacity to nerve regeneration ceases depends on the species. In rodents 
(Kalil and Reh, 1982) and in humans (Chen et al., 2002) this occurs within a 
few weeks postnatally. Simultaneously, the cellular composition of the 
maturing CNS changes by the differentiation of oligodendrocytes and the 
myelination of axons (Kapfhammer and Schwab, 1994). However, adult CNS 
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neurons have not lost the intrinsic capacity to regenerate (Fig. 1), because, 
when provided with a permissive environment such as a portion of a 
peripheral nerve, they will extend long processes into the graft that somewhat 
penetrate CNS tissue (David and Aguayo, 1981). 
Figure 1 A: Axons of the adult 
CNS use a tissue bridge to 
regenerate over long distance 
in a PNS environment 
Panel B: Anterograde and 
retrograde labeled CNS 
neurons after grafting (David 
and Aguayo, 1981)  
 
To restore function following SCI, molecular therapeutic interventions shall 
promote neuron survival, axonal growth and enhance conductivity. In recent 
times, several pharmacological approaches have led to long distance 
regeneration of injured axons and compensatory sprouting being paralleled by 
enhanced functional recovery in the rodent model of SCI. 
For example, it has been shown that neurotrophic factors applied after injury 
promote the survival and maintenance of a variety of injured neurons in the 
mammalian adult CNS (Giehl and Tetzlaff, 1996; Schnell et al., 1994; Tobias 
et al., 2003; Weidner et al., 1999) and survival, sprouting and outgrowth of 
injured fibres within the grey matter, but never within the white matter (Grill et 
al., 1997; Ramer et al., 2000).  
Also the delivery of intracellular cyclic AMP (cAMP) induces axonal sprouting 
of injured sensory neurons in vivo (Lu et al., 2004). Another approach, the 
inactivation of Rho k inase (RO CK), a protein family of GTPases, promoted 
functional recovery and had a neuroprotective effect (Dergha m et al., 2002;  
Fournier et  al., 2003).  One of the most recently evolved strategies to allow 
successful reconnection of neurons to deprived targets is the neutralization of 
the inhibitory effects imposed by the glia scar, by enzymatically degrading the 
axon-inhibitory chondrotin sulphate proteoglycans (David and Lacroix, 2003). 
Chapter 1: Recovery of function following spinal cord injury in primates                            14             
The failure of axonal regeneration is largely attributable to growth inhibitors 
expressed in myelin by oligodendrocytes (Fig. 2), a cell type only found in the 
white matter (Caroni et al., 1988). Numerous myelin associated proteins have 
been found that exert inhibitory properties on neurite outgrowth (Fig. 3). These 
proteins include Nogo-A (Chen et al., 2000; Schwab and Bartholdi, 1996), 
MAG and OMgp (Filbin, 2003). 
Nogo-A was found to be the most expressed inhibitory protein and represent 
an important factor in the restriction of neurite growth after injury. The 
application of the monoclonal antibody IN-1 (mAb IN-1), which was raised 
against a protein later identified as Nogo-A, allowed long distance growth of 
axons and compensatory fiber growth in vitro and in vivo (Caroni and others, 
1988; Schnell and Schwab, 1990). Interestingly, these new grown fibers seem 
to establish functionally meaningful connections with adequate targets. 
Thereafter, several studies have shown that this morphological reorganization 
after SCI is paralleled by motor recovery of skilled forelimb movements and 
locomotion in rats and mice in absence of malfunction, such as neuropathic 
pain (Bradbury et al., 2002; Bregman et al., 1995; Li and Strittmatter, 2003). 
Therefore, the neutralization of endogenous nerve growth inhibitors 
represents a promising approach for therapeutic application to repair the CNS 
in humans. In order to translate these advances the use of the non-human 
primate model is essential (Courtine et al., 2007). In accordance with this 
idea, the aims of this study were to investigate the anatomical fibre plasticity 
and functional recovery in control and in anti-Nogo-A antibody treated 
macaques subjected to a partial cervical spinal cord lesion. 
 
In the following sections of this chapter the main characteristics of Nogo-A 
and its implication in the repair of spinal cord lesion and functional recovery 
will be outlined. Special attention will be paid to the implication of the 
corticospinal tract in and its contribution to functional recovery. 
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Figure 2 Inhibition of axon regeneration. A) Myelin-associated inhibitors, such as Nogo, are 
found on the inner and outer myelin leaflets and may normally prevent axonal sprouting in the 
uninjured CNS. B) After injury, damaged myelin and oligodendrocytes contribute to the 
prevention of regeneration (Goldberg and Barres, 2000). 
 
 
2.1 Axonal growth inhibition and its implication in spinal cord 
repair 
2.1.1 Modulation of interactions with the myelin inhibitor Nogo-A 
 
The Nogo protein is a member of the Reticulon family which comprises 
proteins that are usually associated with the endoplasmatic reticulum (ER). 
The Nogo gene is differentially spliced to generate three isoforms each having 
different N-termini which result into: Nogo-A, Nogo -B and Nogo-C (Chen et 
al., 2000) (Fig. 3). Nogo-A, the largest form, is predominantly expressed in the 
CNS; Nogo-B is a minor isoform and concentrated in the ER of endothelial 
cells; Nogo-C is enriched in the periphery, especially in skeletal muscle 
(Huber et al., 2002). The biological function of Nogo B and C are currently 
unknown. Nogo-A though, has been identified as a protein which exerts a 
strong inhibitory action on neurite outgrowth. It is localized on the surface of 
oligodendrocytes (Chen and others, 2000) and into the inner and outer loops 
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of myelin (Huber et al., 2002). Its topology, predicted from amino acid 
composition and immunohistochemistry, showed that all the three main 
products of the gene encoding Nogo have 188 amino acids at their carboxy 
terminus in common. It is this specific amino acid chain which is in common 
with the Reticulon protein family (Chen and others, 2000; Fournier et al., 
2001; GrandPré et al., 2000; Oertle et al., 2003). 
 
 
 
Figure 3  Structures of three inhibitors of axonal regeneration identified in myelin; 
Nogo exists in three isoforms A, B and C. Their hypothesized topologies are shown 
here. Sequences that are common to all three isoforms are shown in blue and green 
(Filbin, 2003). 
 
 
Three different extracellular exposed peptide chains are involved in the 
process of inhibition. In particular, the N-terminal region of Nogo-A inhibits 
strongly the neurite outgrowth whereas the C-terminal region (Nogo 66) and a 
stretch encoded by the Nogo-A-specific exon leads to growth cone collapse. 
In addition the latter is capable of restricting neurite outgrowth and cell 
spreading. Besides, the N-terminal and C-terminal domains are likely to be 
located on the cytoplasmic side (Oertle and others, 2003). These different 
inhibitory action sites might satisfy the need of a developing neuron to get to 
its correct place (i.e. Nogo-66) and/or restrict its plasticity and regeneration 
(i.e. Nogo-A) by using its different binding sites to the receptors. 
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In what ways Nogo acts on the neuron is not yet fully understood, though 
some functionality has been discovered. A protein which binds to the 
extracellular domain of the Nogo protein (Nogo-66) (Fig. 4) was identified 
(GrandPré and others, 2000). Nogo-66 is common to Nogo-A, -B, -C and 
leads to growth cone collapse when a connection between the two molecules 
is established, hence proving that the protein recognizes a Nogo-66 receptor 
(NgR) (Fournier and others, 2001). 
The Nogo receptor is predominantly expressed in the CNS in neurons and 
their axons (Josephson et al., 2001; Wang et al., 2002) and is attached to the 
outer leaflet of the plasma membrane by a glycosylphosphatidylinositol 
moiety, implying a need for further subunits to efficiently transfer the 
information to the intercellular space (Fig. 3) (McGee and Strittmatter, 2003). 
The Nogo-NgR complex needs to associate with the neutrophin coreceptors 
p75 (Wang et al. 2002) and Lingo-1, a nervous-system specific Nogo receptor 
interacting protein (Mi et al., 2004), to transduce the signal across the plasma 
membrane. This then triggers the activation of RHoA GTPase downstream of 
NgR and thus controls axon growth and extension during development and 
after injury (Niederöst et al., 2002). 
However, that NgR is not the only crucial receptor which is active during the 
signaling process received potential evidence through the findings that cross 
talk between pathways involved in neurotrophin signalling and signalling by 
axon growth inhibitors does exist.  The N-terminal region of Nogo-A (amino-
Nogo), for example, can inhibit neurite outgrowth independent of NgR via an 
unknown receptor (He et al. 2004). Furthermore, at least two other inhibitory 
components of myelin, though with a less inhibitory activity, have been found 
binding to the same NgR as Nogo-66, i.e. the myelin-associated glycoprotein 
(MAG) and the oligodendrocyte-myelin glycoprotein (OMgp) (Filbin, 2003). 
MAG is found in both the CNS and the PNS, where it is located in the 
periaxonal membrane, and is therefore ideally placed to interact with an 
axonal receptor (i.e. NgR) (Filbin, 2003). OMgp is a relatively minor 
component of myelin, and it is believed to be localized largely in the paranodal 
loops, next to the node of Ranvier (Wang et al 2002). Like MAG and Nogo, 
OMgp induces growth cone collapse and inhibits neurite outgrowth when it 
binds to NgR (Niederöst and others, 2002). 
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Figure 4 : A schematic representation of known myelin-associated inhibitors and their 
receptor complexes. Three major myelin inhibitors, including the extracellular domain of 
Nogo-A (Nogo-66), MAG, and OMgp, all bind to NgR with high affinity. This complex in 
turn associates with coreceptors as p75 to transduce the signal across the plasma 
membrane. In addition, the N-terminal region of Nogo-A (amino-Nogo) can inhibit neurite 
outgrowth independently of NgR. It seems that the different activation pathways all 
converge onto the ROCK cascade inside the neuron, leading to an inhibition of neurite 
growth (Woolf and Bloechlinger, 2002). 
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2.1.2 Neutralizing Nogo-A enhances axonal sprouting and 
functional recovery in rodents 
 
The IN-1 monoclonal antibody (mAb IN-1)(Caroni and others, 1988) which is 
an IgM that recognizes the region specific to Nogo A (Brösamle et al., 2000; 
Brösamle et al., 2000; Brösamle et al., 2000) neutralizes the action of Nogo-A 
in vivo. 
To investigate plasticity and compensatory fiber growth after SCI, the 
corticospinal tract (CST) was sectioned unilaterally at the level of the pyramids 
in adult rats. Control or anti-Nogo-A producing hybridoma cells were 
implanted in the hippocampus. In control treated animals sprouting was 
minimal within the spinal cord, the red nucleus and pontine nuclei. In contrast, 
in anti-Nogo-A treated rats sprouting of cortico-bulbar fibers and 
establishment of cortico-rubral and cortico-pontine connections occurred. In 
addition, the uninjured CST sprouted across the midline and branched into the 
denervated dorsal and ventral part of the spinal cord along the entire spinal 
cord (Thallmair et al., 1998). Anti-Nogo-A treated rats showed almost full 
recovery for sensory and a motor task demanding skilled forelimb reaching 
(Z'Graggen et al., 1998). 
The bilateral interruption of the CS connections at the level of the pyramids 
can be compensated by corticorubral and rubrospinal sprouts of these 
pathways. It was observed that following lesion, sprouts grew into the ventral 
grey matter of the cervical cord where they made close apposition to 
motoneurons of forelimb muscles (Raineteau et al., 2002) (Fig. 5). 
Interestingly, in intact animals the rubrospinal tract does not project directly to 
this region (Raineteau et al., 2001). In the anti-Nogo-A treated rats, fast 
muscle EMG responses were evoked following cortical microstimulation. 
However, these responses were abolished after injection of mucimol, a GABA 
antagonist, into the red nucleus, showing the presence of new cortico-rubro-
spinal pathways in anti-Nogo-A antibody treated rats (Raineteau et al., 2002). 
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Figure 4: Photomicrographs depicting the penetration of BDA-labeled rubrospinal 
tract sprouts in the ventral horn of the spinal cord in rats treated with the IN-1 
antibody. Panel A shows axon sprouts at C6 level and in panel B at C7 level 
(Raineteau et al., 2002). 
 
It has been reported that, in adult rats, subjected to lesion of the dorsal 
column of the spinal cord, improved functional recovery occurred in anti-Nogo-
A treated animals (Bregman and others, 1995). In this lesion paradigm, 
control or anti-Nogo-A producing hybridoma cells were implanted in the 
proximity of the ventricular system allowing the antibodies to penetrate along 
the entire CNS. Sprouting and regeneration of CST axons paralleled 
functional recovery. The behavioral findings were confirmed by 
electromyographic examinations (Raineteau et al., 2002). Muscle EMG 
activity was measured in control and anti-Nogo-A treated animals during 
treadmill walking of flexor and extensor muscles. In contrast to control 
animals, in anti-Nogo-A treated animals these EMG recordings confirmed the 
improved step-cycle duration, rhythmicity, and coupling of the hindlimbs (Fig. 
6).  
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Figure 6: Muscle EMG activity recorded in SCI rats during treadmill walking. In the 
top panel a control animal clearly shows an abnormal stepping pattern, whereas the 
pattern of an anti-Nogo-A treated animal is close to normal (Fouad et al., 2001). 
 
The above outlined results indicate a clearly improved functional recovery 
suggesting that the increased plastic and regenerative capabilities of the CNS 
after Nogo-A neutralization result in a functionally meaningful rewiring of the 
motor systems.  
In a further step towards the clinic the mAb IN-1 was partially humanized by 
replacing the murine constant domains with human domains, in order to make 
it more accessible to the human immune system (Brösamle et al., 2000). 
Indeed, this recombinant Fab fragment (rIN-Fab) itself was again able to 
stimulate injured adult rat axons to regenerate over long distance in the spinal 
cord as represented schematically in Fig. 7 
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Figure 7:  Longitudinal sagittal view 
of a rat or mouse dorsal spinal cord 
lesion, transecting the main 
corticospinal tract which shows 
minor spontaneous sprouting 
(black). Nogo-A neutralizing 
antibodies can lead to enhanced 
sprouting of fibers rostral to the 
lesion and to fibres crossing the lesion on remaining tissue bridges into the caudal 
spinal cord and growing down the spinal cord over long distances (drawn in red). 
Spared fibres also show enhanced sprouting in the caudal spinal cord (Schwab, 
2004).  
 
2.1.3  Proof of principle-way to the clinic 
 
Nogo-A is present in humans (Prinjha et al., 2000; Spillmann et al., 1997), 
making its inactivation a possible treatment for SCI patients. Before the 
translation of this technique to humans, an important step is to establish how 
the antibody should be delivered and to show its efficacy in primates. In 
humans to allow a controlled application over weeks, the antibody will be 
applied using implanted pumps. Infusion of antibodies via osmotic minipumps 
proved to be an efficient way to apply antibodies to the CNS of both rat and 
monkeys. Indeed it was shown that in these species the antibody reached its 
antigen via diffusion in the CSF or inside the CNS tissue and was able to 
downregulate Nogo-A expression (Weinmann et al., 2006). Whether the 
application of the anti-Nogo-A antibody onto humans increases plasticity and 
regenerative growth remains unknown. However, application of Nogo-A 
antibodies in the marmoset subjected to spinal injury confirmed that sprouting 
occurred into, through and around the lesion in a primate (Fouad et al., 2004). 
However, the latter study did not address the questions of functional recovery 
and negative side effects, such as allodynia, through aberrant sprouting. We 
investigated these questions in the macaque monkey subjected to unilateral 
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cervical lesion by evaluating their hand and leg function and their recovery 
when Nogo-A is neutralized. 
Why use the non-human primate model? In a recent discussion examining 
whether the non-human primates can expedite the translation of treatments 
for spinal cord injury in humans it was concluded that this animal model can 
probe the effect of therapy-induced neural plasticity on various aspects of 
functional recovery with a precision which cannot be achieved in rodents 
(Courtine et al., 2007). Three major points justify this conclusion: 
First, the general organisation of the CS system in monkeys is very much like 
that in human subjects, in contrast to the rat. Whereas the CST tract in rats 
run in the dorsal columns without making direct corticomotoneural connection, 
in the primate as in humans, the main crossed part of the CST tract runs in 
the dorsolateral funiculus and the uncrossed part run either in the dorsolateral 
or anterior ventral funiculus on the contralateral side. 
Second, the CS projection system is involved, as far as the forelimb is 
concerned, in sophisticated dexterous movements typical of primates 
(Lawrence and Hopkins, 1976; Lemon, 1993; Porter et al., 1985; Porter, 
1987). Along this line, behavioural assessment of manual dexterity is more 
pertinent in monkeys than in rodents, the formers being capable of 
fractionated dexterous movements of the fingers as human subjects. Third, 
neutralization of Nogo-A may not only favour regeneration or sprouting of 
lesioned axons, but may also induce an unspecific growth of axons which may 
cause undesired pathologies, such as allodynia.   
 
 
2.2 Investigating regeneration and functional recovery in 
non-human primate 
 
Proving the efficacy and safety of a treatment in the non-human primate 
provides strong support for the translation of this treatment to the clinics 
(Courtine et al., 2007). Investigations have already been conducted to 
establish whether an anti-Nogo-A antibody treatment induces regeneration. 
To study the action of a regenerative treatment on the level of functional 
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recovery in the non-human primate, we have chosen to perform a unilateral 
partial section of the spinal cord at the border between the C7 and C8 spinal 
segments. The reasons accounting for this choice and some of the 
consequences expected from this lesion with their characteristics are 
presented below. 
 
 
2.2.1 : Lesion level 
 
The distribution of spinal motoneurons is topographically organized. At a 
segmental level, the motoneurons innervating the axial muscles lie most 
medially in the grey matter of the spinal cord, whereas those innervating the 
most distal muscles in the limbs are found most laterally in the ventral horn. 
From an anatomical point of view these latter motoneurons are located most 
closely to the lateral corticospinal tract and receive the highest density of CS 
projections (Holstege, 1991; Ralston and Ralston, 1985).  
Along the neuroaxis, motoneurons innervating a specific muscle are grouped 
in close proximity to each others. Jenny and Inukai (1983) determined the 
topographic organization of these motoneurons pools for the segments 
involved in controlling arm, wrist, and hand (finger) movement (Jenny and 
Inukai, 1983). As illustrated in Fig. 7, each single motoneurons pool spreads 
over two or more segments. The motoneurons projecting to hand muscles are 
located in the spinal segments C8 to Th 2, whereas the cervical segments C5 
and C7 contain motoneurons controlling forearm muscles as well as biceps 
and triceps. 
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Figure 7: Segmental distribution of motoneurons innervating selected muscles of the 
macaque monkey forelimb expressed as the number of retrogradly labeled 
motoneurons after HRP injections in the forelimb muscles. In addition the regions 
affected following a hemi-section lesion between the spinal cord segments C7/C8 as 
done in the present thesis work, are marked blue; the motoneurons not affected are 
shown in yellow (Jenny and Inukai, 1983) 
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2.3 Functional consequences of a spinal cord injury in 
primates 
 
2.3.1  Anatomy of the corticospinal tract and its contribution to 
voluntary movement  
 
The capacity to perform a precise opposition of the thumb and the forefingers 
and independent movements of the fingers depends on the CS system 
integrity, especially on the direct monosynaptic input from primary motor 
cortical areas to motoneurons in the cervical spinal cord, the so called 
corticomotorneural (CM) system (Kuypers, 1981; Lemon, 1993; Phillips, 
1971). CS projections arise from spatially discrete and somatopically 
organized cortical regions (Fig 8). For example, the macaque monkey 
possesses at least six CS neural subpopulations located within the frontal, 
cingulate, parietal and insular cortices (Galea and Darian-Smith, 1994; Galea 
and Darian-Smith, 1995; Kuypers, 1981). 
 
 
Figure 8: The organization of the motor cortical areas in the macaque monkey and the 
qualitative distribution of corticospinal (CS) neurons. Fifty percent of the CS neurons of the 
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frontal lobe are in M1, whereas the other 50% are distributed in the other three motor 
regions (Premotor Area (PM), Supplementary Motor Area (SMA), Cingulate Motor Area 
(CMA)). 
 
Inside these cortical motor areas CS neurons are situated in the deepest part 
of lamina V (Asanuma, 1981; Humphrey and Corrie, 1978; Porter, 1981). The 
majority (about 90%) of the CS fibres decussate and project contralaterally 
(Kuypers, 1981; (Holstege, 1991). Together with other corticofugal fibres they 
project via the internal capsule into the ipsilateral cerebral peduncle. From 
there the largest part of the fibres emerges from the cerebral peduncle and 
continues caudally along the ventral surface of the medulla oblongata towards 
the pyramidal decussation point at the caudal end of the brainstem. After 
decussating they continue on the contralateral side of the spinal white matter 
as the ‘lateral corticospinal tract’ representing 90-95 percent of all descending 
fibers (Lacroix et al., 2004; Rouiller et al., 1996)(Fig. 9, 10). The other 10 
percent emerge in the same manner, but either enter the ‘medial (anterior) 
corticospinal tract ’ by descending ipsilateral, hence not crossing the sides at 
the level of the medulla oblongata, or by descending first and then crossing 
the dorsolateral funiculus at lower spinal segments (Galea and Darian-Smith, 
1997; Kuypers, 1981; Phillips, 1979).  
 
 
Figure 9 : After unilateral injection of the 
anterograde tracer BDA into the hand 
representing area of M1 the CST is labeled 
within the spinal cord. Here at C5 level, on 
a frontal section of the cervical cord, black 
dots indicate the location and distribution of 
the CS axons, forming the dorsolateral 
funiculus (dlf) contralateral to the injection 
site (left half of the cord) and the uncrossed 
CS axons, present in the dorsolateral and 
ventral funiculi ipsilateral to the injection 
site (right side of the cord). 
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Figure 10: Schematic illustration of the main component of the CST. The origin of 
the control of voluntary movements mainly mediated by direct CM connections. The 
green line represents the crossed corticospinal pathway throughout its course from 
its cortical origin till the lateral intermediate zone and lateral motor nuclei.  
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At their level of termination, axons of the CST leave the dorsolateral funiculus 
and establish connections with spinal motoneurons. In primates, a portion of 
these fibers make direct contact with motoneurons. Other fibers leave the CS 
tract as early as in the pyramids or even rostral to it to innervate the cranial 
nerve motor nuclei or other brain stem nuclei. These fibers are known as the 
corticobulbar tract (Holstege, 1991; Kuypers, 1981). 
Most CS fibres are myelinated (Ralston and Ralston, 1985). In total the CST 
tract consists of approximately one million nerve fibres in humans and of 
about four-hundred thousand in the macaque monkey.  
CS fibers project to all of the spinal segments and some have a distinct 
termination pattern onto motoneurons. In macaque monkeys, the CST 
terminates most heavily in the medial part of Rexed lamina VI of the spinal 
grey matter where interneurons of various types are located (Fig.11) (Armand 
et al., 1997; Kuypers, 1981; Peschanski and Ralston, 1985). 
Figure 11 : Photomicrographs taken at cervical level C7 and Th1 from a macaque 
monkey illustrating the projections patterns of the CST from M1 WGA-HRP injections. At 
both levels the CST terminates mainly within the intermediate layer of the spinal gray. 
However within the hand motor nuclei the density of labeled fibers arising from SMA was 
much lower than the density of labeled fibers arising from M1 (Dum and Strick, 1996). 
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As a result of selectively sectioning the CST at the level of the pyramids in the  
nonhuman primate is the permanent deterioration in the ability to make fine 
finger, independent movement of the digits (Tower, 1940); the loss of 
contractual hand orientation (Denny-Brown, 1966) and the degree of recovery 
depending on several factors such as lesion size and age of the animal 
(Hepp-Reymond, 1988). These severe disturbances in monkeys following 
pyramidotomy probably reflect the increased importance of the direct cortico-
motoneural connections for individual digit control. The observation that digital 
control is impaired also in the animals such as the cat, rat and hamster in 
which CM connections are few or absent, allows to suggest that the effects 
seen in the primate do not involve the CM projections alone. 
The medial termination pattern onto interneurons as seen in Fig 11 
emphasizes the importance of indirect control which parallels the direct CM 
connections. The importance of indirect motor control can be illustrated in the 
cat having no direct CM projections. In this species a system has been 
described of short propriospinal neurons located in the cervical spinal cord. 
These interneurons project monosynsaptically to the motoneurons in the 
forelimb segments and receive convergent inputs from the cortico-, rubro-, 
reticulo- and tectospinal descending pathways, as well as afferent input from 
forelimb nerves. At least in the cat, this propriospinal systems stands as an 
integrator between cortex and the motoneurons for cortical motor command 
(Alstermark and Ohlson, 2000; Illert et al., 1977). Similar experiments carried 
out from two different groups in macaque monkeys showed that if 
propriospinal neurons similar to those in the cat are present in the macaque 
monkey, the contribution of this system to the normal control of the forelimb is 
questionable (Lemon et al., 2004; Maier et al., 1998; Maier et al., 2002). In a 
recent review it has been pointed out that these pathways could gain 
importance as soon as other systems fail to transfer the cortical information 
such following an incomplete SCI (Jankowska and Edgley, 2006). 
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2.3.2 The rubrospinal tract  
 
The mammalian red nucleus (RN) processes sensorimotor information from 
the frontoparietal cortex and the cerebellar cortex. It transmits the transformed 
signals back to the cerebellum through the rubroolivary projection and to the 
spinal cord through the rubrospinal (RS) neurons. In the macaque these two 
efferent pathways originate from cytoarchitecturally distinct areas, a 
parvocellular part (RNp) located in the rostral part of the nucleus and a 
magnocellular part (RNm) located caudally.  
The RS pathway is a crossed pathway and sends direct fibres, mainly within 
the dorsolateral funiculus towards motoneuron cell groups in the ventral horn 
of the cervical enlargement of the spinal cord (Fig. 12). The RS fibers are 
about a 100 x less numerous than the corticospinal fibres in nonhuman 
primates (Holstege et al., 1988; Ralston et al., 1988). Functionally, the RS 
tract is implicated in control of hand movements in parallel to the CS tract, in 
particular during coordinated, whole limb movements.  
The lower number of RS fibers compared to CS fibers (100 x less) may be the 
main reason why the rubrospinal system in monkeys cannot completely 
compensate for the loss of direct cortical control on the distal musculature. 
Indeed, in macaque monkeys subjected to pyramidotomy, a specific lesion of 
the CS system which spares the rubrospinal pathway a drastic loss of 
dexterity on the side of the lesion is the consequence. The major difference 
compared with a hemisection, which destroys the corticospinal and 
rubrospinal pathways, is the fact that a more rapid recovery of hand function 
follows.  
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Figure 12: The injection of three different retrograde tracers within the spinal cord of 
macaque monkeys revealed the distribution of neurons retrograde stained in the RN. 
The amount of labeled neurons differed within the main two part of the RN: The pars 
magnocellularis RNm received most whereas very few in the pars parvocellularis 
RNp (Burman et al., 2000; Burman et al., 2000). 
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2.3.3 Effects of lesions to the corticospinal system 
 
Following spinal cord injury, transected axons of the adult mammalian central 
nervous system (CNS) fail to re-grow. Immediately after onset of injury, a 
series of structural changes proximal and distal to the point of transection 
occurs. Whereas the distal stump of the axon degenerates, corresponding to 
the so-called Wallerian degeneration, the proximal stump of the axon dies 
back (i.e. retracts) on a distance of several hundreds microns, as observed 
for instance in the corticospinal tract of mice (Kerschensteiner et al., 2005). A 
typical feature of the transected axonal stumps proximal to lesion is the 
formation of a terminal retraction bulb (Kao et al., 1977). Two opposing 
forces, acting simultaneously, may account for the formation of retraction 
terminal bulbs: 1) the pressure of the axoplasmic flow towards the cut ends of 
the transected axons and 2) interferences of structural changes within the 
axon and myelin sheaths (Kao et al., 1977). Once a terminal retraction bulb is 
formed, the axon becomes stabilized and ceases to retract but fails to re-grow 
(Kalil and Schneider, 1975). 
Up to present the question whether axotomized neurons die is a matter of 
debate. Some studies targeting the corticospinal (CS) tract following 
pyramidotomy or spinal cord lesion, revealed a significant loss of corticospinal 
neurons (Holmes and May, 1909; Levin and Bradford, 1938; Pernet and 
Hepp-Reymond, 1975), whereas other studies concluded that most CS 
neurons survived (Tower 1940). In a recent study in monkeys based on a 
specific marker of pyramidal neurons (SMI-32, including the CS neurons), 
after hemi-section of the cervical cord, there was evidence for a survival of the 
axotomized CS neurons, but their soma shrank as compared to the population 
of intact CS neurons in the opposite hemisphere (Wannier et al., 2005).  
Lesions to the CST either at the pyramids or at cervical level lead to 
behavioral deficits in the non-human primate. However, a major difference 
between these two approaches to lesion the CST tract has to be kept in mind: 
a pyramidotomy interrupts selectively the CST whereas a cervical lesion 
represents a more complex injury situation. A cervical section impacts on both 
descending and ascending projections, such as it affects the crossed CS 
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projections from the opposite motor cortex and the uncrossed CS projections 
from the ipsilateral motor cortex, as well as other descending tracts like the 
rubrospinal and the reticulospinal tracts. All ascending sensory information 
and the propriospinal system are affected as well, though not the uncrossed 
CS axons coming from the contralesional motor cortex. 
The behavioral consequences following bilateral pyramidotomy are a loss of 
posture and limb movements which after 6-8 months post injury return to 
normal. However, control over independent finger movements is only little 
recovered (Fig. 11) (Hepp-Reymond and Wiesendanger 72). Animals with 
unilateral pyramidal lesions show no impairment of the hand contralateral to 
the lesion, while the ipsilateral hand exhibited an improved recovery than 
monkeys subjected to bilateral pyramidal lesions (Lawrence and Kuypers, 
1968). These results led to the conclusion that CM connections to the cervical 
cord are responsible for the control of voluntary movements. 
Following a unilateral lesion of the midcervical cord interrupting the 
dorsolateral funiculus, lateral and ventral columns, macaque monkeys recover 
rapidly their ability to use their hand successfully during a prehension task 
demanding a precision grip. The degree of recovery of manual dexterity 
depends on lesion level and lesion size (Freund et al., 2006; Galea and 
Darian-Smith, 1994; Galea and Darian-Smith, 1995). In contrast to the 
bilateral pyramidotomy a hemisection spares the undecussated descending 
CST fibers which constitute up to 10% of the total amount of CS axons 
(Rouiller et al., 1996). Recently it has been proposed that these spared fibers 
may be responsible for the marked recovery of manual dexterity (Jankowska 
and Edgley, 2006). 
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Figure 13: On the left: Macaque monkey applying the precision grip, the opposition 
between the tip of the index finger and the tip of the thumb. This has been an object 
for investigating the independent control of finger movement and the ones of the 
upper limbs. On the right: Immediately following a section of the corticospinal tract the 
monkey has lost its capacity of independent finger movement and the skill of exerting 
the precision grip. Instead it can only remove food from the slot by grabbing with the 
whole hand (power grip).  
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2.4 Aims of the present thesis 
 
The aim of this thesis was to prove the principle whether the anti-Nogo-A 
antibody treatment strategy leads to axonal regeneration and functional 
recovery in non-human adult primates subjected to a partial section of the 
spinal cord.  
In particular, to asses the behavioral evolution of the anti-Nogo-A antibody 
treatment the following questions were addressed: 
 
1) Does the anti-Nogo-A antibody treatment lead to enhanced recovery of 
manual dexterity as assessed by using a battery of tasks demanding 
the execution of the precision grip and other movements such as a 
ballistic arm movement and hindlimb grasping? 
 
2) Does the infusion of the antibody over a period of four weeks trigger 
inflammatory responses? 
 
3) Does the anti-Nogo-A antibody treatment induce chaotic sprouting 
leading to negative side effects, such as allodynia? 
 
The anterograde labeling of CS axons originating from the contralesional 
hemisphere, allowed us to address the following issues: 
 
4) Does the proximal part of the axotomized CS axons retract from the 
lesion? If yes, in what proportion of CS axotomized axons does such a 
retraction occur and what is the distance of retraction?  
 
5) Does anti-Nogo-A antibody treatment prevent such retraction of CS 
axons? 
 
6) Do some axotomized CS axons attempt to re-approach and eventually 
enter the lesion? If yes, does the anti-Nogo-A antibody treatment make 
such attempts more successful? 
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7) Above the cervical lesion, do the axotomized CS axons sprout, giving 
rise to collaterals medially into the grey matter? 
 
8) Do axotomized CS axons grow around the injury on spared tissue 
bridges to re-innervate the denervated zone caudal to the lesion? 
 
9) Do axotomized CS and RS neurons die or atrophy? If so, can this be 
prevented when Nogo-A is neutralized? 
 
 
 
Chapter 1: Recovery of function following spinal cord injury in primates                            38             
 
3 Material and Methods  
 
Overview of the experimental protocol 
 
The experimental events from the point of time when the monkey was 
habituated to enter the primate chair/cage to the time of sacrifice, ranged 
between eight up to twenty months. Detailed information concerning the 
individual steps is provided in the Material and Method section of the chapters 
2, 3, 4, 5 and 6.  
In short 16 young adult macaque monkeys (Macaca mulatta and fascicularis; 
3.5 to 6.9 years at sacrifice), of either sex were used for these experiments. 
Retention and experimental protocol were in accordance with the Swiss 
federal rules for animal protection and controlled by the local veterinary 
authorities. During the first couple of weeks the monkeys were habituated to 
the animal housekeeping environment and to their room-mates. Usually four 
monkeys of one sex were housed in a detention room of 13 m³ (245cm x 
220cm x 240cm) in size. The retention room contained two smaller cages into 
which the monkeys were transferred by the animal room keepers at 7 am 
during weekdays. Once habituated to their new environment, the monkeys 
were trained for a subsequent transfer into a primate chair or cage. This 
usually took two to four weeks. In the further course, the monkeys were then 
brought into the laboratories in which they were presented with a set of 
behavioural tasks. At the beginning all monkeys were habituated to perform a 
unimanual dexterity task the so-called “modified Brinkman board test”, with 
each of the two hands. Monkeys were trained on a five day per week basis 
during 14-60 days. Then other tests assessing additional aspects of the 
manual dexterity (e.g. a test where the position of the hand during the 
prehension task had to be dynamically controlled, the capacity to perform 
rapid catching movements or the ability to grasp using the hindlimbs) were 
introduced selectively to several monkeys (see Chapters 2 and  4 ). Scoring 
started after the monkeys were habituated to all tests. At least 20-40 sessions 
were taken to establish the level of the pre-lesion baseline.  
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Then, a unilateral cervical spinal cord section was introduced under aseptic 
conditions in the fully anesthetized animal between the 7th and 8th cervical 
spinal cord segments. Immediately following the transsection, an osmotic 
pump containing either a control antibody or an anti-Nogo-A antibody was 
placed under the skin and delivered, via a catheter ending intrathecally a few 
millimeters above the lesion, the antibody during a period of four weeks. 
Following surgery the monkeys were placed separately in a cage to allow 
better conditions for recovery than in the usual group housing with other 
monkeys. After 30 to 60 minutes the monkeys woke up and were rapidly able 
to sit upright in the cage despite their paresis on the ipsilesional side. During 
the next 2-5 days the monkeys regained their mobility to such extent that they 
were again placed together with the other monkeys. Post-lesion data 
acquisition started at the same time and depending on the lesion size the 
monkeys started to recover their manual dexterity within the first four weeks. 
Generally the time course of recovery for the individual monkeys overlapped, 
reaching stable level of performance at 60 to 80 days. When the acquisition of 
behavioral data was finished, biotinylated dextran amine (BDA), an 
anterograde tracer, was injected in the contralesional motor cortex under 
aseptic conditions in the fully anesthetized animal. Another tracer (Dextran 
Fluresocein) was injected into the ipsilesional motor cortex. A survival period 
of approximately 60-80 days was used to allow optimal labeling of the 
descending corticospinal tract within the spinal cord.  
At the end of the survival period, the animals were sacrificed by a lethal 
injection of pentobarbital and perfused transcardiacally. The perfusion was 
continued with 4% paraformaldehyde solution in phosphate buffer and then 
with solutions of the same fixative containing increasing concentrations of 
sucrose. The brain and spinal cord were dissected and placed in a 30% 
solution of sucrose for cryoprotection for a few days. Frozen sections (50 µm 
thick) of the brain were cut in the frontal plane whereas frozen sections (50 
µm thick) of the cervical cord (approximately the segments C6-Th2) were cut 
in the parasagittal longitudinal plane and collected in three series for later 
histological processing. Additional material originating from segments placed 
just rostral and caudal to this tissue were cut in the frontal plane at 50 µm 
thick and collected in three series. BDA and Dextran-Fluorescein staining was 
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revealed in two series of spinal cord sections. The third series of spinal cord 
sections were immunohistochemically processed using the marker SMI-32, an 
antibody recognizing a non-phosphorylated form of neurofilaments. 
The lesion site was reconstructed from camera lucida drawings of individual 
consecutive SMI-32 labeled or BDA stained sections of the cervical cord. An 
alignment of the drawings allowed reconstruction of the location and extent of 
the lesion on a frontal view of the cord. 
Morphometrical analysis was conducted using Neurolucida® software. BDA 
labeled sections of the cervical cord were analyzed for regenerative sprouting 
and the neurons of the primary motor cortex (M1) and of the magnocellular 
part of the red nucleus were analyzed for soma surface area using the SMI-32 
stained brain tissue. 
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1.1 Abstract 
 
In rodents, after spinal lesion, neutralizing the neurite growth inhibitor Nogo-A 
promotes axonal sprouting and functional recovery. To evaluate this treatment in 
primates, twelve monkeys were subjected to cervical lesion. Manual dexterity 
recovery and corticospinal axonal sprouting were enhanced in anti-Nogo-A 
antibody treated monkeys as compared to control-antibody treated monkeys. 
 
1.2 Introduct ion 
Following injury, the adult mammalian central nervous system has limited 
capacity to repair. Transected nerve fibers do not spontaneously re-grow, due in 
part to myelin-associated neurite growth inhibitors such as Nogo-A(Oertle et al., 
2003; Liebscher et al., 2005). After section of the corticospinal (CS) tract in adult 
rats, neutralizing Nogo-A with monoclonal antibodies leads to enhancement of 
axonal re-growth and compensatory sprouting, accompanied by increased motor 
recovery (Oertle and others, 2003; Schmidlin et al., 2004; Weinmann et al., 
2006). The neutralization of Nogo-A represents a promising approach for therapy 
after lesion if its enhancement of functional recovery can be transposed to 
primates. First, the general organization of the CS system is similar in monkeys 
and humans, in contrast to the rat (Liu and Rouiller, 1999). Second, the CS 
system is involved, as far as the hands are concerned, in dexterous movements 
typical of primates (Kazennikov et al., 1994; Rouiller et al., 1996; Kazennikov et 
al., 1998). Behavioral assessment of manual dexterity is more pertinent in 
monkeys than rodents, the former being capable of fractionated dexterous 
movements of the fingers as humans. Third, neutralization of Nogo-A may not 
only favor sprouting of lesioned axons, but may induce unspecific growth of 
axons, causing undesired pathologies. The monkey model offers more 
possibilities than rodents to detect such changes of behavior. 
Neutralization of Nogo-A was found to promote CS axonal sprouting in 
marmosets (Kermadi et al., 2000). 
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The aim of our study was to extend these anatomical data to macaque 
monkeys and assess whether neutralization of Nogo-A enhances motor recovery 
from spinal lesion in primates. 
 
 
1.3 M aterial and Methods 
 
Anti-Nogo-A antibodies 
Two monoclonal antibodies (mAbs) against different sites of Nogo-A were 
used: the mouse mAb 11C7 (Liebscher,T. et al., 2005) was raised against a 18 
amino acid peptide of rat Nogo-A (aa623 – 640), close to the most inhibitory 
region of the Nogo-A protein (Oertle,T. et al. , 2003), which cross-reacts with 
mouse and monkey Nogo-A. The second antibody used, mAb hNogo-A  is 
directed against the Nogo-A specific region of the human Nogo-A sequence. 
Both antibodies recognize primate Nogo-A monospecifically on Western blots 
(Oertle,T. et al. , 2003). Both antibodies increase neurite outgrowth in vitro and 
penetrate deeply the CNS in vivo in monkeys (Weinmann,O. et al. , 2006). The 
antibodies were purified as IgGs and concentrated to 3.7-10 mg/ml in phosphate 
buffered saline (PBS). 
 
Control antibodies 
Purified IgG of a mouse mAb directed against wheat auxin (AMS 
Biotechnology, Oxon/UK) was used as control antibody. 
 
Behavioral testing 
The experiments were carried out on twelve (3-4 years old) rhesus (Macaca 
mulatta) or cynomolgus (Macaca fascicularis ) monkeys of either sex (Table 1), 
ranging from 2.5 to 5.5 kg, in accordance to the Guide for the Care and Use of 
Laboratory Animals (ISBN 0-309-05377-3; 1996) and approved by local (Swiss) 
veterinary authorities. Monkeys were housed in our animal facilities in rooms of 
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12 m3, each containing usually 4 monkeys free to move in the room and to 
interact among each others. In the morning (7 am), before behavioral testing, the 
animal keeper placed the monkeys in temporary cages for subsequent transfer to 
the primate chair by the experimenter. The monkeys had free access to water 
and were not food deprived. The rewards obtained during the behavioral tests 
represented the first daily access to food. After the tests, the monkeys received 
additional food (fruits, cereals). To reduce inter-animal variability, "pairs" of two 
monkeys were formed, placed under the responsibility of the same experimenter, 
and were subjected simultaneously to the same experimental protocol. Within 
each "pair" of monkey, one animal was treated with the anti-Nogo-A antibody 
while the other was treated with the control antibody. However, in most cases, 
this information was not available to the experimenter (“double-blind" procedure; 
see Table 1). The ID codes refer to individual monkeys, as indicated in Table 1, 
and comprise for sake of clarity in the text a “C” or a “A” at the fourth digit 
position, indicating whether the monkey was control-antibody treated or anti-
Nogo-A treated, respectively. However, in the course of the experiments, the 
animals had different names from which the experimenter could not know which 
antibody was infused, at least for the “pairs” of monkeys in which the double blind 
procedure was applied (see Table 1). With the goal to reduce variability, part of 
the data are presented by comparing monkeys within a “pair” (see Fig. 1a, b, c; 
Fig. 2c, d; Fig. 4a2; Fig. 5a, b). 
The manual dexterity of each hand was assessed in all lesioned monkeys with a 
finger prehension task (Fig. 1e), namely our so-called “modified Brinkman board” 
quantitative test, as described in detail earlier (Rouiller et al., 1998; Liu and 
Rouiller, 1999; Schmidlin et al., 2005). Briefly, tests were done using a Perspex 
board (10 cm x 20 cm) containing 50 randomly distributed wells, each filled with a 
food pellet at the beginning of the test. Twenty-five wells were oriented 
horizontally and twenty-five vertically. The dimension of the wells was 15 mm 
long, 8 mm wide and 6 mm deep. Retrieval of the food pellets required 
fractionated finger movements, consisting normally in a dexterous opposition of 
the index finger and the thumb, corresponding to the so-called "precision grip". 
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This manual prehension dexterity task was executed daily, alternatively with one 
or the other hand, 4 to 5 times per week for several months before and after the 
unilateral cervical cord lesion. A daily behavioral session typically lasted 60 
minutes. The performance of each hand was videotaped. The behavioral scores 
were established by counting the number of wells from which the food pellets 
were successfully retrieved and brought to the mouth during 30 seconds (Fig. 1a-
c). After the monkeys reached a stable level of performance (usually after 30-60 
days), as indicated by a plateau of behavioral performance, 30-50 daily sessions 
were considered to establish a stable pre-lesion behavioral score. Functional 
recovery was expressed quantitatively as the ratio in percent of the plateau post-
lesion score to the pre-lesion score. 
Other behavioral tests were considered to assess further the motor capacity 
of the monkeys, such as the previously described natural "reach and grasp 
drawer" task (Kazennikov and others, 1994; Kermadi et al., 1997; Kazennikov 
and others, 1998; Kermadi et al., 1998; Wannier et al., 2002) (see also 
www.unifr.ch/neuro/rouiller/motorcontcadre.htm). Originally, this task was 
developed to study quantitatively bimanual coordination but, in the present case, 
it was executed only unimanually, testing one hand after the other. In addition to 
test grasping while the monkey retrieved the pellet from the drawer, the reach 
and grasp drawer task also allowed assessment of the precise timing for the 
reaching phase towards the drawer as well as the pulling phase during which the 
monkey has to produce enough force to open the drawer while holding firmly the 
drawer's knob. More specifically, in the present report, control-antibody treated- 
and anti-Nogo-A antibody treated-monkeys will be compared for the reaching 
and pulling components of the reach and grasp drawer task (Fig. 2a and Fig. 
4a1,a2). 
Motor capacity was tested further qualitatively using other tests performed 
on a weekly basis, at the end of a behavioral session. For instance, “Ballistic Arm 
Movements” (BAM test) were captured on video sequences while the monkey 
caught, using the two hands or sometimes one hand, pieces of food thrown by 
the experimenter from a distance of about 1 meter (see also 
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www.unifr.ch/neuro/rouiller/motorcontcadre.htm). In the BAM test, synchrony of 
the two hands was assessed as well as the pre-shaping ability to open the 
fingers before retrieving the approaching piece of food (Fig. 2b and Fig. 4b). 
The capacity to grasp with the hindlimb was also tested qualitatively by 
presenting to the animal a large piece of food accessible only with one or the 
other foot, before transferring it from the hindlimb to the hand. This "hindlimb 
grasp" test thus allowed assessment of another motor function affected by the 
cervical lesion, but for which the corresponding motoneurons are located at a 
much greater distance from the lesion (lumbar cord) than motoneurons involved 
in manual capacity (Fig. 4c; see also 
www.unifr.ch/neuro/rouiller/motorcontcadre.htm). 
Before each daily session, to follow the general health condition of the 
animal, the body weight was measured daily (except on week-end), in eight of 
the twelve monkeys involved in the present study (see Supplementary Figure 3f 
and Supplementary Note). The body weight analysis did not include the four 
initial monkeys Mk-AF, Mk-AS, Mk-CS and Mk-CC because their body weight 
was not systematically measured daily but only weekly. 
 
Table 1: List of cervical cord lesioned monkeys included in the present study with identification 
code. 
 
 
Mk-CC Mk-CP  Mk-C G Mk-CS  Mk-CB  Mk-CH  Mk- AS Mk- AF Mk- AP Mk- AA Mk- AM Mk- AC 
species mul. fasc. fasc. mul. fasc. fasc. mul. mul. fasc. mul. fasc. fasc. 
Antibody 
Treatment 
Control 
antibody 
Control 
antibody 
Control 
antibody 
Control 
antibody 
Control 
antibody 
Control 
antibody 
Anti-
Nogo-A 
(11C7) 
Anti-
Nogo-A 
(11C7) 
Anti-
Nogo-A 
(11C7) 
Anti-
Nogo-A 
(11C7) 
Anti-
Nogo-A 
(hNogo) 
Anti-
Nogo-A 
(hNogo) 
“Double-blind” 
procedure 
No Yes Yes No Yes Yes No No Yes No Yes Yes 
ICMS Yes   Yes    Yes     
Hemi-section 
Extent (%) 
38 45 51 63 75 90 41 56 58 72 80 85 
Functional 
Recovery (%) 
83 83 90 22 78 53 100 57 99 88 96 100 
Completeness 
of dlf section 
No No 
(BDA) 
Yes* 
(BDA) 
Yes 
 
Yes 
(BDA) 
Yes 
(BDA) 
No 
(BDA) 
Yes 
(BDA) 
Yes 
(BDA) 
No 
(BDA) 
Yes 
(BDA) 
Yes 
(BDA) 
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Extent of 
dorsal column 
lesion (%) 
0 14 39 47 31 72 9 2 48 100 74 44 
Extent of CS 
and RS 
territory lesion 
(%) 
61 64 70 87 93 100 48 73 100 57 100 100 
Extent of 
ventral lesion 
(%) 
30 24 0 19 38 60 12 0 8 43 5 100 
Rostro-Caudal 
extent oflesion 
(in m) 
505 632 617 925 578 715 488 783 880 1189 1075 1367 
Normalized 
axon ar bor 
length (˜ m) 
- 171.3 48.8 - 36.7 8 - - 59.3 - 46 79.9 
Normalized 
nb.of 
swellings 
- 0.57 0.1 - 0.05 0.01 - - 0.4 - 0.26 0.44 
Nb. of BDA-
labeled CS 
axons at C5 
- 927 1005 - 1186 780 - - 1250 - 1148 270 
% of 
uncrossed CS 
axons at C5 
- 10 4.5 - 9 3 - - 5 - 5 7.0 
Volume of 
BDA injected 
(in l) 
24 24 24 13 20 20 22 25.5 24 40 19 20 
Nb. of BDA 
injection sites 
12 12 12 6 10 10 11 17 12 20 10 10 
Survival time 
(in days) 
21 78 70 35 78 62 72 71 81 74 69 64 
 
At the time of the experiment, the monkeys had different names, not indicating whether the 
animal was infused with the control or the anti-Nogo-A antibody. New names were assigned to 
the monkeys during the writing of the manuscript to improve its readability. 
 
Under species, "mul." is for macaca mulatta while "fasc." is for macaca fascicularis. 
 
The six control antibody treated monkeys are in the six leftmost columns, whereas the six anti-
Nogo-A treated monkeys are in the six rightmost columns ("Anti-Nogo-A") with indication of which 
of the two antibodies was used (mAB11C7 or mAB hNogoA). 
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Under "double-blind procedure", "Yes" refers to monkeys for which the collaborators delivering 
the antibodies (control or anti-Nogo-A) did not know to which monkey they were aimed for. On 
their side, the experimenters taking care of the monkeys did not know which antibody has been 
administered to the corresponding animal. 
 
Under ICMS (intracortical microstimulation), "Yes" refers to the three monkeys subjected to 
extensive ICMS sessions in the primary motor cortex (M1), whose data have been reported 
previously (Schmidlin and others, 2004; Schmidlin and others, 2005). 
 
Functional recovery was assessed here based on the "modified Brinkman board" task, by giving 
in percent the ratio of the post-lesion score to the pre-lesion score. 
 
In the row “completeness of CS (dlf) section”, “Yes” and “No” indicates whether the dorsolateral 
funiculus (dlf) was or was not completely transected unilaterally, respectively. When “BDA” is 
indicated between parentheses, it means that completeness of the section of the dorsolateral 
funiculus unilaterally was assessed based on the BDA-labeling of the CS tract immediately 
above the lesion, in addition to the location and extent of the lesion itself. 
 
* In the monkey Mk-CG, a very small contingent of CS axons, labeled with BDA, escaped from 
the lesion ventrally. However, these few axons then ran ventrally in the white matter, without 
giving rise to collaterals into the area immediately caudal to the lesion, and continued their 
trajectory further below to low thoracic segments. As a consequence, these few preserved CS 
axons did not participate to the reconstruction of the CS tract in the segments immediately 
caudal to the lesion and therefore the lesion of the dorsolateral funiculus was considered as 
complete in this animal too. 
 
For the sake of completeness of information, the extent of the lesion in percent was given 
separately for three sub-territories of white matter in the lesioned hemi-cord. The three territories 
are: the dorsal column (from midline dorsally up to the dorsal rootlet entrance); the ventral 
column (from midline ventral to the ventral rootlet exit) and, laterally, the territory between the 
dorsal and ventral rootlets corresponding mainly to the territories occupied by the CS and 
rubrospinal (RS) tracts. A value of 100%, for instance in the dorsal column, means that 100 % of 
the dorsal column sub-territory was lesioned in the corresponding monkey. 
 
Survival time: number of days separating the injection of BDA in the contralesional M1 and the 
day of sacrifice of the animal. 
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Surgical procedures: partial cervical cord section 
Pre-anaesthesia was induced by intramuscular injection of ketamine 
(Ketalar®; Parke-Davis, 5 mg/kg, i.m.). Atropine was injected i.m. (0.05 mg/kg) to 
reduce bronchial secretions. Before surgery, the animal was treated with the 
analgesic Carprofen (Rymadil®, 4 mg/kg, s.c.). An intravenous catheter was 
placed in the femoral vein for continuous perfusion (0.1 ml/min/kg) with a mixture 
of 1% propofol (Fresenius®) and a 4% glucose solution (1 volume of Propofol 
and 2 volumes of glucose solution), inducing a deeper and stable anaesthesia. 
Methylprednisolone (Solu-Medrol®, Pfizer) was added to the perfusion solution 
(1 mg/ml). The animal was then placed in a stereotaxic framework, with local 
anaesthetic put on the ear bars in order to reduce pain possibly originating from 
the ear canals. During the surgery under aseptic conditions, the following 
parameters were monitored: heart rate, respiration rate, expired CO2, arterial O2 
saturation and body temperature. In the initial experiments, an extra intravenous 
bolus of 0.5 mg of ketamine diluted in saline (0.9%) was added i.v. at potentially 
more painful steps of the surgical procedure, such as laminectomy. In the other 
and more recent experiments, ketamine was added to the perfusion solution (65 
mg/100 ml) thus administered i.v. continuously throughout the whole surgery. 
Placed in a ventral decubitus position, the spinal processes from C2 to Th1 were 
exposed. The paravertebral muscles were retracted and the laminae of the 
segments C6, C7 and Th1 were dissected. A complete C6 laminectomy and an 
upper C7 hemi-laminectomy were then performed. The ligamentum flavum was 
removed. The dura mater was exposed and incised longitudinally. Under the 
microscope, the dorsal root entry zones were easily identified. A unilateral 
incomplete section of the cervical cord at the C7/C8 border was performed using 
the dorsal root entry zone as the most medial landmark. From this target, a 
surgical blade (no 11, Paragon®) was inserted 4 mm in depth perpendicularly to 
the spinal cord, and the section was prolonged laterally to completely cut the 
dorsolateral funiculus. From previously available anatomical material, the rostro-
caudal level where the dorsal rootlets entering respectively the 7th and the 8th 
cervical spinal segments meet was determined, corresponding to the rostral zone 
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of the spinal portion covered by the 6th cervical lamina. The aimed lesion was 
located caudal with respect to the pool of biceps motoneurons but rostral to the 
pool of triceps, forearm and hand muscle motoneurons13 (see also Fig. 3a). The 
muscles and the skin were sutured. The animal usually recovered from 
anesthesia 15-30 minutes after interruption of the perfusion with propofol and 
was treated post-operatively with an antibiotic (Ampiciline 10%, 30 mg/kg, s.c.). 
Additional doses of Carprofen were given daily during one week (pills of Rymadil 
mixed with food). After the spinal lesion, the animal was kept alone in a separate 
cage for a couple of days, to allow better conditions for recovery than the usual 
group housing with other monkeys. 
 
Antibody treatments 
The treatment with control (six monkeys) or anti-Nogo-A (six monkeys) 
antibodies lasted during 4 weeks post-lesion delivered from an osmotic pump 
(Alzet ®, 2ML2), placed in the back of the animal, using a small silastic tube 
positioned intrathecally 3-5 mm above the cervical lesion. The pump was 
implanted within a few minutes after the lesion of the cervical cord. The pump 
had a volume of 2 ml, allowing treatment during 2 weeks, after which it was 
replaced under anaesthesia by a second pump for another 2 weeks treatment. In 
five monkeys (pilot animals), the experimenters knew which one of the two 
antibodies was contained in the pumps (Table 1). For the seven other monkeys, 
the antibody contained in the pump was blind for the experimenters (Table 1) 
until the end of the experiments (sacrifice of the animal and reconstruction of the 
cervical lesion). After four weeks of treatment, the pump and the silastic tube 
were removed. When removed, each pump was checked for the volume left in 
order to ensure that the antibody was indeed delivered. 
 
Post-lesion behavioral, electrophysiological and pharmacological investigations 
The manual dexterity assessment using the "modified Brinkman board" task 
was pursued along a period of two to three months post-lesion, in order to reach 
a plateau (Fig. 1a-c). Then an amount of 30-50 daily sessions were considered to 
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establish the “post-lesion” behavioral score, corresponding to the so-called 
“functional recovery” expressed in percent of the pre-lesion behavioral score. In 
three monkeys (“Mk-CC”, “Mk-CS” and “Mk-AF”), extensive intracortical 
microstimulation (ICMS) sessions were conducted in the motor cortex bilaterally 
in order to study the post-lesional plasticity of the motor map both in the 
contralesional (Schmidlin,E. et al., 2004) and ipsilesional (Schmidlin,E. et al., 
2005) hemispheres. In the same three monkeys, the post-lesional ICMS sessions 
were followed by reversible inactivation sessions by infusing the GABA agonist 
muscimol in the contralesional or ipsilesional hand representation area in M1 
(Schmidlin,E. et al., 2004, 2005). 
 
 
Tracing experiments and histological assessment of the lesion 
After completion of the post-lesion behavioral and electrophysiological 
(ICMS) sessions, the anterograde tracer “Biotinylated Dextran Amine” (BDA, 
Molecular Probe®) was injected in the contralesional hemisphere. In the three 
monkeys subjected to electrophysiological mapping, the chronic chamber 
allowed positioning of Hamilton syringes containing BDA at sites in the M1 hand 
area identified based on the pre- and post-lesion ICMS data. In order to obtain an 
uptake of BDA also from more proximal CS neurons, BDA was also injected at 
ICMS sites corresponding to forearm territories (wrist, elbow, shoulder) as well as 
more medially in M1 leg territories. In the other monkeys, using stereotaxic 
landmarks, a craniotomy was performed under propofol anesthesia to expose the 
central and arcuate sulci contralesionally. Injections of BDA were performed in 
M1, i.e. in the rostral bank of the central sulcus, following the central sulcus going 
from lateral (hand representation) to medial (leg representation). A second series 
of BDA injections were performed more rostrally with respect to the central 
sulcus, also going from lateral to medial, but at a depth aiming for the part of M1 
located on the surface of the cerebral cortex. The parameters of BDA injections 
are given for each monkey in Table 1. In the first two monkeys (Mk-CC, Mk-CS), 
the survival time after BDA injection was set to three weeks, as used before in 
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intact monkeys15. However, the cervical lesion substantially slowed down the 
anterograde axonal transport of BDA and therefore the tracer did not reach the 
cervical segments. These animals were not considered further for the anatomical 
analysis (Table 1). In contrast, a much longer survival time (60 days) allowed 
transport of BDA up to thoracic level in the other ten monkeys (Table 1). The 
animals were finally sacrificed under deep, lethal anaesthesia (90 mg of sodium 
pentobarbital/kg body weight) by transcardiac perfusion with 0.9% saline (400 ml) 
and continued with fixative (3 liter of 4% phosphate buffered paraformaldehyde in 
0.1 M phosphate buffer, pH=7.6). Perfusion was continued with solutions (2 liters 
each) of the same fixative containing increasing concentrations of sucrose (10, 
20 and and 30%). The brain and spinal cord were dissected and placed in a 30% 
solution of sucrose (in phosphate buffer) for cryoprotection during seven days. 
Frozen sections (50 µm thick) of the brain were cut in the frontal plane and 
collected in eight series, whereas frozen sections (50 µm thick) of the cervical 
cord (approximately segments C6-T3) were cut in the paralongitudinal plane and 
collected in 3 series for later histological processing. Upper cervical segments 
and lower thoracic spinal segments were cut in the frontal plane at 50 µm thick 
and sections were also collected in three series. One series of spinal sections 
were revealed for BDA staining, as described in detail in previous reports15,16. 
The second series of spinal cord sections were immunohistochemically 
processed to visualize the corticospinal axons using the marker SMI-32, as 
recently reported, a series of sections also used to reconstruct the location and 
extent of the cervical lesion, as described in detail earlier (Schmidlin,E. et al., 
2004, Wannier,T. et al. 2005). 
As other descending motor tracts (e.g. rubrospinal, reticulospinal) may also 
contribute to recovery, the overall extent of the lesion was quantitatively 
assessed by the percentage of hemi-cord lesioned. In other words, the extent of 
the cervical lesion was expressed quantitatively in percent, given by the ratio of 
the reconstructed lesion area (as shown by the red or blue area in Fig. 3b online) 
to the total area of the corresponding hemi-cervical cord. The extent of the 
cervical lesion ranged across monkeys from 38% to 90% of the spinal hemi-cord 
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(Table 1). The rostrocaudal extent of the cervical lesion ranged from 488 to 1367 
m (see also Table 1). The third series of sections were processed to visualize 
another anterograde tracer (Dextran-Fluorescein) injected in the ipsilesional 
hemisphere, but these data will not be presented here. 
 
Measurement of CS axonal arborization 
On every paralongitudinal section processed for BDA (150 µm interval), the 
presence of BDA labelled CS axonal arbors was investigated caudal to the lesion 
at 200x magnification on a light microscope (Olympus®). Using neurolucida® 
software, each BDA-labelled axonal segment was traced and the location of 
boutons terminaux and en passant were registered. The same software allowed 
counts of axonal swellings and the cumulated length of axonal arbors labeled 
with BDA caudal to the lesion. Boutons en-passant were defined as a swelling 
with a diameter twice the diameter of the axonal branch before and after the 
swelling itself. For each monkey, the contour of the lesion (vertical arrow in Fig. 
4c-d and Fig. 5a-b) and the labeled CS axonal segments were plotted on a 
drawing of superimposed reconstructions of paralongitudinal sections of the 
cervical-thoracic cord (Fig. 4c-d and Fig. 1a-b). Rostral to the lesion, the densely 
packed line segments represent the BDA-labeled CS tract above the lesion and 
interrupted by the transection of the dorsolateral funiculus (Fig. 4c-d and Fig. 5a-
b). Some of the transected CS axons exhibited a retraction from the rostral limit 
of the lesion (data not presented here). 
Out of the ten monkeys injected with BDA and for which a survival time was 
long enough (Table 1), the seven monkeys conducted according to the “double-
blind” procedure were selected for the quantitative analysis of BDA labeling 
caudal to the lesion. The expected number of CS axonal arbors and swellings 
labeled with BDA depends on the size of the BDA injection in M1, on the 
efficiency of tracer uptake and axonal transport. In order to normalize the data 
across monkeys, the number of BDA-labeled CS axons was counted rostral to 
the lesion, at C5 level on a frontal section. Then the cumulated length of CS 
axonal arbors caudal to the lesion was divided by the total number of labeled CS 
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axons at C5 level (Fig. 4e and g). A similar normalization was performed for the 
number of CS axonal swellings (Fig. 4f-g). 
The statistical comparisons between the two groups of monkeys (anti-Nogo-
A treated versus control-antibody treated) regarding functional recovery and CS 
axonal sprouting were conducted using the non parametric Mann and Whitney 
test. 
 
 
1.4 Results 
The motoneurons controlling hand muscles in macaque monkeys are located at 
cervical and thoracic levels (Jenny and Inukai, 1983) (Fig.1a). Deficits of manual 
dexterity were produced in twelve monkeys by unilateral cervical cord lesion at 
C7-C8 border, rostral to the hand motoneurons (Fig.1a,b; Methods and Materals; 
Table1), aimed unilaterally at the dorsolateral funiculus, which was completely 
interrupted in eight monkeys. In four monkeys, the lesion was incomplete with a 
few CS axons preserved in the dorsolateral funiculus. The monkeys exhibited 
dramatic post-lesion loss of manual dexterity ipsilesionally, accompanied by 
hindlimb dysfunction.  
The deficit of manual dexterity was followed by a progressive recovery. 
However, in a first "pair" of monkeys (Fig.2a) subjected to a large lesion, 
recovery was fast and complete in the anti-Nogo-A treated animal (Mk-AM), in 
contrast to the control-antibody treated monkey (Mk-CH). In a second "pair" of 
monkeys (Fig.2b), the anti-Nogo-A treated monkey (Mk-AC) had a larger lesion 
but exhibited faster recovery than the control-antibody treated monkey (Mk-CG). 
Similarly, in a third "pair" of monkeys (Fig.2c), the anti-Nogo-A treated monkey 
(Mk-AF) recovered better than the control-antibody treated one (Mk-CS). The 
functional recovery, plotted as a function of lesion extent (Fig.2d), was 
significantly higher  
Based on a “reach and grasp drawer” test (Fig.3a1, a2), assessing ability to 
generate force with the fingers, the anti-Nogo-A treated monkeys tended to 
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recover faster the capacity to pull the drawer post-lesion than the control-
antibody treated monkeys (P=0.27), especially in case of large lesions (Fig.4a). 
The difference was statistically significant when excluding the monkey MK-CP 
with incomplete lesion of the dorsolateral funiculus (P=0.05). Catching an object 
thrown to the monkey (“ballistic arm movements” test; Fig.3b) also revealed 
faster recovery of the capacity to pre-shape the hand (extension of fingers) in the 
anti-Nogo-A treated monkeys (Fig.4b), a trend however not statistically significant 
(P=0.12 without monkey Mk-CP). No difference between the two groups of 
monkeys regarding capacity of prehension with the hindlimb was observed 
(Fig.3c). 
 
Chapter 2: Nogo-A antibody treatment enhances sprouting and functional recovery 65 
 
Legend to Figure 1 
 
Organization of the CS projection in the
macaque monkey and reconstructions of the
cervical lesions performed in the 12 monkeys. 
(a) Location of motoneurons in cervical and
thoracic cord segments controlling forelimb
muscles in the macaque monkey (Re-drawn
from Jenny and Inukai10). 
(b) Reconstruction in the frontal plane, from
paralongitudinal sections, of the lesion extent at
cervical level C7/C8 (see Table1). The gray
area represents the spinal gray matter. Note
some distortion of the hemi-cord on the lesional
side. The dorsolateral funiculus was completely
interrupted in eight monkeys, whereas in four
monkeys (asterisks) it was incompletely
transected. 
(c) Schematic representation of the macaque
monkey corticospinal (CS) projection from the
right motor cortex. The cervical lesion (gray bent
line segments) did not interrupt the uncrossed
CS axons originating from the contralesional
hemisphere, except in Mk-AC. The arrow below
the lesion points to the spinal cord region in
which the presence for BDA axonal arbors was
quantitatively assessed in the present study. 
(d) The behavioral data derived from the
assessment of manual dexterity based on the
“modified B rinkman b oard” test are shown
here exclusively for the group of control-antibody
treated monkeys excluding the two animals
subjected to intracortical microstimulation (thus
corresponding to the blue symbols of Fig. 1 d).
As indicated by the regression line for these 4
control-antibody treated monkeys (coefficient of
correlation of R=-0.879), the data indicate that,
in control-antibody treated monkeys, functional
recovery of manual dexterity is inversely
correlated to the extent of the hemi-cord lesion. 
 
 
 
 
 
Chapter 2: Nogo-A antibody treatment enhances sprouting and functional recovery 66 
 
 
 
 
Figure 2 
Quantitative assessment of manual dexterity pre- and post-lesion. 
To reduce inter-individual variability, direct comparisons were performed first between two monkeys forming 
a so-called “pair” (Methods). 
(a-c) For three "pairs" of monkeys, comparison of behavioral scores assessing manual dexterity, before and 
after the lesion (day 0), derived from the "modified Brinkman b oard" task (number of pellets retrieved 
within 30 seconds) for the hand affected by the cervical lesion. The extent of the blue/red zones in the 
“semicircular figurines” represents the extent of the hemi-cord lesion for each monkey (but does not indicate 
the location of the lesion). The two monkeys displayed in c were subjected to intracortical stimulation 
(ICMS), possibly explaining the less prominent recovery than in the other monkeys. 
(d) Relationship between the extent of the hemi-cord lesion and the degree of functional recovery for the 
“modified Brinkman board” test. The blue circles are for control-antibody treated monkeys, whereas the 
anti-Nogo-A treated monkeys are represented by red squares. Three monkeys were plotted separately 
(yellow symbols) because being subjected to extensive ICMS (Schmidlin,E. et al.  2005; Rouiller,E.M. et 
al.1996), a procedure that may have reduced their manual capacity. The recovery of manual dexterity was 
significantly higher (Mann-Whitney test, P=0.028) in the five anti-Nogo-A treated monkeys (red squares) 
than in the four control-antibody treated monkeys (blue circles). A statistically significant difference was also 
found if all twelve monkeys are included (Mann-Whitney test, P=0.037). (e) Left hand of a monkey 
performing the “modified Brinkman board” task, using the precision grip (opposition of thumb and index 
finger). 
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Figure 3 
Assessment of motor capacity of fore- and hind-limbs. 
(a1, b, c ) Views extracted from video sequences of one representative trial performed post-lesion by a 
control-antibody treated monkey (Mk-CS) and an anti-Nogo-A treated monkey (Mk-AP) in the “reach and 
grasp drawer”, “ballistic arm movements” and “hindlimb grasp” tests, respectively. The control-antibody 
treated monkey did not grasp properly the drawer knob and did not develop enough force to pull the drawer 
as the knob slipped in between the fingers. The control-antibody treated monkey did not pre-shape the 
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ipsilesional hand (absence of fingers extension: see arrow) in the ballistic task and did not recover foot 
grasping. The anti-Nogo-A treated monkey successfully opened the drawer and pre-shaped the hand 
(fingers extension) in the ballistic task but foot grasping was not recovered. 
(a2) Quantitative assessment of the “reach and gra sp drawer” task in two anti-Nogo-A treated monkeys 
(Mk-AF; Mk-AP) and two control-antibody treated monkeys (Mk-CS; Mk-CP). The time interval (in ms) 
between contact with the knob and pulling onset was plotted as a function of the corresponding daily 
session, before (days -50 to 0) and after (days 0 to 100) the lesion. The thick red/blue line represents the 
average time interval derived from five trials (with SD given by the red/blue dots), whereas all observations 
are represented by a “+” sign. The anti-Nogo-A treated monkeys recovered a time interval comparable to 
pre-lesion, whereas the control-antibody treated monkeys did not (Mk-CS did not recover at all the drawer 
task). 
 
 
 
CS axons were labeled by injecting the anterograde tracer BDA in the 
contralesional motor cortex (Fig.1c). In the “pair” of monkeys Mk-CH and Mk-AM, 
CS axonal arbors were more numerous caudal to the lesion in the anti-Nogo-A 
treated than in the control-antibody treated monkey (Fig.4c-d). After 
normalization (Table 1; Fig.5a-b), in six monkeys with complete CS transection in 
which BDA-labeling data could be quantified caudal to the lesion, the normalized 
cumulated axonal arbor length was larger in the anti-Nogo-A treated than in the 
control-antibody treated monkeys (Fig.4e), a trend however not statistically 
significant (P=0.12). The normalized number of CS axonal swellings caudal to 
the lesion was significantly larger (Fig.4f) in the anti-Nogo-A treated than in the 
control-antibody treated monkeys with complete lesion (P<0.05; if monkey Mk-
CP is included, the difference is not statistically significant: P=0.29). Accordingly, 
the normalized number of axonal swellings plotted as a function of normalized 
axonal arbor length was higher in the anti-Nogo-A treated monkeys (Fig.4g). 
Sprouting was observed on a total distance of about 10-12 mm and occurred 
from axotomized CS axons (Fig.4c) but sprouting from intact CS axons from both 
hemispheres may also have occurred. 
The monkeys treated with anti-Nogo-A antibodies did not lose weight (Fig.5f) and 
remained cooperative with the experimenter. Furthermore, the monkeys did not 
exhibit signs of discomfort or pain when the experimenter touched their body or 
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manipulated their limbs. These observations suggest that the rewiring induced by 
the anti-Nogo-A treatment did not generate chronic pain (see Discussion).  
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Legend to Figure 4 
Anti-Nogo-A enhanced motor recovery and CS axonal sprouting. 
Days required post-lesion to recover the ability to perform the reach and grasp drawer (a) and 
ballistic arm movement (b) tasks plotted as a function of lesion extent. Monkey Mk-AF was not 
tested before 30 days for technical reasons. In monkey Mk-CP (asterisk), the dorsolateral 
funiculus was not completely interrupted, possibly explaining the rapid recovery. Two monkeys 
did not recover during the three months of observation (+signs). 
(c-d): CS axons were labeled by multiple, widespread BDA injections in the contralesional motor 
cortex. In two monkeys, in which all labeled CS axons were interrupted, BDA-labeled axonal 
arbors caudal to the lesion were more numerous in the anti-Nogo-A treated (Mk-AM) than in the 
control-antibody treated monkey (Mk-CH). The gray area rostral to the lesion delineates the gray 
matter. 
In the seven monkeys in which BDA-labeling was quantitatively analyzed caudal to the lesion, the 
normalized cumulated CS axonal arbor length (mm) and the normalized number of axonal 
swellings emitted by CS axons (representing putative re-established contacts with interneurons or 
motoneurons deprived of inputs as a result of the lesion) were plotted as a function of lesion 
extent (e-f). Monkey Mk-CP, with incomplete section of the dorsolateral funiculus (asterisk), 
exhibited profuse sprouting from spared CS axons. The number of CS axonal swellings was 
plotted as a function of the cumulated CS axonal arbor length (in mm) for the seven monkeys (g). 
(See legend of Fig.2 for symbol and semicircular figurine conventions) 
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1.5 Discussion 
 
Neutralization of Nogo-A promotes re-growth of CS (and possibly other) 
axons around the lesion and into the denervated spinal cord in macaque 
monkeys, in line with previous observation in marmoset (Fouad et al., 2004). For 
the first time in primates, anti-Nogo-A antibody treatment also led to considerable 
functional recovery. The time course and limitation of spontaneous manual 
dexterity recovery in the control-antibody treated monkeys are consistent with 
earlier reports for monkeys subjected to lesion at C3-C5 level (Galea and Darian-
Smith, 1997; Sasaki et al., 2004). This time course was shortened and the 
recovery of skilled hand function was nearly complete when neutralizing Nogo-A 
(Figs.2-4). Neutralization of Nogo-A by specific antibodies infused intrathecally 
leads to impressive functional recovery and enhanced regenerative axonal 
sprouting and elongation not only in spinal cord lesioned adult rats but also in 
adult primates, in absence of detectable malfunctions. These observations 
represent an important proof of principle on the way to a novel therapy of spinal 
cord and brain lesions in humans. 
The position and size of the cervical sections were inevitably variable across the 
monkeys (Fig. 1b). However, it turned out that the most crucial requirement for 
the validity of the present model was to completely transect the dorsolateral 
funiculus unilaterally, a condition achieved in eight out of the twelve monkeys, 
leading to substantial manual deficit of the ipsilesional hand. Complete CS tract 
lesions were even more necessary for the interpretation of the anatomical data 
caudal to the lesion. 
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Legend to Figure 5 
Morphological analysis of labeled CS
axons; health condition of monkeys. 
(a, b) Same data (BDA-labeled CS
axons) as in Fig.2c-d, but for two
other monkeys. Paradoxically, more
BDA-labeled CS axonal arbors caudal
to the lesion were found in the control-
antibody treated (Mk-CG) than in the
anti-Nogo-A treated (Mk-AC) monkey.
However, the cortical BDA injections
labeled quite different amounts of CS
axons, namely 1,005 in Mk-CG and
270 in Mk-AC, respectively. After
normalization with respect to the total
number of CS axons labeled, the
cumulated axonal arbors length and
the number of axonal swellings were
actually larger in the anti-Nogo-A
treated monkey (Mk-AC) than in the
control-antibody treated monkey (Mk-
CG; see Table 1). 
The two photomicrographs d and e
illustrate the appearance of BDA-
labeled CS axonal arbors at locations
caudal to the lesion, as indicated in c,
on a paralongitudinal section of the
cervical-thoracic cord. Arrows point to
axonal swellings (boutons terminaux
and en passant). Scale bars: 1 mm in
c, 100 m in d and 200 m in e. 
(f) Average body weight (with SDs),
pre-lesion (30 days; leftmost bar),
post-lesion during infusion of the
antibodies (30 days; middle bar) and
after offset of antibody administration
(30 days; rightmost bar), as an
indicator of health condition (see
Discussion), in four anti-Nogo-A
treated monkeys (red) and four
control-antibody treated monkeys
(blue). The green horizontal lines
represent, for each monkey, a level
corresponding to a loss of 5% from
the average body weight pre-lesion. 
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The size of the cervical lesion remains a crucial concern. For ethical reasons, 
nearly complete spinal lesions were discarded, in particular to keep the animals 
in decent post-lesion health condition. The extent of the lesion was aimed at 
generating a significant deficit of manual dexterity, exhibiting however a clear 
enhancement by the anti-Nogo-A. Moreover, further extension of the lesion more 
ventrally in the white matter or medially in the gray matter may also affect the 
degree of recovery, involving other descending tracts such as the rubrospinal, 
reticulospinal, tectospinal and vestibulospinal tracts (Hashimoto and Fukuda, 
1991; Feraboli-Lohnherr et al., 1997; Raineteau et al., 2001; Schucht et al., 2002; 
Raineteau et al., 2002; Ruitenberg et al., 2003; Fouad et al., 2005)}, as well as a 
more indirect contribution via propriospinal projections, as shown in rats (Bareyre 
et al., 2004). However, the possible role played by the propriospinal projection in 
monkeys for manual dexterity remains controversial (Sasaki and others, 2004; 
Lemon, 2004). 
Descending tracts other than the CS projection were not labeled in the present 
investigation and therefore how much they were affected by the lesion remains 
uncertain, as well as to what extent the anti-Nogo-A treatment enhanced 
sprouting of the rubrospinal, reticulospinal, tectospinal and vestibulospinal tracts 
for instance. In addition, the spread of the lesion into the dorsal and ventral 
columns may also affect the behavioral data. Table 1 indicates for each monkey 
the extent of the lesion (given in percent) affecting three sub-territories of the 
white matter, namely the dorsal column, the ventral column and the lateral zone 
of the white matter (in between the dorsal and ventral rootlets), corresponding to 
the location of the partly overlapping corticospinal and rubrospinal (RS) tracts. 
From these data, due to the limited number of monkeys, it was not possible to 
extract a systematic relationship between the functional recovery and the extent 
of the lesion within one or the other of these three sub-territories of the white 
matter. Indeed, the functional roles of these different sub-territories are not 
independent and, to address the impact of lesioning one of them, would require 
the comparison of several monkeys with the same lesion of the RS and CS tracts 
and assess the effects of lesions of graded extent aimed at the ventral column for 
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instance. Due to restrictions in the use of non-human primates, the contribution 
to manual deficits of damage to separate territories of the cervical cord could not 
be addressed in the present study. 
Recovery of manual dexterity following cervical cord lesion paralleled the 
density of CS axonal arbors, which have re-innervated the territory immediately 
caudal to the lesion, containing the motoneurons controlling hand muscles. Such 
partial reconstruction of the lesioned CS tract was clearly enhanced by anti-
Nogo-A treatment, thus possibly promoting better and faster recovery as 
compared to control-antibody treated monkeys. Among the possible mechanisms 
leading to the partial reconstruction of the CS tract caudal to the lesion, sprouting 
from the CS tract originating from the ipsilesional hemisphere was ruled out in 
control-antibody treated monkeys because reversible inactivation of the 
ipsilesional motor cortex did not affect the recovered manual dexterity score 
(Schmidlin,E. et al.,  2004, 2005). On the other hand, reversible inactivation of 
the contralesional motor cortex completely suppressed the recovered manual 
dexterity score (Schmidlin et al., 2005), indicating that the limited, spontaneous 
reconstruction of the CS tract caudal to the lesion occurs from axons originating 
from the contralesional hemisphere in the form of sprouting of the transected CS 
axons (green solid lines in Fig. 1c) and/or sprouting of the undecussated CS 
projection not affected by the lesion, crossing the midline below the lesion (yellow 
solid lines in Fig. 1c; see also in the rat Weidner,N., et al. 2001). A significant role 
played in the recovery by the axotomized CS axons in the form of sprouting 
(green lines in Fig. 1c) is compatible with previous observations that most 
axotomized CS neurons in the contralesional hemisphere do not die(Davison, 
1937; Tower, 1940; Lassek, 1942; Wannier et al., 2005). As far as the anti-Nogo-
A treated monkeys are concerned, reversible inactivation experiment conducted 
in one monkey indicates that the enhanced reconstruction of the CS tract caudal 
to the lesion also derives from sprouting of the CS tracts originating from the 
contralesional hemisphere (green and yellow lines in Fig. 1c). However, in the 
anti-Nogo-A treated monkeys, one cannot rule out at that step a possible 
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contribution of sprouting of the CS tract originating from the ipsilesional 
hemisphere. 
As observed previously in rodents {Bregman, 1995 9875 /id;Schwab, 2004 
22523 /id;Liebscher, 2005 24410 /id, anti-Nogo-A enhanced sprouting of the CS 
tract was limited to 10-12 mm caudal to the lesion (Fig. 4c-d; Fig. 5a-b), sufficient 
however to re-address the hand motoneurons denervated after the lesion, thus 
possibly promoting recovery of manual dexterity. The extent of sprouting was not 
sufficient to reach the lumbar segment, thus explaining the absence of functional 
recovery of grasping with the hindlimb in anti-Nogo-A treated monkeys (Fig. 3c). 
As a result of multiple, widespread BDA injection in the right motor cortex, 
the following distribution of CS axons was observed in the cervical cord (Fig. 1c). 
The main (crossed) CS tract (90-95% of axons) runs in the cervical cord in the 
opposite dorsolateral funiculus (green dots at C5 level), whereas the uncrossed 
CS projection (5-10% of CS axons) runs in the homolateral dorsolateral and 
ventral funiculi (yellow dots at C5 level), in line with previous reports 
(Rouiller,E.M. et al., 1996; Wannier,T et al. 2005). Such distribution of CS 
components is also consistent with a recent report at the level of the lumbar cord 
({Lacroix, 2004 22711 /id}.  
. 
 
The general health condition of the monkeys was assessed quantitatively 
by their body weight measured regularly, in general before each daily behavioral 
session. The body weight data are presented for eight monkeys (Fig. 5f). Note 
that none of the monkeys exhibited a loss of weight post-lesion (during the 30 
days of antibody infusion) larger than 5%. According to the guidelines 
established by the local veterinary authorities, a loss of body weight of 10% or 
greater is considered as an indicator of pain or discomfort, prompting the 
exclusion of the animal from the daily protocol (e.g. ICMS, behavioral test, etc). 
In parallel to a generally stable body weight, the monkeys did not exhibit any 
reduction of co-operatively and motivation to perform the behavioral tests. No 
signs of epilepsy, aggression or excessive fear with respect to the experimenter 
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and animal keeper were observed. Acceptance of passive manipulation of the 
limbs by the experimenter was unaffected by the treatment. The general social 
behavior of the anti-Nogo-A antibody treated monkeys with respect to the other 
monkeys sharing the same detention room was not modified, in particular the 
grooming behavior. Furthermore, when moving freely in the detention room, the 
anti-Nogo-A treated monkeys did not take action to avoid contacts of the affected 
body side with the floor, the walls or other objects. 
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Anti-Nogo-A antibody treatment 
promotes recovery of manual dexterity 
after unilateral cervical lesion in adult 
primates: further behavioural data 
 
 
 
This chapter has been adapted from an article originally submitted to Journal 
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1.1 Abs tract 
 
In rodents and primates subjected to spinal cord lesion, neutralizing the neurite 
growth inhibitor Nogo-A promoted regenerative axonal sprouting and functional recovery 
(Liebscher et al., 2005; Freund et al., 2006). In the latter report, the recovery of manual 
dexterity was based on a single quantitative behavioural readout. The goal of the present 
report was to extend these data using refined behavioural analyses and statistical 
assessments. The recovery of manual dexterity following unilateral cervical lesion was 
investigated in thirteen adult monkeys, seven receiving an anti-Nogo-A antibody, whereas 
a control antibody was infused in six monkeys. 
Monkeys were trained to perform the “modified Brinkman board” task requiring 
opposition of the index finger and thumb to grasp food pellets, placed in vertical and 
horizontal oriented slots. Two parameters were quantified before and following spinal cord 
injury: 1) the “score” as defined by the number of pellets retrieved within 30 seconds; 2) 
the “contact time” as defined by the duration of digit contact with the food pellet before 
successful retrieval. During a few postoperative weeks, the hand was severely impaired in 
all monkeys, followed by progressive functional recovery. In control monkeys, the recovery 
of manual dexterity was inversely correlated to lesion extent, with residual impairment for 
both parameters, whereas anti-Nogo-A antibody treated monkeys recovered better and 
completely (or nearly so), irrespective of lesion size. The difference of functional recovery 
between the two groups of monkeys was statistically significant (Mann and Whitney tests, 
p<=0.05) for both parameters and for both vertical and horizontal slot orientations. 
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1.2 I ntroduction 
 
In the adult mammalian central nervous system (CNS), lesions lead to persistent 
motor and sensory deficits, to an extent depending on the location and size of injury. 
Transected nerve fibres do not spontaneously re-grow in the CNS of adult mammals, due 
in part to the presence of myelin-associated neurite growth inhibitors such as Nogo-A (Yiu 
and He, 2006; Schwab, 2004). After section of the corticospinal (CS) tract in adult rat, 
neutralizing Nogo-A with monoclonal antibodies led to enhancement of axonal re-growth 
and compensatory sprouting, in parallel to increased functional recovery (Schnell and 
Schwab, 1990; Bregman et al., 1995; Thallmair et al., 1998; Brösamle et al., 2000; 
Schwab, 2004; Liebscher et al., 2005). 
Following incomplete spinal cord injury, non-human primates show spontaneous, but 
incomplete functional recovery with persisting post-lesion deficits (Galea and Darian-
Smith, 1997a,b; Sasaki et al., 2004; Schmidlin et al., 2004). Recently, extending the above 
data in rat, adult non-human primates were subjected to spinal cord injury and treated with 
the neutralizing antibody against the neurite outgrowth inhibitor Nogo-A. They showed an 
enhancement of functional recovery, in parallel to an increased sprouting of the CS tract, 
both caudal and rostral to the lesion site (Freund et al., 2006, 2007). These studies 
emphasized the importance of using adult non-human primate models of spinal cord injury 
for a proof of principles before going into clinical trials (Courtine et al., 2007; Lemon and 
Griffiths, 2005). In particular, the advantages to use non-human primate in this matter is for 
instance the fact that the general organisation of the CS system is very alike to that of 
human subjects, in contrast to the rat (Nudo and Frost, 2006). 
The present report provides a new and more detailed behavioural and statistical 
analysis than the recent report by Freund et al. (2006). These new results demonstrate 
that anti-Nogo-A antibody treatment significantly enhanced the recovery of manual 
dexterity after cervical cord lesion, as compared to control antibody treated adult monkeys. 
More specifically, the present study aimed first at refining previously shown statistical 
analysis of the behavioural scores derived from the standard behavioural assessment of 
manual dexterity (the so-called “modified Brinkman board” task). Second, more 
importantly, a new parameter is introduced here for the same task, namely the “contact 
time”, defined as the time required grasping the first food pellet aimed by the monkey. This 
new parameter demonstrates more accurately the manual dexterity as it reflects the 
precision grip between thumb and index finger, a prerogative of primates including humans 
(see Lemon and Griffiths, 2005 for review). 
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1.3 Materials and Methods 
 
The experiments were carried out on thirteen (3.5-6.9 years old) rhesus (Macaca 
mulata) or cynomolgus (Macaca fascicularis) monkeys of either sex, ranging from 3.0 to 5 
Kg, in accordance to the Guide for the Care and Use of Laboratory Animals (ISBN 0-309-
05377-3; 1996) and approved by local (Swiss) veterinary authorities. Three recent reports 
(Freund et al., 2006,2007; Wannier et al., 2005) described in detail the behavioural task 
considered in the present report (“modified Brinkman board” task; see Fig. 1E and also 
www.unifr.ch/neuro/rouiller/motorcontcadre.htm), the surgical procedures (including 
transaction of the CS tract in the cervical cord at C7/C8 level), the treatment with the anti-
Nogo-A (n=7) or the control (n=6) antibodies and the neuroanatomical investigations 
(including the assessment of spinal lesion location and extent). The antibodies’ 
characteristics and the issue of antibody penetration in the CNS were reported elsewhere 
(Weinmann et al., 2006; Freund et al., 2007). 
The present study includes the same twelve recently reported monkeys (Freund et 
al., 2006) and a thirteenth monkey (Mk-AK), on which the experiment was completed later, 
belonging also to the group of anti-Nogo-A antibody treated monkeys (Fig. 1B), but in Mk-
AK antibody infusion was initiated seven days post-lesion (Fig. 1A), in contrast to 
immediate infusion on the day of the lesion in the other six anti-Nogo-A antibody treated 
monkeys. In all anti-Nogo-A antibody treated monkeys, the antibody was delivered during 
four weeks. 
The monkeys ID codes to refer to individual monkeys (Table 1 in Freund et al., 2006) 
comprise for sake of clarity in the text a “C” or an “A” at the fourth digit position, indicating 
whether the monkey was control antibody treated or anti-Nogo-A antibody treated, 
respectively. However, in the course of the experiments, the animals had different names 
from which the experimenter could not deduce which antibody was infused, at least for the 
“pairs” of monkeys in which the “double blind” procedure was applied (Table 1 in Freund et 
al., 2006). 
A new statistical test was introduced to assess the overlap/segregation between two 
groups of data (Figures 2E,F; 4C,D), taking into account two parameters, namely the 
extent of the lesion and the percent of functional recovery. We use Fisher’s linear 
discriminant function providing maximal separation between the two groups (see e.g. 
Everitt B. (2005), An R and S-plus Companion to Multivariate Analysis, Springer). The idea 
is to find a linear function of the observed variables such that the ratio of the between-
group variance to its within-group variance is maximized. We used the R package to get 
the two axes of each Figures 2E,F and 4C,D. Axis 1 (dashed line) yields maximal 
separation, and the projected sample is provided on the orthogonal axis 2 (solid line). 
Chapter 3: Recovery of contact time after cervical spinal cord injury                                              86 
 
Then, the axis 2 was proportionally enlarged and positioned vertically (green arrows). As 
regards of statistics, the sample size does not permit to rely on normality assumptions, and 
we considered the statistical problem of separation of the projected samples using the 
non-parametric Mann and Whitney U test. 
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1.4 Resul ts 
 
The general schedule of the experiment is represented in Figure 1A. In three of the 
thirteen monkeys (Mk-CS, Mk-CC and Mk-AF) a comprehensive intracortical 
microstimulation (ICMS) mapping of M1 hand area was conducted on both hemispheres 
(Schmidlin et al., 2004, 2005), a procedure which may have in part reduced their manual 
dexterity recovery. The location and extent of the cervical cord lesion is represented for the 
thirteen monkeys in Figure 1, including four animals in which the CS tract was not 
completely transected (asterisks). A typical lesion is shown in Figure 1D for monkey Mk-
AK, at a sagittal plane where it covers the entire dorso-ventral extent of the cervical cord. 
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Figure 1 
Experimental time course, lesion histology and manual dexterity tests 
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Panel A: Time course of the experiment. AB=osmotic pump implanted to deliver the antibody 
(control or anti-Nogo-A) at the time of the lesion in 12 monkeys. The antibody infusion was delayed 
by one week in monkey Mk-AK (dashed line). The neuroanatomical tracer BDA was injected in the 
contralesional motor cortex (Freund et al., 2006, 2007). 
Panels B and C: Reconstruction in the frontal plane, from paralongitudinal sections, of the lesion 
extent at cervical level C7/C8 in all monkeys. The grey area represents the grey matter of the 
cervical cord. Note that, due to the lesion, the hemi-cord on the side of the lesion has been 
distorted to some extent. In four monkeys (asterisk), the dorsolateral funiculus was not completely 
transected (see Table 1 in Freund et al., 2006). The lesion for twelve monkeys (all except Mk-AK) 
has been illustrated in previous reports (Freund et al., 2006, 2007). 
Panel D: Photomicrograph of a sagittal section of the cervical cord taken from monkey Mk-AK, 
illustrating the lesion site. Scale bar= 1mm. 
Panel E: Photograph illustrating the “Modified Brinkman Board” task used to assess manual 
dexterity pre- and post-lesion (modified from Freund et al., 2006). The board comprises 50 slots 
containing a food pellet (dashed arrows), 25 oriented vertically (open arrow) and 25 horizontally 
(filled arrow). The monkey grasps the pellet by performing the precision grip (opposition of index 
finger and thumb). 
 
 
 
 
1. Behavioural assessment of post-lesion recovery of manual dexterity using scores 
Following unilateral cervical injury, the manual dexterity of the ipsilesional hand was 
severely impaired, as assessed by the “modified Brinkman board” test. In our previous 
report (Freund et al., 2006), only the total score was presented whereas, here, scores for 
the vertical and horizontal slots (number of pellets retrieved in 30 sec) are presented 
separately (Fig. 2). Retrieval from the horizontal slots is expected to more difficult as it 
requires a rotation of the hand in addition to the precision grip. For two monkeys 
conducted in parallel by the same experimenter and having a comparable lesion (Fig. 2A), 
the anti-Nogo-A antibody treated monkey (Mk-AM) exhibited a faster and better recovery 
(100% and 75% of the pre-lesion scores for the vertical and horizontal slots) than the 
control antibody treated monkey (Mk-CH: 60% and 40%, respectively). Along the same 
line (Fig. 2B), in two other monkeys conducted in parallel, the anti-Nogo-A antibody treated 
monkey (Mk-AC) with a clearly larger lesion recovered faster and slightly better (100% for 
both orientations) than the control antibody treated monkey (Mk-CG: 95% and 85% for the 
vertical and horizontal slots, respectively). 
The relationship between lesion extent and recovery of manual dexterity in all 
monkeys, for vertically and horizontally oriented slots (Fig. 2C, D), shows that the control 
antibody treated monkeys (blue circles) are characterized by an inverse significant 
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correlation between lesion extent and the percent of recovery (r=-0.942 for vertical and r=-
0.841 for horizontal slots). In contrast, in the anti-Nogo-A antibody treated monkeys (red 
squares), the recovery was substantially enhanced and, most importantly, reached 90-
100% irrespective of the lesion extent. 
Fig. 2
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Quantitative assessment of manual dexterity based on “scores” 
Panels A-B: For two "pairs" of monkeys, comparison of the behavioural scores obtained before and 
after the lesion (day 0, represented by the vertical dashed line) derived from the "Modified 
Brinkman board" task (number of pellets retrieved in 30 seconds), for the hand affected by the 
cervical lesion. The control antibody treated monkeys are in the left column (blue symbols) and the 
anti-Nogo-A antibody treated monkeys in the right column (red symbols). The scores were plotted 
separately for the vertical (dots) and horizontal (open symbols) slots. Monkeys in the same "pair" 
were assessed in parallel under the same behavioural protocol and by the same experimenter. For 
each plot, the inset on the upper right is a reminder of the lesion location and extent. 
Panels C, D: Relationship between the extent of the hemi-cord lesion in % and the degree of 
functional recovery in % for the “Modified Brinkman board” test for vertically (C) and horizontally 
(D) oriented slots (blue circles for control antibody treated monkeys and red squares for anti-Nogo-
A antibody treated monkeys). Three monkeys were plotted separately (green symbols) because 
the experimental protocol was different (they were subjected to extensive intracortical 
microstimulation). 
Panels E, F: Illustration of the statistical analysis conducted on the data presented in panels C and 
D, respectively (for better visualization, circles are for control antibody treated monkeys whereas 
crosses are for anti-Nogo-A antibody treated monkeys). A line was searched for which the sum of 
distances between each data point and its projection onto the line was minimal (dashed lines in 
Figs. 2E,F). Then, the data points were projected in the direction given by this line onto an 
orthogonal line segment (full line inside the grey box; note that the values on that segment are 
independent of the y axis of the initial plot). The green arrow points to an enlargement of the solid 
line onto which the data points were projected (n=6 for the control antibody treated monkeys and 
n=7 for the anti-Nogo-A antibody treated monkeys). The rank of the values on the projected 
segment was statistically analysed using the Mann-Whitney U test.  
 
 
 
In our previous report (Freund et al., 2006), the statistical analysis between the two 
groups of monkeys (anti-Nogo-A and control antibody treated monkeys) was based on a 
Mann and Whitney test taking into consideration only the manual dexterity score, but not 
the lesion extent, a crucial parameter in the present matter, especially for the control 
antibody treated monkeys (Fig. 2C, D). A new statistical procedure was introduced to 
consider both the behavioural score and the lesion extent by plotting the data as in Figures 
2C and D but computing a line defined by minimizing the sum of distances between each 
data point and its projection onto the line (dashed lines in Figs. 2E,F). Then, data points 
were projected in the direction given by this line onto an orthogonal line segment (the 
values on that segment are independent of the y axis of the initial plot). Finally, the overlap 
between the two treatment groups of monkeys (blue circles for control antibody treated 
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monkeys and red crosses for anti-Nogo-A antibody treated monkeys) was assessed using 
the Mann and Whitney test. The two groups of monkeys are significantly different for the 
vertical slots (p=0.03) and horizontal slots (p=0.05). 
 
2. Beh avioural as sessment of post -lesion reco very of manual d exterity us ing 
contact time 
The data presented above, based on the standard analysis of the “modified Brinkman 
board” task (score given by the total number of pellets retrieved in 30 seconds), reflect not 
only the grasping ability but also other components of the movements such as the 
reaching phase, thus introducing more variability. Another source of variability may be the 
level of motivation and attention of the animal, changing from one day to another as well 
as along a daily session, thus affecting the data when considering a sustained 
performance lasting as much as 30 seconds. In order to investigate solely the capacity of 
fine finger movement (i.e. the precision grip between index finger and thumb), the grasping 
phase was analysed by measuring the so-called “contact time”. It is defined as the time 
interval separating the first “contact” of the index finger with the food pellet and the final 
successful grasping using pad to pad opposition of the index finger and thumb (when the 
pellet left the slot), respectively for the first vertical and the first horizontal slots visited by 
the monkey’s hand. 
For the same two pairs of monkeys as in Figure 2, the “contact time” was plotted as a 
function of time pre- and post-lesion (Figs. 3A, B). Before lesion, all monkeys exhibited a 
short and fairly stable “contact time”, which increased substantially immediately after the 
lesion, becoming more variable from one daily session to the next. However, the anti-
Nogo-A antibody treated monkeys (red symbols in Figs. 3A, B) recovered faster and better 
than the control antibody treated monkeys (blue symbols in Figs. 3A,B). 
The “contact time” in the vertical and horizontal slots has been plotted for all thirteen 
monkeys (box and whisker plots in Figs. 3C, D), showing the pre-lesion values compared 
with the post-lesion values at plateau, after recovery. For the vertical and the horizontal 
slots, the “contact time” values were significantly longer post-lesion than pre-lesion in four 
of the six control antibody treated monkeys (Mann and Whitney: p<0.05; Fig. 3C), 
corresponding to an incomplete recovery. In sharp contrast, the post-lesion “contact time” 
values in six of the seven anti-Nogo-A treated monkeys were not statistically different 
(Mann and Whitney: p>0.05) from the pre-lesion values (Fig. 3D), thus reflecting 
substantial functional recovery. Furthermore, the post-lesion “contact time” values are less 
variable in the anti-Nogo-A antibody treated than in the control antibody treated monkeys. 
The “contact time” values were plotted in percent of recovery for the vertical and 
horizontal slots, respectively (Figs. 4A, B). The data were processed statistically as 
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described above (Figs. 2E, F). The anti-Nogo-A antibody treated monkeys were 
statistically different from the control antibody treated monkeys with respect to recovery of 
“contact time” for both the vertical slots (Mann and Whitney: p<0.01; Fig. 4C) and the 
horizontal slots (p<0.01; Fig. 4D). 
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Figure 3 
Quantitative assessment of manual dexterity based on “contact time” 
Panels A, B: The contact time (in seconds), i.e. the time needed for a successful picking using the 
opposition of index finger and thumb in a pad to pad fashion, was plotted for two pairs of monkeys 
as a function of time (days) with respect to the lesion. The control antibody treated monkeys are in 
the left column (blue) and the anti-Nogo-A antibody treated monkeys in the right column (red). Data 
are shown before the lesion and over the post-lesion weeks for the vertically (filled symbols) and 
horizontally (open symbols) oriented slots. On the abscissa, day zero (vertical dashed line) is for 
the time point of the cervical lesion. For each plot, the inset on the upper right is a reminder of the 
lesion location and extent. 
Panels C, D: The contact times measured before lesion and within the last ten post-lesion sessions 
in the plateau reflecting the recovery are distributed in the form of box and whisker plots. For each 
monkey, the left bar is for pre-lesion data whereas the right bar is for post-lesion data. In the box 
and whisker plots, the thick horizontal line in the box corresponds to the median value, whereas 
the top and bottom of the box are for the 75 and 25 percentile values respectively. The top and 
bottom extremities of the vertical lines on each side of the box are for the 90 and 10 percentile 
values, respectively. The asterisks indicate a statistically significant difference between pre- and 
post-lesion contact time values (Mann and Whitney test, p<=0.05) whereas “n.s.” is for a non-
significant difference (p>0.05). 
 
 
As compared to our recent report (Freund et al., 2006), an additional monkey was 
introduced here (Mk-AK), in which the anti-Nogo-A antibody was infused after a delay of 
one week post-lesion. The recovery of manual dexterity was complete in this delayed 
treatment monkey (Mk-AK), both for the score (Fig. 2C,D) and the contact time (Fig. 4A,B) 
parameters, as it was observed in most anti-Nogo-A antibody treated monkeys subjected 
to immediate post-lesion treatment. 
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Figure 4 
Relationship between contact time and hemi-cord lesion extent 
Panel A, B: Relationship between the extent of the hemi-cord lesion and the functional recovery for 
the contact time needed for the first successful picking. Same conventions as in Figure 2C,D. 
Panel C, D: Graphic illustration of the statistical analysis conducted on the contact times for the 
vertical (C) and horizontal (D) slots. Same conventions as in Figure 2E,F. 
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1.5 Dis cussion 
 
Using a more detailed behavioural analysis with a new parameter (“contact time”), 
specifically reflecting finger dexterity, and introducing a new statistical test, the present 
report extends our initial observations (Freund et al., 2006) and demonstrates 
quantitatively that anti-Nogo-A antibody treatment in adult Macaque monkeys promotes 
functional recovery from cervical hemi-section. The anti-Nogo-A antibody enhanced 
recovery is paralleled by an increase of corticospinal axonal sprouting both caudal and 
rostral to the lesion (Freund et al., 2006, 2007). 
An intrinsic difficulty of such lesion study is the considerable variability between 
individuals; the impact being even more substantial on an animal model (monkeys) for 
which ethical considerations drastically limits the number of animals. In rodents, the inter-
individual variability is dealt with in part by increasing the number of animals included in 
the treated and control groups. In the present study, the inter-individual variability is due to 
inevitable variations in the location and extent of the lesion, as well as parameters related 
to motivational and attentional states of the monkeys. The variability related to the lesion 
extent was taken into account here statistically, in contrast to our previous report (Freund 
et al., 2006), by introducing a non-parametric statistical test comparing the anti-Nogo-A 
antibody treated (n=7) and control antibody treated monkeys (n=6) with assessment of 
both the percent of recovery and lesion extent. The statistical comparisons shown in 
Figures 2E and F (scores) and 4C and D (“contact time”) include all monkeys, irrespective 
of differences related to the lesion (Fig. 1B) or to the experimental protocol, such as the 
inclusion of three monkeys subjected to extensive ICMS sessions (green symbols in Figs. 
2C,D and 4A,B). The new statistical test demonstrates that the anti-Nogo-A antibody 
treated monkeys (n=7) recovered their manual dexterity significantly better than the control 
antibody treated monkeys (n=6), as assessed either with the score (number of pellets 
retrieved for both vertical and horizontal slots) or with the contact time to retrieve the first 
pellet from the vertical or horizontal slots. Note however that, on contrary to what was 
expected, the recovery was comparable for the vertical and horizontal slots. 
Whereas twelve monkeys were the same as those described in Freund et al. (2006), 
a thirteenth monkey was included here, belonging to the group of anti-Nogo-A antibody 
treated monkeys (Mk-AK). This animal differed from the other six monkeys of the same 
group by a delayed onset of anti-Nogo-A antibody infusion by one week. The goal here 
was to tentatively test the impact of such delay, which may be required in spinal cord 
injured patients to allow their stabilization before any intervention. These very preliminary 
data in a single monkey suggest that a delay of one week does not impact on the anti-
Nogo-A antibody enhanced recovery. However, a larger number of animals with delayed 
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infusion are needed to confirm this observation and to determine the length of delay from 
which a decrease of efficacy occurs. 
The originality of the present report is the newly introduced readout of manual 
dexterity (the “contact time” in the “modified Brinkman board” task) coupled to a new 
statistical analysis, forming together a pertinent, sensitive and robust assessment of 
functional recovery after cervical lesion in a non-human primate model, in spite of an 
inevitable inter-individual variability related to lesion characteristics. The new readout 
(contact time with the first pellet) reduces the impact of motivational variability and focuses 
on the finger dexterity, characteristic of primates (see Lemon and Griffiths, 2005 for 
review), by assessing the retrieval time itself without taking into account the less controlled 
inter-pellet time interval. The inter-individual variability mainly due to lesion properties is in 
line with the strong variability also encountered in spinal cord injured patients, thus making 
the present behavioural model in monkey clinically relevant. In spite of this inter-individual 
variability, the original behavioural readout (contact time) and bi-variate statistical 
assessment clearly demonstrate that anti-Nogo-A antibody treatment indeed promotes 
functional recovery from spinal cord lesion in primates. The Nogo-A antibody treatment 
thus represents a promising approach for improved clinical intervention in spinal cord 
injured patients, most likely in combination with complementary strategies. 
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1.1 Abstract 
After injury, re-growth of axons in mammalian adult central nervous system is 
highly limited. However, in monkeys subjected to unilateral cervical lesion (C7-
C8 level), neutralization of an important neurite outgrowth inhibitor, Nogo-A, 
stimulated axonal sprouting caudal to the lesion, accompanied by enhanced 
functional recovery of manual dexterity, as compared to lesioned monkeys 
treated with a control antibody (Freund et al., 2006). The present study aimed at 
comparing the same two groups of monkeys for axonal sprouting rostral to the 
cervical lesion. The corticospinal tract was labeled by injecting the anterograde 
tracer BDA in the contralesional motor cortex. The corticospinal axons were 
interrupted at the level of the lesion, accompanied by retrograde axonal 
degeneration (axon dieback), reflected by the presence of terminal retraction 
bulbs. The number of terminal retraction bulbs was lower in anti-Nogo-A 
antibody treated monkeys and, when present, they were found closer to the 
lesion than in control antibody treated monkeys. As compared to control antibody 
treated monkeys, the anti-Nogo-A antibody treated monkeys exhibited an 
increased cumulated axon arbor length and a higher number of axon arbors 
going in the medial direction from the white to the grey matter. Higher in the 
cervical cord (at C5 level), the anti-Nogo-A treatment enhanced the number of 
corticospinal fibers crossing the midline, suggesting axonal sprouting. Thus, the 
anti-Nogo-A antibody treatment enhanced axonal sprouting rostral to the cervical 
lesion; some of these fibers grew around the lesion and into the caudal spinal 
segments. These processes paralleled the observed improved functional 
recovery. 
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1.2 Introduction 
Following spinal cord injury, the re-growth of injured axons in the adult 
mammalian central nervous system (CNS) is extremely limited. Immediately after 
onset of injury, a series of structural changes occur that are proximal and distal 
to the point of transection. Whereas the distal stump of the axon degenerates, 
corresponding to the so-called Wallerian degeneration, the proximal stump of the 
axon dies back (i.e. retracts) by several hundreds microns, as observed for 
example in the corticospinal (CS) tract of mice (Kerschensteiner et al., 2005). A 
typical feature of the transected axonal stumps proximal to the lesion is the 
formation of a terminal retraction bulb (Kao et al. 1977a,b; Kalil and Schneider, 
1975; Houle and Jin, 2001). 
The fate of axotomized CS neurons in the monkey is controversial, with 
claims of significant loss (e.g. Pernet and Hepp-Reymond, 1975; Wolfarth, 1932; 
Holmes and May, 1909; Levin and Bradford, 1938), contrasting with evidence for 
survival of most CS neurons (Lassek, 1948; Tower 1940). In a recent study, we 
confirmed that most CS neurons survived the axotomy, but their soma shrink 
(Wannier et al., 2005). In spite of the survival of their cell body, only a very 
limited re-growth of injured nerve fibers may take place in the adult mammalian 
CNS due to the presence of neurite outgrowth inhibitors, such as Nogo-A (e.g. 
Caroni et al., 1988; Schwab 2004) within the CNS myelin. In fact, a therapeutic 
approach based on the application of antibodies neutralizing Nogo-A resulted in 
enhanced re-growth or regenerative sprouting of CS axons following spinal cord 
lesion in rats (e.g. Schnell and Schwab, 1990; Bregman et al., 1995; Thallmair et 
al., 1998; Brösamle et al., 2000; Liebscher et al., 2005; see Schwab 2004 for 
review), in marmosets (Fouad et al., 2004) and in macaque monkeys (Freund et 
al., 2006). Compared with animals also subjected to a spinal cord lesion and 
treated with a control antibody, the anti-Nogo-A antibody treatment promoted 
sprouting of CS axons caudal to the lesion, in the area of denervated 
motoneuron pools. In rats (Bregman et al., 1995; Thallmair et al, 1998; Schwab, 
2004; Liebscher et al., 2005) and macaque monkeys (Freund et al., 2006), the 
sprouting of CS axons caudal to the lesion, promoted by anti-Nogo-A antibody 
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treatment, was paralleled by an enhancement of functional motor recovery for 
various specific behavioral tasks, even leading to a complete recovery of 
performance on some of them. 
Knowing that the re-growth of CS fibers caudal to a cervical spinal lesion 
occurred in parallel with better functional recovery of the hand in monkeys 
(Freund et al., 2006), the aim of the present study was to investigate, 
anatomically, how a cervical cord hemi-section affects the CS axons rostral to 
the lesion in terms of die-back and formation of terminal retraction bulbs (see 
Fig. 1A). A specific goal was to assess whether the anti-Nogo-A antibody 
treatment may reduce or prevent axonal retraction effects proximal to the lesion 
and, in addition, favor local axonal sprouting. Thirteen macaque monkeys were 
therefore subjected to a cervical cord lesion unilaterally interrupting the 
dorsolateral funiculus; seven monkeys were treated with an anti-Nogo-A 
antibody whereas the other six received a control antibody. The anterograde 
labeling of CS axons originating from the contralesional hemisphere, allowed us 
to address the following issues:  
- Does the proximal part of the axotomized CS axons retract from the 
lesion? If yes, in what proportion of CS axotomized axons does such a retraction 
occur and what is the distance of retraction? Does anti-Nogo-A antibody 
treatment prevent such retraction of CS axons? 
- Do some axotomized CS axons attempt to re-approach and eventually 
enter the lesion? If yes, does the anti-Nogo-A antibody treatment make such 
attempts more successful? 
- Above the cervical lesion, do the axotomized CS axons sprout, giving rise 
to collaterals medially into the grey matter and/or growing around the lesion thus 
possibly contributing to the enhanced presence of CS axons observed caudal to 
the lesion in anti-Nogo-A antibody treated monkeys (Freund et al., 2006) 
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1.3 M aterials and Methods 
Animals 
The experiments were conducted on sixteen adult macaque monkeys 
(Macaca mulatta and fascicularis, Tables 1 and 2; see also Supplementary Table 
1 in Freund et al., 2006) of either sex. Surgical procedures and animal care were 
conducted in accordance with the Guide for the Care and Use of Laboratory 
Animals (ISBN 0-309-05377-3; 1996) and approved by local (Swiss) veterinary 
authorities. Conditions of housing of the animals as well as the behavioral 
procedures aimed at assessing the manual dexterity of monkeys before and 
after the lesion were described in detail earlier (Schmidlin et al., 2004; 2005; 
Freund et al., 2006). Only the methods specifically relevant for the present study 
will be described below in detail. Out of the sixteen monkeys, thirteen were 
subjected to a unilateral cervical cord lesion (see below). The lesioned monkeys 
were 3.5 to 6.9 years old at time of sacrifice, thus corresponding to young adult 
monkeys, and their weight ranged from 3.0 to 5.0 kg. The other three monkeys 
(see Table 2 for age and weight) were intact and were considered here for 
comparison of some tracing data (Fig. 5E and F) with the lesioned monkeys. 
One of the three intact monkeys was used in a previous tracing study describing 
the CS projection originating from the primary motor cortex (Rouiller et al., 1996). 
 
Surgical procedures: unilateral lesion of the dorsolateral funiculus 
In thirteen monkeys a unilateral cervical cord lesion was performed as 
follows. Intramuscular injection of ketamine (Ketalar®; Parke-Davis, 5 mg/kg, 
i.m.) was performed to induce anesthesia and atropine was injected i.m. (0.05 
mg/kg) to reduce bronchial secretions. Before surgery, the animal was treated 
with the analgesic Carprofen (Rymadil®, 4 mg/kg, s.c.). Then, a continuous 
perfusion (0.1 ml/min/kg) through an intravenous catheter placed in the femoral 
vein with a mixture of 1% propofol (Fresenius ®) and a 4% glucose solution (1 
volume of propofol and 2 volumes of glucose solution) induced a deep and 
stable anaesthesia. The animal was then placed in a stereotaxic headholder, 
using ear bars covered at their tip with local anesthetic. Surgery was carried out 
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under aseptic conditions. The following parameters were monitored: heart rate, 
respiration rate, expired CO2, arterial O2 saturation and body temperature. In 
early experiments, an extra intravenous bolus of 0.5 mg of ketamine diluted in 
saline (0.9%) was added at potentially more painful steps of the surgical 
procedure, such as laminectomy. In later experiments, ketamine was added to 
the perfusion solution and delivered throughout surgery (0.0625 mg/min/kg). 
Placed in a ventral decubitus position, the spinal processes from C2 to Th1 were 
exposed. The paravertebral muscles were retracted and the laminae of the 
segments C6, C7 and Th1 were dissected. A complete C6 laminectomy and an 
upper C7 hemi-laminectomy were then performed. The ligamentum flavum was 
removed in order to expose the dura mater, which was incised longitudinally. 
From previously available anatomical material, the rostro-caudal level at which 
the dorsal rootlets entered respectively the 7th and the 8th cervical spinal 
segments corresponded to the rostral zone of the spinal cord covered by the 6th 
cervical lamina. The dorsal root entry zone at the C7/C8 border was then 
identified, providing a medial landmark for placing a surgical blade (no 11, 
Paragon®), which was used to perform an incomplete section of the cervical 
cord at this level. The surgical blade was inserted 4 mm in depth perpendicular 
to the spinal cord, and the section was prolonged laterally to completely cut the 
dorsolateral funiculus. In most cases, such a section completely interrupted the 
CS tract unilaterally. As illustrated in detail in a recent report (Freund et al., 
2006), the lesion was aimed at a site caudal to the biceps motor nucleus but 
rostral to the nuclei of triceps, forearm and intrinsic hand muscles (Jenny and 
Inukai, 1983). The muscles and the skin were sutured. The animal usually 
recovered from anesthesia 15-30 minutes after interruption of the perfusion with 
propofol and was treated post-operatively with an antibiotic (Ampiciline 10%, 30 
mg/kg, s.c.). During the week following the surgery, additional doses of 
Carprofen were given daily (pills of Rymadil mixed with food). After the spinal 
lesion, the animal was kept alone in a separate cage for a couple of days in 
order to perform a careful watch of its condition. 
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In addition, the transient separation in a cage allowed better conditions for 
recovery than the usual group housing with other monkeys, in which the animal 
was usually replaced two to five days after surgery. Some of the behavioral 
deficits due to the lesion were described previously (Freund et al., 2006), as well 
as the time course of recovery observed with various motor tasks. 
 
Anti-Nogo-A antibody treatment 
The treatment lasted 4 weeks, using either the anti-Nogo-A antibody or 
control antibody (14.8 mg in 4 weeks) delivered from an osmotic pump, placed in 
the back of the animal a few minutes after the lesion of the cervical cord. A small 
silastic tube, attached at one of its extremity to the pump, was positioned 
intrathecally 3-5 mm rostral to the cervical lesion. The pump had a volume of 2 
ml but one or the other of two types of pumps were used, allowing treatment 
during 4 or 2 weeks. In the latter case, after 2 weeks of treatment, the first pump 
was replaced under anesthesia by a second pump for another 2 weeks 
treatment. Seven monkeys received either one of two monoclonal antibodies 
(mAbs) against different sites of Nogo-A (Table 1): the mouse mAB 11C7 
(Liebscher et al., 2005) was raised against a 18 amino acid peptide of rat Nogo-
A (aa623 – 640), close to the most inhibitory region of the Nogo-A protein (Oertle 
et al., 2003), which cross-reacts with mouse and monkey Nogo-A. The second 
antibody used, mAb hNogo-A was raised by immunization with the whole Nogo-
A specific region of the human Nogo-A sequence. The characterization of the 
two anti-Nogo-A antibodies was performed as follows. Cynomologus monkey 
brain tissue (cerebral cortex) was homogenized in T-PER lysis buffer (Pierce) 
using a rotor stator. For Western Blots, aliquots corresponding to 10 µg total 
protein were separated on a 4-12% NuPAGE gel (Invitrogen). The protein bands 
were transferred to a nitrocellulose membrane. The membrane was blocked for 1 
hour at room temperature in blocking buffer (2% blocking reagent (Amersham) in 
TBS-T), then incubated with either 0.1 nM hNogoA mAB or 1nM 11C7 antibody 
in blocking buffer for 2 hours, followed by 1 hour incubation with either anti-
human or anti-mouse peroxidase coupled secondary antibodies (1:500 000 
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dilution in blocking buffer). Signals were detected using ECL-Advance Western 
Blot detection reagents (Amersham) and exposure to film for 1 minute. Both 
antibodies recognize primate Nogo-A monospecifically on Western blots (Figure 
1B; see also Oertle et al., 2003). The antibodies were purified as IgGs and 
concentrated to 3-10 mg/ml in phosphate buffered saline (PBS). In the other six 
monkeys, a control antibody was infused, corresponding to a purified IgG of a 
mouse mAb directed against wheat auxin (AMS Biotechnology, Oxon/UK). 
In safety studies conducted in the monkey, remaining antibodies were 
retrieved form the pump at the end of the treatment (after 4 weeks), when the 
osmotic pumps were removed. The antibody hNogoA mAB was found to be 
completely stable. Both anti-Nogo-A antibodies used were shown to be 
distributed with the flow of CSF over most of the spinal cord and brain within 7 
days of infusion and to penetrate deeply into the parenchyma (Weinmann et al, 
2006). They are internalized together with endogenous Nogo-A protein into 
endosomal and lysosomal structures, leading to a down regulation of Nogo-A 
(Weinmann et al, 2006). The concentrations chosen for the anti-Nogo-A antibody 
treatment (3-10 mg/ml) are high in relations to the high sub-nanomolar affinities 
of the antibody for Nogo-A. Therefore, differences in efficacy are not expected at 
these concentrations. Due to the limited number of monkeys treated either with 
one (11C7) or the other (hNogoA) of the two anti-Nogo-A antibodies, the issue of 
whether there was a difference in efficacy between the two could not be 
addressed. 
In the first six lesioned monkeys included in the study (pilot animals), the 
identity of the antibody contained in the pump was known to the experimenters 
(Supplementary Table 1 in Freund et al., 2006). For the seven other lesioned 
monkeys, the experimenters were blind as to the antibody contained in the pump 
(Supplementary Table 1 in Freund et al., 2006) until the end of the experiment 
(sacrifice of the animal and reconstruction of the lesion). The pump and the 
silastic tube were removed after four weeks of treatment. Each pump was then 
checked for the volume left in order to ensure that the antibody has been 
properly delivered. 
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Tracing experiments and histological assessment of the lesion 
The anterograde tracer Biotinylated Dextran Amine (BDA, Molecular 
Probe®) was injected in the contralesional hemisphere (motor cortex) of the 
thirteen lesioned monkeys to label the CS tract, using Hamilton syringes. 
Similarly, for comparison, BDA was injected unilaterally in the motor cortex of 
three additional intact monkeys (Table 2). Under propofol anesthesia (see 
above), a craniotomy was performed to expose the central and arcuate sulci. 
Injections of BDA were performed in the primary motor cortex (M1), i.e. in the 
rostral bank of the central sulcus, in a territory corresponding mainly to the hand 
representation. Based on previously available monkeys in which the hand 
representation was determined by intracortical microstimulation (Rouiller et al., 
1996, 1998; Schmidlin et al., 2004, 2005), the hand territory was estimated to be 
located immediately rostral to the central sulcus, extending medio-laterally 
between 10 to 15 mm from midline, with its most lateral extent roughly 
corresponding to the genu of the arcuate sulcus. In this territory of about 5-6 mm 
along the medio-lateral axis, three to four syringe penetrations were aimed 
perpendicularly to the cortical surface, at 1.5 to 2 mm distance from each other. 
To cover most of the rostral bank of the central sulcus, BDA was typically 
deposited along each syringe penetration at two (rarely three) depths, usually at 
sites located 3 and 7 mm below the pial surface. Usually one to three additional 
syringe penetrations were performed more medially, still along the central 
sulcus, to cover the representation of more proximal territories (wrist, elbow, 
shoulder, trunk). The detailed parameters of BDA injections are given for each 
monkey in Table 1. Based on our previous experience with tracing the CS tract 
with BDA in monkeys (Rouiller et al., 1996), the survival time after BDA injection 
was set to three weeks for the first two lesioned animals. However, it turned out 
that the cervical lesion substantially slowed down the anterograde axonal 
transport of BDA and therefore the tracer did not reach the cervical segments of 
interest. For this reason, a much longer survival time (around 60-80 days) was 
applied to the other eleven lesioned monkeys, allowing transport of BDA up to 
Chapter 4: Enhanced sprouting rostral to lesion in anti-Nogo-A treated monkeys        111 
 
thoracic level. Furthermore, it appeared that in two lesioned monkeys, the BDA 
staining was not dense enough in the cervical cord for a full anatomical analysis. 
Consequently these four animals (too short survival time or insufficient staining) 
were not considered further in the present study. The list of the nine lesioned 
monkeys considered in the present study for the analysis of CS axons rostral to 
the cervical lesion is given in Table 1. 
At the end of the survival period, the animals were sacrificed under deep 
(lethal) anaesthesia (90 mg of sodium pentobarbital/Kg body weight) by 
transcardiac perfusion with 0.9% saline (400 ml). The perfusion was continued 
with fixative (3 liters of 4% phosphate buffered paraformaldehyde in 0.1 M 
phosphate buffer, pH=7.6) and solutions (2 liters each) of the same fixative 
containing increasing concentrations of sucrose (10, 20 and 30%). The brain and 
spinal cord were dissected and placed in a 30% solution of sucrose (in 
phosphate buffer) for cryoprotection for seven days. Frozen sections (50 µm 
thick) of the brain were cut in the frontal plane whereas frozen sections (50 µm 
thick) of the cervical cord (approximately the segments C6-T3) were cut in the 
parasagittal longitudinal plane and collected in three series for later histological 
processing. Upper cervical segments and lower thoracic spinal segments were 
cut in the frontal plane at 50 µm thick and sections were also collected in three 
series. BDA staining was revealed in one series of spinal cord sections, as 
described in detail in previous reports (Rouiller et al., 1996, 1998). The second 
series of spinal cord sections were immunohistochemically processed to 
visualize corticospinal axons using the marker SMI-32, as recently reported 
(Wannier et al., 2005), a series of sections also used to reconstruct the location 
and extent of the cervical lesion (Fig. 1C), as described in detail earlier 
(Schmidlin et al., 2004; Wannier et al., 2005). The third series of sections was 
processed to visualise another anterograde tracer (Dextran-Fluorescein) injected 
in the ipsilesional hemisphere, but these data will not be presented here. A light 
microscope (Olympus) and Neurolucida® software were used for analyses of CS 
axon numbers, retraction, arbor length, sprouting and trajectories. 
 
Chapter 4: Enhanced sprouting rostral to lesion in anti-Nogo-A treated monkeys        112 
 
Normalization of BDA labeled CS axons 
Due to variations in the uptake of the tracer BDA (Table 1; see also 
Supplementary Table 1 in Freund et al., 2006), the number of BDA labeled CS 
axons varied from one animal to the next. In order to normalize the BDA data 
across monkeys, the total number of BDA-labeled CS axons was counted at C5 
level on a frontal section in the white matter, in the two dorsolateral funiculi and 
in the ventral funiculus ipsilateral to the BDA injection in the cerebral cortex 
(Table 1). 
 
Measurement of retraction of lesioned CS axons and number of CS axons with 
terminal retraction bulbs 
On the photomicrographs of the parasagittal cervical cord sections 
processed for BDA visualization, a first line was drawn along the rostral border of 
the lesion using CorelDraw® software. A second line, parallel to the first one, 
was drawn 600 µm more rostrally, following the orientation of the axons. The first 
line offered a fixed point of reference for measuring the distance of CS axonal 
retraction (Fig. 2A). The distance of the center of each terminal bulb (identified 
as being at least twice the axon caliber) to the lesion border was measured 
within this space. Only CS axons with terminal bulbs located in the white matter 
at a maximal distance of 600 µm from the edge of the lesion were used for this 
analysis (Fig. 2A). A more specific question was addressed to the terminal bulbs 
located in the first 100 µm from the rostral border of the lesion. CS axon arbors 
displaying no such terminal bulbs were not taken into consideration for 
measurement, because it could not be excluded that the cut end of the axons 
was leaving the plane of the section, thereby continuing on an adjacent section. 
The cumulated number of CS axon with terminal bulbs observed on the BDA 
sections analyzed was finally divided by the total number of BDA-labeled CS 
axons observed at C5, for normalization as explained above. The above 
assessments of the number of CS axons with terminal retraction bulbs (Figs. 2D 
and 2F) and the distance of retraction (Fig. 2E) are represented schematically by 
the numbers "1" and "2" in Figure 1A. 
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Measurement of CS axon arborization and CS sprouting 
In the grey matter, the presence of BDA labeled CS axon arbors was 
investigated at the immediate border of the lesion and within an area extending 
up to 500 µm away from the rostral limit of the lesion at a total magnification of 
200x. For this analysis (schematically represented by the number "3" in Figure 
1A), all parasagittal spinal cord sections processed for BDA visualization (150 
µm intervals) on the ipsilesional cervical side were chosen. Using neurolucida® 
software, each BDA-labeled axon segment in the grey matter was traced. Then 
the cumulated axon arbor length was computed and normalized with respect to 
the total number of CS axons labeled at C5 level, as described above. 
Using the software neurolucida® as well, the BDA-labeled CS axon arbors 
which attempted to enter the lesion by crossing the rostral limit of the lesion were 
drawn. The cumulated number of CS axon arbors intercepting the rostal border 
of the lesion was determined in each monkey (analysis represented 
schematically by the number "4" in Fig. 1A). 
To analyze further the sprouting of the CS axons in the region rostral to the 
lesion, BDA-labeled CS axon arbors entering into the grey matter were counted 
up to a distance of 3 mm away from the rostral border of the lesion on the 
parasagittal sections (number "5" in Fig. 1A). For this analysis, histological 
sections exhibiting BDA-stained CS axons in the white and grey matter were 
selected (ranging from 5 to 9 slides across animals). At their crossing with the 
white/grey matter border, these axon arbors were generally oriented along a 
perpendicular axis, although some of them showed an orientation that was 
slightly oblique from the axis perpendicular to the white/grey matter border. 
Furthermore, at more rostral levels in the cervical cord, five frontal sections 
taken at C5 level were selected to count the number of CS fibers crossing the 
midline at C5 (analysis represented schematically by the number "6" in Fig. 1A). 
Using neurolucida® software, a vertical line was superimposed onto the midline 
of the frontal section of the cervical cord at C5 level and two additional vertical 
lines were drawn at a distance of 250 µm on each side away from the line on the 
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midline (Fig. 5C). CS axon arbors crossing these lines were counted (if the same 
axon arbor was long enough to intercept two or three lines, it was counted once) 
and the cumulated number for the five frontal sections were normalized by 
dividing by the total number of CS axons present at C5 level in the white matter, 
as described above. 
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Figure 1  
Panel A: Schematic representation of the macaque monkey corticospinal (CS) projection 
originating from the right primary motor cortex (M1) as seen at cervical cord level, as a result of 
BDA injection (green syringe) in the right motor cortex. At C5 level, on a frontal section of the 
cervical cord, green dots indicate the location and distribution of the CS axons, forming the 
dorsolateral funiculus (dlf) contralateral to the injection site and the uncrossed CS axons, present 
in the dorsolateral and ventral funiculi ipsilateral to the injection site. At C7/C8 level, the 
ensemble of black oblique lines represent the cervical lesion performed in the present study in 
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thirteen monkeys. Rostral to the lesion, parallel green thick lines represent CS axons in the 
dorsolateral funiculus, interrupted by the lesion. Axonal sprouting is represented by thinner lines 
arising from the thick green lines. The numbers “1” to “6” point to the six sites of the quantitative 
analyses performed in the present study as explained in the method section. The brown syringe 
is for pharmacological reversible inactivation experiments of the contralesional primary motor 
cortex (M1), as previously reported (Schmidlin et al., 2004) and mentioned in the discussion. The 
thick vertical dashed line represents midline, whereas the thin vertical dashed line represents the 
boundary between the white (wm) and the grey (gm) matter. 
Panel B: Both monoclonal antibodies against Nogo-A, 11C7 and anti-hNogo-A, recognize a 
single band running at the expected molecular weight of Nogo-A in cortex homogenates of adult 
macaque monkeys separated by SDS polyacrylamide gel electrophoresis. 
Panel C: Reconstruction from parasagittal sections in the frontal plane of the location and extent 
of the lesion at C7/C8 lesion performed in the nine monkeys included for the present analysis of 
the CS tract rostral to the lesion. Lesions in blue are for the control antibody treated monkeys 
(n=4) whereas red represents the lesion in the anti-Nogo-A antibody treated monkeys (n=5). The 
asterisks point to the two monkeys with incomplete lesion of the dorsolateral funiculus (see text). 
 
1.4 Results 
Morphology of the unilateral cervical cord lesion 
Following unilateral injection of BDA in the contralesional primary motor 
cortex (M1) mainly in the hand representation, the main CS tract was found at 
cervical cord level (C5) in the left dorsolateral funiculus, representing 90-95% of 
the whole CS population (Fig. 1A). The uncrossed CS projection (representing 5-
10% of CS axons) was found in the dorsolateral and ventral funiculi homolateral 
to the BDA injection (Fig 1A). These figures are consistent with a recent report 
on the distribution of CS axons at the level of the lumbar cord (Lacroix et al., 
2004). The unilateral section of the cervical cord was aimed at transecting the 
crossed CS tract in the left dorsolateral funiculus (Fig. 1C). In seven out of nine 
lesioned monkeys included in the present anatomical analysis, the dorsolateral 
funiculus was indeed completely interrupted, as assessed on the basis of the 
location and extent of the lesion (Fig. 1C) in comparison to the location and 
extent of the dorsolateral funiculus in an intact monkey after BDA injection in M1. 
In addition, BDA labeling of CS axons in the white matter provided evidence that 
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all axons in the dorsolateral funiculus were indeed sectioned in these seven 
monkeys. On the other hand, in two monkeys (indicated by an asterisk in Fig. 
1C), the lesion did not completely interrupt the dorsolateral funiculus in its most 
ventro-lateral extent and therefore some CS fibers were spared. The intact BDA-
labeled CS fibers were easily detectable, because of their straight course in the 
white matter; they were excluded from the anatomical analysis. 
The lesion territory was easily distinguishable from the intact spinal cord 
tissue. A scar consisting of non-homogenous tissue and of cysts of various 
diameters was observed, acting as a clear physical impediment for axonal re-
growth in the rostro-caudal direction (Fig. 3A). 
 
Effects of anti-Nogo-A antibody treatment on CS axons in the region rostral to 
the cervical cord lesion 
In order to evaluate whether the anti-Nogo-A antibody treatment favored 
the maintenance, growth and/or sprouting from the CS axons in the area rostral 
to the cervical cord lesion, six quantitative morphological analyses were 
conducted at specific locations, represented schematically by the numbers "1 to 
6" in Figure 1A, and presented below in the paragraphs numbered accordingly. 
The detailed results obtained for these six analyses are given for each individual 
lesioned monkey in Table 1. 
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Figure 2  
Panels A-C: The panel A photomicrograph displays transected BDA-labeled CS fibers at the 
proximity of the rostral border of the lesion in the white matter. The lesion border appears as non-
homogenous axon free tissue distinct from more rostral intact spinal cord tissue. The arrows with 
double heads illustrate how the distance was measured between a terminal retraction bulb and 
the rostal border of the lesion. L=Lesion; wm, white matter. The panels B and C 
photomicrographs illustrate at higher magnification BDA labeled CS axons close to the lesion 
forming retraction bulbs (arrows). Scale bars=50µm. 
Panel D: Normalized number of terminal retraction bulbs observed within a territory extending 
600 m away from the lesion border in the rostral direction for the nine lesioned monkeys 
included in the present study, separately for the control antibody treated monkeys (n=4) and the 
anti-Nogo-A antibody treated monkeys (n=5). The site of this analysis is schematically 
represented by the number “1” in Figure 1A. 
Panel E: For each monkey, the distance between each terminal retraction bulb observed and the 
rostal limit of the lesion was plotted. Superimposed on the individual measurements, the box and 
whisker plot depicts the median value (horizontal bar in the middle of the box) and the 25 and 75 
percentiles (bottom and top extremities of the box, respectively). The site of this analysis is 
schematically represented by the number “2” in Figure 1A. 
Panel F: Instead of considering a territory of 600 m away from the lesion in the rostral direction 
(panels A, D and E), a more restricted area only 100 m away from the lesion was considered. 
The horizontal bar represents the % of the total number of terminal retraction bulbs observed up 
to 600 m away from the lesion which terminates not further than 100 m from the rostral border 
of the lesion. 
 
 
1) Appearance and number of  terminal retraction bulbs on transected BDA 
labeled CS axons 
In all monkeys subjected to cervical cord lesion, BDA-labeled CS axons 
displaying terminal retraction bulbs were found rostral to the lesion (Fig. 2A, B 
and C), corresponding to a common feature for transected axons that underwent 
retrograde degeneration (Kao et al., 1977a,b; Kalil and Schneider, 1975; Houle 
and Jin 2001). To investigate the influence of anti-Nogo-A antibody treatment 
upon the transected CS axons, the region rostral to the lesion was scanned at 
high magnification for CS axons exhibiting terminal retraction bulbs. 
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Terminal retraction bulbs in the area rostral to the lesion, in a territory of 
white matter extending 600 µm away from the lesion border, were counted in 
each monkey and cumulated for all parasagittal sections analyzed. For 
normalization, the cumulated numbers of terminal retraction bulbs in each 
monkey were divided by the total number of BDA-labeled CS fibers in the white 
matter at C5 level. Strikingly, in anti-Nogo-A antibody treated monkeys, the 
normalized cumulated numbers of CS axons exhibiting terminal retraction bulbs 
were significantly lower (approximately 4x on average) than in control antibody 
treated monkeys (Fig. 2D). This difference was statistically significant (Mann and 
Whitney test: P<0.05). Furthermore, from a qualitative point of view, anti-Nogo-A 
antibody treated monkeys, instead of exhibiting the standard terminal retraction 
bulbs, often showed outgrowing sprouts being tortuous in shape and decorated 
with varicosities, strongly resembling boutons en passant  and terminaux that 
approached the lesion border (Fig. 3B and C). 
Chapter 4: Enhanced sprouting rostral to lesion in anti-Nogo-A treated monkeys        121 
 
 
Figure 3 
Panel A: Photomicrograph of a parasagittal 
spinal cervical-thoracic cord section 
illustrating the appearance of BDA-labeled 
CS fibers in the grey matter, rostral to the 
lesion (arrow). The section was taken from 
an anti-Nogo-A antibody treated monkey. 
The CS axons in the white matter and the 
CS axon arbors in the grey matter, shown at 
higher magnification below in panels B and 
C, are located in the cervical cord as 
indicated by the two rectangles. 
Panels B and C: Typical examples of 
sprouting from transected CS axons in the 
white (B) and grey matter (C) giving rise to 
collaterals directed towards the lesion 
border. These axons were tortuous and 
irregular in growth with varying diameter 
and varicosities (arrows) along their course 
and at their termination. wm=white matter; 
gm=grey matter. 
Scale Bar=1 mm in panel A, 100 m in 
panel B and 50 m in panel C. 
 
 
 
2) CS axonal retraction (axonal dieback) 
To address the issue of a response of the transected CS axons to anti-
Nogo-A antibody treatment, the distance of retraction from the lesion for the CS 
axons exhibiting a terminal retraction bulb was measured. All terminal retraction 
bulbs within a distance of 600 µm from the rostral limit of the lesion were 
included. 
The average retraction distance from the lesion border was markedly 
reduced in anti-Nogo-A antibody treated monkeys as compared to the control 
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antibody treated monkeys (Fig. 2E). This difference was not statistically 
significant (Mann and Whitney test, P>0.05). However, because of the large 
variability across monkeys and because of the much lower number of CS axons 
with terminal retraction bulbs in the anti-Nogo-A antibody treated monkeys with 
regard to that in the control antibody treated monkeys, the conditions were not 
favorable to detect a possible treatment-induced population difference (Fig. 2E). 
A prominent difference appeared, however, when focusing on a more 
restricted area, within 100 µm of the rostral limit of the lesion (Fig. 2F). About 
10% of transected CS axons displaying a terminal retraction bulb were found in 
the control antibody treated monkeys. In contrast, this proportion ranged 
between 27 and 60% in the anti-Nogo-A antibody treated monkeys (see also 
Table 1). As the total number of terminal retraction bulbs was much higher in the 
control antibody treated monkeys (Fig. 2D), the data of Figure 2F indicate that 
the transected CS axons in anti-Nogo-A antibody treated monkeys rarely formed 
terminal retraction bulbs, but when they did, they were located close to the 
lesion. In contrast, the numerous terminal retraction bulbs in the control antibody 
treated monkeys had generally retracted further from the lesion. 
 
3) Density of CS axon arbors in the grey matter rostral to the lesion 
To investigate whether anti-Nogo-A antibody treatment induced changes 
within the grey matter of the cervical cord above the lesion, the BDA-labeled CS 
axon arbors within the spinal cord 500 µm rostral to the lesion on parasagittal 
sections were traced bilaterally at a magnification of 200x. The sections were 
then superimposed (Fig. 4A-D), showing for each animal the density of axon 
arbors in the white matter rostral to the lesion (brown lines) as well as in the grey 
matter rostral to the lesion (black lines on the left side of the lesion in Fig. 4A-D). 
For completeness of the information, BDA-labeled CS axon arbors caudal to the 
lesion were also represented. However, these data were described in a recent 
report (Freund et al., 2006) and will therefore not be considered further. At first 
sight, numerous BDA-labeled CS axon arbors are present in the grey matter 
rostral to the lesion (Fig. 4A-D), without obvious difference between the two 
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groups of monkeys. To quantify the density of CS axon arbors in the grey matter 
rostral to the lesion, their cumulated length was measured (see methods). The 
cumulated axon arbor length was then normalized by dividing by the total 
number of BDA-labeled CS axons present at C5 level in the white matter, and 
plotted as a function of the extent (in % of the hemi-cord) of the lesion (Fig. 4E). 
If one excludes the animal Mk-CP (asterisk in Fig. 4E) which had an incomplete 
lesion of the CS tract, there is a clear trend showing that anti-Nogo-A antibody 
treated monkeys (red squares in Fig. 4E) displayed a higher cumulated axon 
arbor length than the control antibody treated monkeys (blue circles), thus 
indicating that the anti-Nogo-A antibody treatment enhanced axon sprouting in 
the grey matter rostral to the cervical lesion. However, this trend was not 
statistically significant (Mann and Whitney test, P>0.05). 
More labeled CS axon arbors are visible rostral and caudal to the lesion in 
Mk-CG (control antibody treated) than in Mk-AC (anti-Nogo-A antibody treated): 
this apparent contradiction is due to the much higher (4 times) total number of 
CS axons labeled with BDA in Mk-CG than in Mk-AC (see Table 1). If normalized 
according to the total number of CS axons labeled with BDA, then Mk-AC 
exhibits a larger cumulated axon arbor length rostral to the lesion (Fig. 4E) and a 
higher number of axon swellings caudal to the lesion (Fig. 4F) than Mk-CG (see 
also Freund et al., 2006). Furthermore, the extent of the lesion was smaller in 
Mk-CG than in Mk-AC. 
 
4) CS axon arbors entering the lesion 
On the parasagittal reconstructed sections used for the CS axon arbor 
length measurements, special attention was paid to CS axon arbors entering the 
scar tissue of the lesion. Examples are shown in Figure 5A, where more CS 
axons entered the lesion in three anti-Nogo-A antibody treated monkeys (red) 
than in one control antibody treated monkey (blue). For quantification, BDA-
labeled CS axon arbors that crossed the rostral border of the lesion were 
counted in each monkey, normalized (according to the total number of BDA-
stained CS axons at C5) and compared between the two groups of monkeys 
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(Fig. 5D). All anti-Nogo-A antibody treated animals exhibited a higher number of 
CS axon arbors entering the scar tissue than the highest number of such axons 
found in the group of control monkeys (Fig. 5D, Table 1). This difference 
between the two groups of monkeys is statistically significant (Mann and Whitney 
test: p<0.05). Typically, the course of these fibers was highly irregular, showing 
that they were regenerating rather than surviving fibers. Nevertheless, even in 
anti-Nogo-A antibody treated monkeys, the number of CS axons entering the 
lesion remains very low (Fig. 5D). Furthermore, none of these CS fibers reached 
the caudal border of the lesion. These results indicate that the CS axon arbors 
observed caudal to the lesion (Freund et al., 2006) did not arise from transected 
CS axons which would have regenerated straight through the lesion but rather 
from regenerating axons having grown around the lesion on bridges of spared 
white and grey matter. 
5) CS axon collaterals entering the grey matter rostral to the cervical lesion 
To determine whether anti-Nogo–A antibody treatment possibly enhanced 
CS axon collateral sprouting, the number of axon arbors leaving the cervical 
white matter and entering the grey matter was counted in the two groups of 
monkeys. Axons were counted within a territory extending as far 3 mm rostral 
from the lesion (Figs. 1A and 5B). Only six monkeys (Mk-CB, Mk-CH, Mk-CP, 
Mk-AP, and Mk-AM, Mk-AG) fulfilled the criterion of sufficient quality of BDA 
staining to identify clearly such CS axon arbors leaving the white matter and 
entering the grey matter. The numbers of such CS axon arbors was normalized 
and plotted as a function of the extent of the hemi-cord lesion (Fig. 5E). The 
number of CS axon arbors passing from the white to the grey matter was lower 
in the three control antibody treated monkeys than in the three anti-Nogo-A 
antibody treated monkeys, without any obvious relationship to lesion size in 
either group of monkeys (Fig. 5E). For comparison, the same measurement was 
conducted in an intact monkey (Mk-I3; Table 2), exhibiting a normalized number 
of CS axon arbors entering the grey matter rostral to the lesion slightly lower 
than the three control antibody treated monkeys subjected to cervical cord lesion 
(Fig. 5E). 
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6) CS axons crossing the midline at C5 
In the case of complete hemi-section of the spinal cord, CS axons growing 
around the lesion in an attempt to re-innervate the denervated spinal cord caudal 
to the lesion, would have to cross the spinal cord midline. For this reason, we 
examined the frontal sections taken at the level C5 to determine whether BDA-
labeled CS axons crossed the midline in the grey matter and if such midline 
crossing was enhanced by the anti-Nogo-A antibody treatment (Fig. 5C; see also 
methods sections). The sum of CS axons crossing the midline at C5 in each 
monkey was normalized to the total number of labeled CS axons and plotted as 
a function of the lesion extent (Fig. 5F). The anti-Nogo-A antibody treated 
monkeys exhibited a higher number of midline crossing CS axons than the 
control antibody treated monkeys (Fig. 5F). There was no relationship to the 
lesion extent in either group of monkeys. For comparison, the same analysis was 
conducted in three intact monkeys (Table 2), exhibiting a normalized number of 
CS axons crossing the midline at C5 equal or lower than the four control 
antibody treated monkeys subjected to cervical cord lesion (Fig. 5F). 
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Figure 4  
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Panels A-D: Superimposed reconstructions of parasagittal sections of the cervical-thoracic cord 
showing the lesion (vertical arrow) as well as the density of BDA-labelled CS axon arbors present 
around the lesion, in four different monkeys (with a reminder of their lesion extent). Two monkeys 
received the control antibody (Mk-CH and Mk-CG in panels A and C) whereas in the other two 
monkeys the anti-Nogo-A antibody was delivered (Mk-AM and Mk-AC in panels B and D). 
Rostral to the lesion, the densely packed brown line segments represent the BDA-labelled CS 
axons in the white matter, interrupted by the transection of the dorsolateral funiculus. The 
position of the rostral stump of CS fibers in the white matter and of the axon arbors in the grey 
matter is schematic, as derived from a superimposition of sections, some of which were located 
more lateral than those for which their contour is represented here. The black line segments 
represent the CS axon arbors traced rostrally in the grey matter and caudally to lesion. In these 
four monkeys, the dorsolateral funiculus was completely transected. A less detailed version of 
these 4 reconstructions has been previously published in Freund et al. (2006), where the CS 
axon arbors rostral to the lesion were not represented. 
Panel E: Relationship between the normalized cumulated axon arbor length in the grey matter 
rostral to the lesion as a function of the extent (in %) of the hemi-cord lesion. Cumulated axon 
arbor lengths were measured only rostral to the lesion. Blue circles are for control antibody 
treated monkeys whereas red squares are for the anti-Nogo-A antibody treated monkeys. The 
site of this analysis is schematically represented by the number “3” in Figure 1A. 
Panel F: The present data about the axonal sprouting of the CS tract rostral to the lesion 
(reflected here by the normalized cumulated axon arbor length) was plotted as function of the 
normalized number of CS axonal swellings observed caudal to the lesion, as reported recently 
(Freund et al., 2006). 
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1.5 Discussion 
The present study provides evidence that, after unilateral cervical lesion 
that sections the dorsolateral funiculus, anti-Nogo-A antibody treatment 
decreased the normally occurring retrograde degeneration of the CS axotomized 
axons: the number of terminal retraction bulbs formed by the axotomized CS 
axons was smaller in the group of anti-Nogo-A antibody treated monkeys than in 
the group of control antibody treated monkeys (Fig. 2D) and the terminal 
retraction bulbs were closer to the lesion (Fig. 2E and F). Thus, anti-Nogo-A 
antibody treatment prevented to some extent the phenomenon of axonal 
dieback. More CS axons grew into the lesion scar, but their regeneration through 
the scar tissue remained unsuccessful. In contrast, increased numbers of CS 
axon arbors were seen in the anti-Nogo-A antibody treated spinal cord rostral to 
the lesion. Some of these fibers arborized in the spinal cord caudal to the injury, 
as recently reported (Freund et al., 2006). 
With respect to the question of direct regeneration of the cut stem axon or 
collateral axonal sprouting, there is evidence here that both were enhanced by 
anti-Nogo-A antibody treatment. Axotomized CS axons growing and penetrating 
into the lesion area were more numerous in the anti-Nogo-A antibody treated 
monkeys than in the control antibody ones. However, none of the CS axons 
penetrating the scar seemed to be able to reach its distal end. Scar associated 
growth inhibition factors probably account for this blockade of regeneration 
(Rhodes and Fawcett, 2004). 
CS axons rostral to the injury gave rise to collaterals. The anti-Nogo-A 
antibody treatment enhanced the presence of CS axon arbors in the grey matter 
rostral to the lesion, the number of CS axon arbors (possibly corresponding to 
CS axon collaterals) passing from the white to the grey matter and, finally, the 
number of CS axon arbors crossing the segmental midline at C5 level. These 
measurements show that axonal sprouting took place rostral to the cervical 
lesion, and that some of these fibers were in position to grow around the lesion 
in order to re-innervate the spinal cord territory caudal to the lesion deprived of 
CS input. The anti-Nogo-A antibody treatment enhanced CS axonal sprouting 
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and re-growth, confirming previous observations in anti-Nogo-A antibody treated 
rats (Liebscher et al., 2005). 
The larger number of CS axon arbors observed caudal to the lesion in the 
anti-Nogo-A antibody treated monkeys correlates with enhancement of functional 
recovery, especially of manual dexterity, i.e. functions known to depend on direct 
inputs from CS fibers (Freund et al., 2006). As further discussed hereunder, in 
our view the present data suggest a mechanism of functional recovery relying on 
collateral sprouting that arises from the axotomized CS axons rostral to the 
lesion, possibly contributing to the increased presence of CS axonal arbors in 
the grey matter of the spinal segments caudal to the lesion (green curved lines in 
Fig. 1A). Again, these data are consistent with previous data in rodents showing 
that "regenerative sprouting" enhanced in anti-Nogo-A antibody treated rats 
consisted of CS collaterals growing around the lesion on remaining tissue 
bridges (e.g. von Meyenburg et al., 1998; Brösamle et al., 2000; Schwab, 2004; 
Liebscher et al., 2005). 
The present study did not address the possibility that some CS axon arbors 
observed caudal to the lesion (Freund et al., 2006) could result from sprouting 
arising from the undecussated CS axons not affected by the cervical lesion (Fig. 
1A). In rats subjected to a spinal cord lesion interrupting the main CS tract, axon 
sprouting from the intact ventral CS tract was indeed found to play an important 
role in the spontaneous post-lesion recovery (Weidner et al., 2001). CS fibers 
from the intact side have been seen to cross the spinal cord midline in rats after 
unilateral pyramidotomy and anti-Nogo-A antibody application (Thallmair et al., 
1998). In earlier studies in macaques, we found that reversible inactivation by 
intracortical muscimol infusion in the contralesional hemisphere several months 
post-lesion leads to a loss of recovered manual dexterity (Schmidlin et al., 2004; 
see brown syringe in Fig. 1A). In contrast, reversible inactivation of the 
ipsilesional hemisphere in control antibody treated monkeys did not affect the 
post-lesional functional recovery (Schmidlin et al., 2005), indicating that the 
decussated CS tract originating from the ipsilesional hemisphere does not play a 
major role in the recovery. Altogether, the present data as well as our recent 
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report (Freund et al., 2006) favor the notion that collateral sprouting and growth 
of the axotomized CS tract after cervical cord lesion may play a role in the post-
lesion functional recovery. 
It remains to be determined whether other descending tracts (rubrospinal, 
reticulospinal, long propriospinal projections) may also contribute, as shown in 
the rat (e.g. Hashimoto and Fukuda, 1991; Feraboli-Lohnherr et al., 1997; 
Raineteau et al., 2001; Schucht et al., 2002; Ruitenberg et al., 2003; Bareyre et 
al., 2004; Fouad et al., 2001). The possibility that the rubrospinal and 
reticulospinal tracts may play a role in the functional recovery is consistent with 
the observation reported in Freund et al. (2006) that the two control antibody 
treated monkeys with a lesion leaving intact a significant portion of these two 
tracts spontaneously recovered much better than the control antibody treated 
animal in which the lesion interrupted these two tracts completely. 
The correlation between the anti-Nogo-A antibody enhancement of CS 
sprouting rostral to the cervical lesion (present study) and the density of CS tract 
axons caudal to the lesion (Freund et al., 2006) is shown in Figure 4F. The 
normalized cumulated axon arbors length as determined rostral to the lesion 
(present study) was plotted as a function of the normalized number of CS axonal 
swellings found caudal to the lesion, as reported recently (Freund et al., 2006). 
The control antibody treated monkeys subjected to complete transection of the 
dorsolateral funiculus exhibited no or only few CS axonal swellings caudal to the 
lesion; this was correlated with limited axonal sprouting rostral to the lesion in 
these animals (Fig. 4F: three blue circles on the left of the plot). In sharp 
contrast, the four anti-Nogo-A antibody treated monkeys, all subjected to 
complete transection of the dorsolateral funiculus, exhibited much higher 
numbers of CS axonal swellings caudal to the lesion. This again correlated with 
a significantly higher density of CS axon arbors arising from sprouts rostral to the 
lesion (red squares in Fig. 4F). The control antibody treated monkey Mk-CP (with 
an asterisk in Fig. 4F) needs to be considered separately because the lesion of 
the dorsolateral funiculus was incomplete (Fig. 1C), leaving a small bundle of CS 
axons intact. The intact CS axons reaching the region caudal to the lesion 
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sprouted profusely at that level, giving rise to numerous axon arbors and 
swellings. This animal showed a much better functional recovery than the other 
control antibody treated monkeys (Freund et al., 2006). 
 
Comparison with previous studies 
The present model of cervical cord lesion in the monkey can be compared, 
at least from a behavioral point of view, to previous studies in which macaque 
monkeys were subjected to a lesion of the cervical cord (Galea and Darian-
Smith, 1997; Sasaki et al., 2004). Although the transection of the dorsolateral 
funiculus was aimed at lower cervical segments (C7/C8) than in these two 
studies (C3-C4), we observed an extent and a time course of functional recovery 
(Freund et al., 2006) largely comparable to that reported by Galea and Darian-
Smith (1997). In contrast, Sasaki et al. (2004) reported an even faster, if not 
immediate, time course of recovery of precision grip and independent finger 
movements (1-28 days), although weakness in force and deficit in pre-shaping 
lasted longer. The two studies of lesion at C3-C4 level (Galea and Darian-Smith, 
1997; Sasaki et al., 2004) did not analyze the plasticity of the CS tract in the 
vicinity of the cervical lesion, thus preventing a comparison with the present 
anatomical data. 
A different neutralizing antibody against Nogo-A, mAbIN-1, was applied in 
marmosets with a thoracic lesion (Fouad et al., 2004). CS fibers growing around 
the lesion and into the caudal spinal cord were observed (Fouad et al., 2004), 
but the animals were not tested behaviorally preventing correlation with 
functional recovery. 
A post-lesion sprouting of the CS tract was shown to be present in hamster 
only at perinatal ages (Kuang and Kalil, 1990). Adult hamsters subjected to 
pyramidotomy exhibited a retraction of the axons rostral to the lesion by a 
substantial distance, up to about 6-7 mm after several months. The present data, 
derived from macaque monkeys subjected to cervical lesion, are markedly 
different because the distance of retraction was much smaller. Indeed, after 4-6 
months post-injury, most terminal retraction bulbs were located not more than 1 
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mm from the lesion. Furthermore, in the marmoset as well, the terminal 
retraction bulbs appeared to be located close to the lesion after two weeks post-
injury (Fouad et al., 2004). These data are in line with earlier reports in monkey 
and man that retrograde degeneration of axotomized CS axons was limited to 
the region immediately above the lesion (Tower, 1940; Bronson et al., 1978). In 
rats, axonal dieback following spinal cord lesion was studied for the rubrospinal 
and reticulospinal tracts (Houle and Jin, 2001). The authors observed an 
average retraction of the axons over a mean distance of about 500 µm, which is 
in the same order as the retraction of the CS axons seen in monkeys (Fouad et 
al., 2004; present study). The limited axonal dieback is thus favorable for a 
regenerative sprouting from the axotomized axons, giving rise to collaterals 
which can grow in the caudal direction around the lesion in order to re-innervate 
the region caudal to the lesion. 
In the present study, young adult monkeys (3.5 – 6.9 years old at time of 
sacrifice) were subjected to the spinal cord lesion (Table 1). It cannot be 
excluded that some of the axonal sprouting (although limited) observed in the 
control antibody treated monkeys occurred due to the relatively juvenile state of 
some of the animals and would not have taken place in older animals. Similarly, 
it is not established whether the enhancement of sprouting due to the anti-Nogo-
A treatment would have reached the same extent in older animals. Nevertheless, 
most of our animals (except maybe Mk-AG) had an age at the time of the lesion 
(3.5 years or more) at which the myelination of the CS tract reached the adult 
stage, as full myelination was reported to last as long as 36 months (Olivier et 
al., 1997). As far as the CS tract is concerned, the animals included in the 
present study can thus be considered as adult monkeys. 
As a result of BDA injection in M1, the number of CS labeled axons 
observed at C5 level on transverse sections (up to 2282; see Table 1) appears 
low considering that the total number of CS axons was estimated to be 400'000 
and that the number of CS neurons retrogradely labeled after tracer injection in 
the upper spinal cord amounted up to 72'000 in the entire frontal lobe (Dum and 
Strick, 1991). A few explanations may account for this. First of all, only 50% of 
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the precentral CS axons originate from M1 (Dum and Strick, 1991; He et al., 
1993, 1995). Second, the BDA injections formed patchy territories leaving in 
between zones where there was no or less uptake. Third, the BDA injections did 
not cover the entire M1; instead they were focused to the hand (forelimb) 
representation. Fourth, a contingent of CS axons terminates above C5. In 
addition, BDA infusion was limited to the rostral bank of the central sulcus and 
therefore the whole rostral part of M1 was not injected. Furthermore, as 
compared to other anterograde tracers such as WGA-HRP for instance, the 
uptake of BDA appears less prominent. However, to explain the surprisingly low 
number of CS axons labeled with BDA in the present study, one may consider 
the likely possibility that the very fine axons making the majority of the CS tract 
are not labeled or escaped detection at light microscopy level, as suggested by 
our observation that most BDA labeled CS axons visible in our material at C5 
level are relatively large in diameter. In this context, for the same reason, one 
cannot exclude that some fine CS axons unlabeled with BDA or undetected at 
light microscopic level were spared by the lesion. 
 
In conclusion, the present study demonstrates quantitatively that anti-Nogo-A 
antibody treatment attenuated the retraction of axotomized CS axons after 
cervical cord injury and enhanced axonal sprouting rostral to the lesion. Within 
the scar tissue, growth of these fibers is blocked by inhibitory factors other than 
Nogo-A. Some fibers, however, succeeded in bypassing the scar, presumably by 
remaining on grey matter bridges. These axons growing around the lesion 
probably make an important contribution to the incomplete but significantly 
enhanced reconstruction of the CS fiber plexus caudal to the lesion in the anti-
Nogo-A antibody treated monkeys (Freund et al., 2006), more so than the fibers 
attempting to regenerate and to re-enter the lesion itself. The contingent of CS 
axons growing around the lesion in the grey matter is believed to be an 
anatomical correlate of the functional recovery observed in the anti-Nogo-A 
antibody treated animals. 
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Mk-CP Mk-CG Mk-CB Mk-CH Mk-AP Mk-AG Mk-AM Mk-AS Mk-AC 
Species fasc. fasc. fasc. fasc. fasc. fasc. fasc. mul fasc. 
Anti-Nogo-A 
treatment 
No No No No Yes 
(11C7) 
Yes 
(hNogoA) 
Yes 
(hNogoA) 
Yes 
(11C7) 
Yes 
(hNogoA) 
“Double-blind” 
procedure 
Yes Yes Yes Yes Yes No Yes No Yes 
Completeness of 
CS (dlf) section 
No 
(BDA) 
Yes 
(BDA) 
Yes 
(BDA) 
Yes 
(BDA) 
Yes 
(BDA) 
Yes 
(BDA) 
Yes 
(BDA) 
No 
(BDA) 
Yes 
(BDA) 
Extent of hemi-
cord lesion (%) 
45 51 75 90 58 78 80 41 85 
Extent of grey 
matter cut (%) 
77 73 81 74 85 81 71 86 100 
Number of BDA-
labeled CS axons 
at C5 
927 1005 1186 780 1250 2282 1148 168 270 
% of uncrossed 
CS axons at C5 
10 5 9 3 5 9 5 11 7 
          
Volume of BDA 
Injected (in l) 
24 24 20 20 24 28 19 22 20 
Number of BDA 
Injection sites 
12 12 10 10 12 15 10 11 10 
Total nb. of 
injection tracks 
6 6 5 5 6 7 6 4 6 
Survival time post 
BDA injection 
(days) 
78 70 78 62 81 70 69 72 64 
Nb. of days 
between lesion 
and BDA 
injection 
81 70 147 76 79 42 69 210 71 
Age of the animal 
at sacrifice 
(years) 
6.9 ~4 5 ~4 6.5 3.5 ~4 6.25 ~4 
          
(1) Number of 
retraction bulbs / 
number of CS 
axons at C5 
0.06 0.053 0.116 0.09 0.058 0.019 
 
0.004 0.006 0.015 
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Table 1 : List of the lesioned monkeys included in the present study with identification 
code 
 
 
 
 
Detailed information on the nine monkeys included in the present anatomical study. 
Eight of the nine monkeys were part of the previous report, describing the behavioral 
recovery and the properties of the CS axon collaterals caudal to the lesion (Freund et 
al., 2006; see their Table 1). One additional animal (Mk-AG) was newly introduced in the 
present study. 
Number of CS 
axons with 
terminal bulbs 
56 53 137 70 72 44 5 2 4 
(2) Mean 
distance of 
axonal retraction 
in m (std-dev) 
291.5 
(98.3) 
326 
(292.3) 
407.5 
(171.2) 
310.7 
(154.5) 
240.8 
(144.5) 
145.9 
(101.8) 
116.5 
(155.3) 
 179.4 
(143.8) 
% of terminal 
retraction bulbs 
100m rostral to 
the lesion 
13% 7% 1% 7% 27% 36% 60% 0% 40% 
(3) Normalized 
axon arbor length 
rostral to lesion 
41.624 
 
14.961 
 
35.769 
 
23.33 
 
41.914 
 
71.12 
 
64.752 
 
 31.307 
 
(4) Normalized 
number of CS 
axotomized 
axons entering 
lesion area 
0.003 
 
0.0039 
 
0.0093 
 
0.014 
 
0.03 
 
0.022 
 
0.0366 
 
 0.0851 
 
(5) Normalized 
number of CS 
axons going from 
white to grey 
matter 
0.135  0.111 0.128 0.213 0.301 0.169   
(6) Normalized 
number of CS 
axons crossing 
midline at C5 
0.045 0.028 0.025 0.041 0.06 0.06 0.05   
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At the time of the experiment, the monkeys had different names, not indicating whether 
the animal was infused with the control or the anti-Nogo-A antibody. 
 
Under species, "mul." is for macaca mulata while "fasc." is for macaca fascicularis. 
 
The four control antibody treated monkeys ("Anti-Nogo-A treatment: No") are in the four 
leftmost columns, whereas the five anti-Nogo-A antibody treated monkeys are in the five 
rightmost columns ("Anti-Nogo-A treatment: Yes") with indication of which of the two 
antibodies was used (mAB11C7 or mAB hNogoA). 
 
Under "double-blind procedure", "Yes" refers to monkeys for which the collaborators 
delivering the antibodies (control or anti-Nogo-A) did not know to which monkey they 
were aimed for. On their side, the experimenters taking care of the monkeys did not 
know which antibody has been administered to the corresponding animal. 
 
In the row “completeness of CS (dlf) section”, “yes” and “No” indicate whether the 
dorsolateral funiculus (dlf) was or was not completely transected unilaterally, 
respectively. “BDA”, indicated between parentheses, means that completeness of the 
section of the dorsolateral funiculus unilaterally was assessed based on the BDA-
labeling of the CS tract immediately above the lesion. If "yes", this means that there was 
no BDA-labeled axon spared by the lesion in the aimed dorsolateral funiculus. If "no", 
this means that few BDA-labeled axons in the dorsolateral funiculus were spared by the 
lesion. 
 
For four animals, their age was not precisely determined when they were received in our 
animal facility and was estimated to be around 3 years old at that time. Therefore, their 
age was estimated to be around 4 years old when sacrificed. 
 
 
The grey cells in the table are for parameters that could not be determined in the 
corresponding monkeys. 
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Mk-I1 Mk-I2  Mk-I3  
Species fasc. fasc. fasc. 
Age at sacrifice (year); weight 
(kg) 
4; ~5 8.3; ~10 7.7; ~10 
Volume of BDA injected (in l) 10 22.5 25.5 
Number of injection sites 7 15 17 
Number of injection tracks 3 9 11 
Survival time post-injection 
(days) 
25 42 48 
    
Normalized number of CS axons 
going from white to grey matter 
+ ++ 0.078 
Normalized number of CS axons 
crossing midline at C5 
0.02 0.021 0.025 
Number of CS axons in the white 
matter at C5 (for normalization) 
1766 984 1922 
Number of crossed CS axons at 
C5 (% of total) 
1620 (91.7%) 859 (87.3%) 1735 (90.3%) 
Number of uncrossed CS axons 
at C5 (% of total) 
146 (8.3%) 125 (12.7%) 187 (9.7%) 
 
Table 2: List of the three “intact” monkeys included in the present study with 
identification code 
 
The data (in Bold) derived from these three intact (unlesioned, untreated) animals were 
used to establish a baseline for the analyses presented for the lesioned monkeys in 
Figures 5E and 5F. 
 
In the two intact monkeys (Mk-I2 and Mk-I3), injection of tracer in the motor cortex was 
the unique intervention, following the protocol described in the method section. Mk-I1 
was used in a previous tracing study (Rouiller et al., 1996), in which the primary motor 
cortex was mapped using intracortical microstimulation before BDA injection. 
 
Under species, "fasc." is for macaca fascicularis. 
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+ In Mk-I1, the cervical segment C6-T3 was not cut in the sagittal plane (but in the frontal 
plane) and therefore the assessment of the number of axons entering the grey 
matter could not be made. 
 
++ In Mk-I2, the quality of the BDA reaction at C6-T3 did not allow the assessment of the 
number of axons entering the grey matter. In contrast, the block including C5 
(sectioned in the frontal plane) was processed separately and the BDA reaction 
allowed the determination of the number of CS axons crossing midline. 
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Chapter 5 
 
 
Fate of rubrospinal neurons after 
unilateral section of the cervical spinal 
cord in adult macaque monkeys: 
effects of an antibody treatment 
neutralizing Nogo-A 
 
 
 
This chapter has been adapted from an article originally published in Journal 
of Brain Research (P. Wannier-Morino*, E. Schmidlin,*, P. Freund, A. Belhaj-
Saif, J. Bloch, A. Mir, M.E. Schwab, E.M. Rouiller and T. Wannier; In Press, 
2007) 
 
* The first two authors contributed equally to the study. 
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1.1 Abstract  
 
The present study describes in primates the effects of a spinal cord injury on the number 
and size of the neurons in the magnocellular part of the red nucleus (RNm), the origin of 
the rubrospinal tract, and evaluates whether a neutralization of Nogo-A reduces the 
lesioned-induced degenerative processes observed in RNm. Two groups of monkeys were 
subjected to unilateral section of the spinal cord affecting the rubrospinal tract; one group 
was subsequently treated with an antibody neutralizing Nogo-A; the second group 
received a control antibody. Intact animals were also included in the study. Counting 
neurons stained with a monoclonal antibody recognizing non-phosphorylated epitopes on 
neurofilaments (SMI-32) indicated that their number in the contralesional RNm was 
consistently inferior to that in the ipsilesional RNm, in a proportion amounting up to 35%. 
The lesion also induced shrinkage of the soma of the neurons detected in the 
contralesional RNm. Infusing an anti-Nogo-A antibody at the site of the lesion did not 
increase the proportion of SMI-32 positive rubrospinal neurons in the contralesional RNm 
nor prevent shrinkage. 
 
Section: Sensory and Motor system 
 
Keywords: Red nucleus, Nogo-A, spinal cord lesion, primate. 
 
Abbreviations 
CS: corticospinal 
BDNF: brain derived neurotrophic factor 
RN: red nucleus 
RNm: red nucleus pars magnocellularis 
RNp: red nucleus pars parvocellularis 
RS: rubrospinal 
SCI: spinal cord injury 
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1.2 Introduction 
The effects of spinal cord injury on directly connected supraspinal structures like the 
magnocellular part of the red nucleus (RNm) are poorly known in primates. In the rat, after 
a spinal cord lesion at cervical levels, axotomized reticulospinal (RS) neurons shrink and 
display modification in the expression of various molecules (Egan et al., 1977; Tetzlaff et 
al., 1991; Novikova et al., 2000; Kwon et al., 2002; Kwon et al., 2004). In this species, the 
RNm regains a normal aspect if brain derived neurotrophic factor (BDNF) is provided (Liu 
et al., 1999; Novikova and others, 2000; Kwon and others, 2002). Because neurotrophic 
substances are uptaken at synapses, the amount of neurotrophic factors accessible to a 
neuron relates ultimately to the number of synapses that this neuron possesses. 
Increasing this number may therefore contribute to protect a neuron from the degenerative 
processes triggered by axotomy. 
In the monkey, a unilateral section of the dorsolateral funiculus at cervical levels 
provoked shrinkage of the axotomized corticospinal (CS) neurons and alteration of their 
expression of non-phosphorilated neurofilaments, but did not conduct to measurable cell 
death (Wannier et al., 2005a). For the same lesion, the treatment with an antibody 
neutralizing the neurite growth inhibitor Nogo-A induced sprouting of CS axons (Freund et 
al., 2006; Freund et al., 2007). In parallel to these morphological changes, the anti-Nogo-A 
treatment also enhanced functional recovery (Freund and others, 2006). In monkey, an 
interruption of the RS tract induced degenerative changes in the RNm (Padel et al., 1981). 
As the neutralization of Nogo-A in rodents promotes regeneration of CS and sprouting of 
RS fibers (Raineteau et al., 2002), this treatment could have the same effect in primate. In 
this case, the improved access to neurotrophic substances may lead to a reduction of the 
lesion induced degenerative changes in the RNm. The present investigation aims at 
examining this issue by comparing the number and size of neurons in both RNm in 
monkeys subjected to a unilateral lesion of the cervical spinal cord and in intact monkeys. 
Moreover, the effects of a treatment with an antibody neutralizing Nogo-A on RNm 
neurons will be assessed.  
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1.3  Results 
Location and extent of the cervical lesion 
The RS tract is a crossed pathway that runs in the dorsolateral funiculus partially 
overlapping the lateral corticospinal tract and extending somewhat ventrally. As a 
consequence of this overlap, the CS and RS tracts cannot easily be segregated on a 
coronal section of the spinal cord. The extent and the location of the cervical cord hemi-
section are shown in Figure 1 for ten of the eleven lesioned monkeys. The total extent of 
the lesion is given in Table 1 (percentage of hemi-section). To tentatively determine more 
specifically the extent of the lesion affecting the territory comprising the RS and CS tracts 
we considered only the lateral funiculus, i.e. the white matter going from the dorsal to the 
ventral rootlet zone (dashed lines in Fig. 1). A lesion extent was thus recalculated 
reflecting more accurately the portion of CS and RS tracts affected by the lesion (Table 1: 
lateral funiculus lesion extent in %). In five of the eleven lesioned monkeys, the section of 
the lateral funiculus between the dorsal and the ventral rootlets reached 100% of the 
territory and thus the lesion of the RS tract was considered as complete in these animals 
(asterisks in Fig. 1). In two animals (Mk-CS and Mk-CB), the lesion covered more than 
87% of the lateral funiculus and the territory spared by the lesion was situated most 
laterally (Fig. 1), a territory normally not occupied by the RS tract. These two monkeys 
were thus considered as subjected to nearly complete transection of the RS tract (asterisk 
in parentheses in Fig. 1). In contrast, in three monkeys, the lesion extent in the lateral 
funiculus was below 75% (open circles in Fig. 1), and therefore the lesion of the RS tract 
was considered incomplete. Particularly, in Mk-AS the extent of the lesioned lateral 
funiculus was below 50%.   
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Anti-Nogo-A antibody treated monkeys
Mk-AC * Mk-AM *
Mk-AF ° Mk-AP * Mk-AS °
Control antibody treated monkeys
Mk-CG ° Mk-CB (*) Mk-CH * Mk-CS (*)
Figure 1
Mk-AG *
 
Figure 1 
Location and extent of the cervical spinal cord lesions, performed at C7/C8 in the anti-
Nogo-A antibody treated animals (six animals, red area) and in the control antibody 
treated animals (four animals, blue area). In one anti-Nogo-A antibody treated animal 
(Mk-AT) the lesion extent could not be assessed and thus it is not represented in this 
figure. Dashed lines indicate the extent of the lateral funiculus, going from the dorsal to 
the ventral rootlets.  Asterisks indicate complete lesion of the zone occupied by CS/RS 
tracts. Asterisks in parentheses indicate a nearly complete lesion of the CS/RS tracts. 
Open circles indicate an incomplete lesion of the CS/RS tracts. Arrows in Mk-AF and in 
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Mk-CG indicate the quadrant of the ventral lateral funiculus where some fibres of the RS 
tract might have been spared (Mk-CG) or cut (Mk-AF) by the lesion. 
 
 
 
 
The number of SMI-32 positive neurons in the contralesional RNm is reduced in lesioned 
animals. 
The RNm is located in the ventral part of the midbrain. On coronal sections stained 
for SMI-32, RNm was easily identified by its large and strongly stained neurons, its ovoid 
shape and its vicinity to the roots of the oculomotor nerve (Fig. 2A). The RNm was clearly 
distinguished from the parvocellular part of the RN (RNp) which was situated more 
rostrally, containing smaller, more densely packed and more faintly SMI-32 stained cells 
(not shown). On Nissl-stained sections adjacent to the SMI-32 labelled ones, large 
neurons were also visible at low magnification and their number and distribution appeared 
comparable to the SMI-32 pattern of distribution (Fig. 2 E-F). This observation was 
confirmed quantitatively in two monkeys (Mk-AF and Mk-CS) by counting the cell nuclei in 
adjacent sections of the RNm stained respectively for SMI-32 and Nissl (numbers between 
parentheses in Table 2). For the other animals, as the contour of SMI-32 stained neurons 
was easier to define than that of Nissl stained cells, we conducted our analysis on SMI-32 
stained sections. At first sight, in animals subjected to the cervical lesion, the 
contralesional RNm exhibited a reduction of the number of SMI-32 positive neurons as 
compared to the ipsilesional side (Fig. 2 C-D); neurons might have degenerated or 
shrunken and/or reduced their expression of non-phosphorilated neurofilaments, thus 
loosing their strong SMI-32 staining (Wannier and others, 2005a). Indeed, faintly stained 
RNm neurons were visible on the contralesional side at high magnification (400x).  RNm 
neurons were counted on both sides and their somatic cross-sectional area was measured 
on sections spaced 400 µm apart along the entire rostro-caudal extent of the RNm, only 
considering SMI-32 labelled cell bodies with a visible nucleus (Fig. 2B).  
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C Ipsi D Contra
BAA
E Ipsi F Contra
FIGURE 2
Figure 2 
A-D: Photomicrographs of SMI-32 stained frontal sections of the RNm. In panel A the RNm 
of an intact animal (Mk-IR) is shown. Note the proximity of the RNm with the roots of the 
oculomotor nerve (large arrows). Large and darkly positive SMI-32 neurons (thin arrows 
point to a few of them) are loosely packed and are arranged to form a round shaped 
nucleus. At higher magnification (panel B), neurons show a multipolar shape with several 
dendritic processes. The neuron in the image has a clearly visible nucleus, which was the 
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criterion to be included in the morphometric analysis (cell count and somatic size). Panels 
C and D show the RNm on the ipsi- and contralesional side respectively of a representative 
animal subjected to a unilateral spinal cord lesion (Mk-CS). Both sides appear less 
intensively stained if compared to panel A, reflecting individual and methodological 
variability. In panel D (contralesional RNm) the number of SMI-32 positive cells appears 
lower than in panel C (ipsilesional RNm). In addition, the intensity of staining appears also 
reduced in panel D as compared to panel C and A. 
E-F: Photomicrographs of Nissl stained sections of the RNm adjacent to sections displayed 
in C and D, respectively. Arrows in C and E and in D and F respectively indicate the same 
blood vessels. Similarly to SMI-32 staining, the number of cell bodies appears lower in 
panel F than in panel E. Scale bar in A (same for C, D, E, F): 1 mm. Scale bar in B: 100 
µm. 
 
 
As the number of sections labelled with SMI-32 antibody and including the RNm 
was relatively low for each animal (6 to 9), the number of cells counted in each RNm was 
fairly small (Fig 3A), ranging from 39 neurons (Mk-CB contra) to 174 neurons (Mk-IR right). 
Indeed, the estimated number of neurons was variable across animals irrespective of the 
lesion and/or treatment with anti-Nogo-A or control antibodies (Table 2). This variability 
was best reflected by the RNm cell numbers on each side in the four intact animals (Table 
2, rightmost four columns), in which a relative difference in cell number between the two 
RNm reached up to 25.8 % (Fig. 3A), though not statistically significant. In the eleven 
monkeys subjected to the cervical lesion, there was a systematic lower number of RNm 
neurons contralesionally. In three monkeys the difference was statistically significant (Fig. 
3A, p < 0.05) whereas the difference did not reach significance level in seven monkeys 
(0.05 < p ≤ 0.1). The least significant difference was found in the monkey (Mk-CG) 
subjected to an incomplete transection of the RS tract (Fig. 1, open circle). In Mk-AS the 
difference could not be statistically evaluated (see methods). To assess further the impact 
of the lesion, the cell number difference was expressed in percentage between the RNm 
on both sides for each animal (Fig. 3B and Table 2). For animals with complete or nearly 
complete lesion of the RS/CS tracts territory (asterisks in Fig. 1), the percentage difference 
of SMI-32 positive RNm neurons between the two sides ranged from -29.0% to -52.4% 
(Fig. 3B and C). In contrast, intact monkeys showed a cell number difference between the 
two RNm, ranging from -3.3% to 25.8%, figures which could be considered as indicative of 
the inter-individual and intrinsic methodological variability. Interestingly, Mk-AF, which had 
a relatively restricted lesion extent (73.4 %), exhibited a high cell number difference 
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between the two RNm (-48.7%). On the other hand Mk-CG, which had also an incomplete 
lesion comparable to Mk-AF, showed a relatively lower cell number difference (-37.1 %, 
not significant, see above), although still higher than the values found in intact monkeys. In 
these two latter monkeys the extent of the lesion in percentage was similar; however when 
the territory of the lateral funiculus lesioned was considered it appeared that in Mk-AF the 
part of the lesion going ventro-laterally was coherent with a bigger impact on the RS tract 
than in Mk-CG (arrows in Fig. 1). Finally in Mk-AS, which had a highly incomplete lesion 
(below 50%) sparing a large part of the territory occupied by the RS tract (Fig.1), the cell 
number difference was accordingly comparable to values observed in intact animals.  
In the lesioned monkeys, no obvious relationship was found between these values 
of RNm neurons and the fact that some animals were treated with an anti-Nogo-A whereas 
other animals received a control antibody (Fig. 3C). To statistically evaluate this 
observation, we compared the values of cell number difference between the RNm on the 
two sides expressed in percentage among the three groups of animals (Group 1, red in 
Fig. 3B: lesioned, anti-Nogo-A antibody treated animals; Group 2, blue: lesioned, control 
antibody treated animals; Group 3, green: intact animals) using the non parametric Mann 
and Whitney test.  The comparison values between groups 1 and 2 were not statistically 
significant (p > 0.05), confirming thus the observation that the anti-Nogo-A antibody 
treatment did not prevent a reduction of the number of large SMI-32 positive RNm neurons 
contralesionally. On the other hand, as compared to intact animals (group 3), the 
difference in large SMI-32 positive cell number between the two RNm was statistically 
significant (p < 0.05) in the two groups of lesioned monkeys (Fig. 3B). 
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Figure 3 
A: Histograms of the number of SMI-32 positive cells (with a visible nucleus) counted in the RNm 
on the contralesional (brown) and ipsilesional (yellow) sides. The first seven animals (red names) 
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were subjected to unilateral cervical cord lesion and subsequently treated with the anti-Nogo-A 
antibody. The next four animals (blue names) were lesioned and treated with a control antibody. 
The last four animals (green names) were intact. In these latter animals “contra” and “ipsi” 
corresponded to the left and right RNm, respectively.  The statistical significance of the cell 
number difference between the RNm on the two sides was calculated using the Wilcoxon signed-
rank, 1-tailed test. The number of neurons for each histological section of the RNm of both sides 
throughout the entire extent of the RNm was compared. In three of the lesioned animals this 
difference was statistically significant (p < 0.05, asterisks). In seven lesioned monkeys the 
difference was not statistically significant (p< 0.1 or p = 0.2 in Mk-CG). All the intact animals 
exhibited a cell number difference that was not statistically significant. For Mk-AS the statistical 
significance could not be calculated (see methods). 
B: Difference in the number of SMI-32 positive cells calculated in percentage between the two 
sides of the RNm in the animals shown in the same order as in panel A. Colour codes indicate 
the different animal groups as in panel A: in red the lesioned animals, treated with the anti-Nogo-
A antibody; in blue the lesioned animals treated with a control antibody; in green the intact 
animals. In Mk-AS, characterized by an incomplete lesion of the RS tract (less than 50%), the 
difference appeared comparable to the one of the intact monkeys (“green” animals). Beside this 
animal, the percentage difference in lesioned animals showed a high variability ranging from 17 
to 35%. Note that Mk-CG and Mk-AF have also an incomplete lesion of the RS tract (less than 
75%, open circles in figure 1). To statistically evaluate the impact of the anti-Nogo-A or control 
antibody treatment on the cell number difference between the RNm of the two sides, we 
compared the values among the three groups of animals.  The difference among the two groups 
of lesioned animals was not statistically significant (p > 0.05) whereas the difference between 
each group of lesioned animals and the group of intact animals was statistically significant (p < 
0.05). 
C: The data shown in panel B were plotted against the extent of the lesion of the lateral funiculus 
calculated in percentage (see Table 2). Red squares are for lesioned animals treated with the 
anti-Nogo-A antibody. Blue circles are for lesioned animals treated with a control antibody. Green 
triangles are for intact animals. For easier comparison with the other animals, the value for Mk-IZ 
has been set as positive number in this figure. The variability of the values calculated for the 
lesioned animals appears independent of the fact that the animal was treated with an anti-Nogo-
A or a control antibody. Mk-AT is not shown as the lesion extent could not be estimated (see 
Table 1 and methods). 
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Do the SMI-32 positive RNm neurons shrink? 
As mentioned above, shrinkage of RNm neurons as consequence of the cervical 
hemisection has also to be considered. To address this issue, we calculated the somatic 
cross-sectional area of the RNm neurons that were included in the cell counting (Table 2), 
and these measurements were shown for each monkey as paired box and whisker-plots 
for the contralesional and ipsilesional sides, respectively (Fig. 4 A-C). Figs. 4A and 4B 
show the distribution of somatic cross-sectional areas of RNm neurons in the anti-Nogo-A 
antibody treated and control antibody treated groups for the lesioned monkeys, 
respectively. In all lesioned monkeys, a systematic and substantial decrease of the cross-
sectional somatic area was observed in the contralesional RNm as compared to the 
ipsilesional RNm. For all lesioned animals, the shrinkage of cross-sectional somatic area 
of RNm neurons contralesionally was statistically significant (Mann-Whitney U-test, p< 
0.05), irrespective of the treatment with the anti-Nogo-A or with a control antibody. The 
intact animals, in sharp contrast and as expected, did not show any systematic and 
significant difference (p > 0.05) in neuronal cross-sectional somatic area between left and 
right RNm (Fig. 4C). 
The percentage difference between the median values of the cross-sectional 
somatic areas on each RNm for each animal was calculated and the values plotted against 
the extent of the lateral funiculus lesion (Fig. 4D). In intact animals, the difference of the 
median area between the two RNm ranged from 1.1% to -9.4%. Once more these figures 
reflect the normal individual and methodological variability. In contrast, all animals 
subjected to a cervical cord hemisection exhibited a significant shrinkage of the RNm 
neurons contralesionally, with a difference between the two sides ranging from -13.6% to -
36.7 %, not overlapping with the range found for intact monkeys (Fig. 4D).  
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Figure 4 
A: Box and whisker plots showing the distribution of somatic cross-sectional areas of 
SMI-32 positive RNm neurons in lesioned animals treated with an anti-Nogo-A antibody. 
For each animal the contralesional (c) and the ipsilesional (i) RNm are shown. The soma 
areas did not follow a normal distribution and therefore were graphically represented in 
the form of box and whisker plots, emphasizing the median value. Consequently, the 
statistical analysis was conducted using a non-parametric unpaired test (see below). In 
the box and whisker plots, the horizontal black line in the box corresponds to the median 
value, whereas the top and bottom of the box are for the 75 and 25 percentile values 
respectively. The top and bottom extremities of the vertical lines on each side of the box 
are for the 90 and 10 percentile values, respectively. A statistical comparison between 
the two RNm on each side was conducted for each animal using the non-parametric 
Mann and Whitney test. All animals of this group exhibited a statistically significant 
difference of soma area across the two RNm of each side (**=p<0.001;***=p<0.0001) 
B: Box and whisker plots showing the distribution of somatic cross-sectional areas of 
SMI-32 positive neurons in lesioned animals treated with a control antibody. For each 
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animal the contralesional (c) and the ipsilesional (i) RNm are shown. Other conventions 
are as in panel A. All animals of this group showed a statistically significant difference of 
soma area across the two RNm on each side (*=p<0.01; ***=p<0.0001). 
C: Box and whisker plots showing the distribution of somatic cross-sectional areas of 
SMI-32 positive neurons in intact animals. The two RNm are indicated here as right (r) 
and left (l). As expected, the comparisons of cross sectional areas between the RNm on 
each side did not show any statistically significant difference (n.s. =p>0.05). 
D: The difference, expressed in percentage, between the median values of somatic 
cross-sectional areas of SMI-32 positive neurons in the contralesional and ipsilesional 
RNm was plotted against the extent of the lateral funiculus lesion expressed in 
percentage (see Table 2). Red squares are for lesioned animals treated with the anti-
Nogo-A antibody. Blue circles are for lesioned animals treated with a control antibody. 
Green triangles are for intact animals. The variability among values in lesioned animals 
appears independent of the antibody treatment. Mk-AS which had a rather incomplete 
lesion (less than 50%) shows a very high (the highest) value of cell surface difference 
between the two RNm. Mk-CH characterized by a complete lesion has a rather low (but 
significant, see box plot in B) value of cell surface difference.  
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1.4 Discussion 
 
In the present investigation we have shown that unilateral cervical cord injury 
interrupting RS axons also affects the neurons of origin in the contralesional RNm. 
Although the majority of RS neurons in the contralesional RNm clearly survived to 
axotomy, there was a significant reduction of the number of SMI-32 positive neurons. In 
addition, these neurons showed a significant shrinkage of their soma. Finally, our results 
indicate that treatment with an anti-Nogo-A antibody, applied at the level of the spinal cord 
lesion, did not reduce the decrease of the number of SMI-32 positive neurons counted in 
the contralesional RNm or their soma shrinkage. 
Lesion extent 
In primates both the lateral CS and the RS tracts are found in the lateral funiculus of 
the spinal cord and influence mostly the distal but also the proximal muscles of the 
forelimb (Belhaj-Saïf et al., 1998; Belhaj-Saïf and Cheney, 2000). In particular, though in 
primates the RS tract is reduced in size with respect to other mammals such as cat or rats, 
it has been shown that after unilateral lesion of the CS tract at the level of the pyramids, 
the RNm shows a certain degree of functional reorganisation that may contribute to the 
recovery of motor function for the forelimb (Belhaj-Saïf and Cheney, 2000). However, a 
lesion of the lateral funiculus at cervical level of the spinal cord will affect both the RS and 
the CS tracts as in this area the two pathways overlap to some extent, although the RS 
tract lays slightly more ventrally that the CS tract in the lateral funiculus. Despite the fact 
that, in the present study, the RS tract was not traced, the analysis of the reconstructed 
cervical cord hemisections (Fig. 1) allowed assessment of the degree of completeness of 
RS tract transection, by expressing the lesion extent as the percentage of the quadrant of 
white matter going from the dorsal to the ventral rootlet zone. Tracing studies in monkeys 
have shown that the RS tract is included entirely in this quadrant (Holstege et al., 1988; 
Burman et al., 2000b).  
Cell bodies selection and analysis: technical considerations 
In the monkey the RNm constitutes the caudal third of the entire RN and it is 
composed of loosely scattered large cells together with a few smaller cells (Ralston and 
Milroy, 1989). In individual histological sections large neurons were few and were 
segregated in small groups among the fibres fascicles of the oculomotor nerve (Fig. 2A). 
SMI-32 labelled neurons were rather large (Fig. 2B) and showed a radial spread of 
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relatively large dendrites. This morphology corresponded to the description of monkey RS 
neurons previously reported (Padel and others, 1981; Burman et al., 2000a). 
The number of SMI-32 positive neurons was estimated in one series of sections 
over the whole extent of the RNm. Thus, we did not count the absolute number of SMI-32 
positive neurons in the RNm. Instead, we compared the relative number of RNm cells 
counted on both sides of the brain of each animal. Because the number of SMI-32 stained 
neurons in RNm is relatively low (see results), we did not use a stereological probe to 
estimate their number but we counted all visible nuclei of the labelled cells on the analyzed 
sections. This approach is considered as adequate as all samples were analyzed using 
the same procedure and the number of cells is low (Geuna, 2000; Lavenex et al., 2000; 
Benes and Lange, 2001). In the present case, in addition, the validity of the method is 
supported a posteriori by the absence of overlap between lesioned and intact monkeys in 
a large group of animals as well as by the absence of difference between the RNm on both 
sides in intact monkeys.  
Cervical cord (C3) hemisection in rat induced, beside other molecular changes, a 
reduction of neurofilament mRNA in RS neurons (Tetzlaff and others, 1991). This is 
probably also the case in RS neurons in monkey as the labelling on the contralesional side 
was fainter than on the ipsilesional side. Thus it might be possible that the SMI-32 
antibody would not label some neurons because the expression of the epitope recognised 
is strongly reduced. However, when we compared Nissl labelled sections of the RNm of 
lesioned animals to adjacent sections labelled with SMI-32, the numbers of cells found in 
RNm were comparable (Table 2).  
Cell number 
Counts of RNm cells on both sides showed inter-individual and methodological 
variability, as shown for intact monkeys (Fig.3 A, B “green” group) where the percentage 
difference between the two sides ranged from -3.3 to 25.8% but it was not statistically 
significant. In lesioned monkeys the difference in the number of SMI-32 positive cells 
detected in the contralesional and ipsilesional sides was statistically significant in three 
monkeys (Fig. 3A, p< 0.05, asterisk). In the other monkeys the difference was not 
significant (p > 0.05), but as the statistical analysis was done on a relatively small number 
of data points (cells counted in each section, especially in Mk-CB and Mk-CG), these 
values indicate a tendency towards a difference in cell number between the two RNm. In 
these eleven animals, the values of percentage cell difference were rather variable, 
ranging from -8.1% to -52.4%. Interestingly, the two animals having the highest values 
(Mk-CS, -51.2% and Mk-CB, -52.4 %) were also the ones having a longer period of 
Chapter 5: Axotomized RN cell are affected following cervical spinal injury                                162 
 
survival after the lesion (around 200 days, Table 1). Otherwise, the high variability could 
not be systematically correlated to any other parameter.  
In the absence of direct evidence of cell death or apoptosis, the question arises as 
to whether the decrease in the number of SMI-32 positive RNm neurons reported in the 
present study reflects cell death or rather changes in the phenotype of axotomized RS 
neurons which then impairs their detection. In the adult rat, some reports have suggested 
that SCI leads to the death of a sizable proportion of RS neurons (Mori et al., 1997; Houle 
and Ye, 1999; Novikova and others, 2000), while some other reports have brought 
evidence that the axotomized RS shrink but survive in an atrophic state (Kwon and others, 
2002), (Prendergast and Stelzner, 1976).  These discrepancies of interpretation may result 
from methodological differences; in particular they may reflect the inherent difficulty to 
detect shrunken neurons.  In the case of the monkey, chromatolytic RNm neurons have 
been observed after SCI, a feature that is consistent with cell death (Bodian, 1946; Padel 
and others, 1981). Moreover, in investigations of the fate of CS neurons using the same 
material as in the present report, we observed that CS neurons can be detected on SMI-32 
stained material despite their axotomy induced atrophy and phenotype changes (Wannier 
and others, 2005a; Beaud et al., 2006). These observations suggest that the method was 
adequate to reveal atrophic neurons and hence that in the primate, some RS neurons die 
in consequence of an axotomy at the level of the cervical spinal cord. This would in turn 
indicate that RS neurons in different species react differently to axotomy. In the adult 
opossum, most RS neurons survive SCI, but a limited proportion of RS neurons 
consistently disappears, an observation that was interpreted as indicative of limited cell 
death (Xu and Martin, 1990). Furthermore, this idea is supported by observations on CS 
neurons. In the adult rat, SCI leads to apoptosis in MI (Hains et al., 2003). However, as 
mentioned above, in the macaque, the total number of SMI-32 positive cells in layer V of 
MI remains unchanged (Wannier and others, 2005a), indicating that there occurred no 
sizeable CS neurons loss. However, there remain space for debate, since after a spinal 
cord lesion in the macaque, only few apoptotic cells were detected inside the dorsolateral 
funiculus rostrally to the lesion (Crowe et al., 1997). This data suggests that the lesion 
induced at most a limited degeneration of the CS and RS axons, and hence that their cells 
of origin survive. In view of this data, additional evidence is required to establish the exact 
fate of axotomized RS neurons in the macaque. 
Cell size 
The measurement of the cross-sectional somatic areas of neurons in the RNm of 
both sides revealed that in all lesioned animals the contralesional RNm showed a 
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significant reduction in cell size as compared to the ipsilesional side (Fig. 4). Conversely, 
in intact animals the cell size difference between the two RNm was not statistically 
significant. The median values of somatic cross-sectional areas of SMI-32-positive 
neurons obtained in the four intact monkeys ranged from 601 to 1268 µm, indicating a high 
inter-individual variability. These values are however in agreement with values previously 
reported (Padel and others, 1981; Burman and others, 2000a). In lesioned animals the 
ipsilesional RNm showed median values ranging between 526 and 1023 µm. These values 
indicated again a considerable individual variability and were comparable, as expected, to 
the ones observed in intact animals. In contrast, the contralesional RNm showed lower 
median values ranging from 413 to 787 µm. The box plot distribution and statistical 
analysis showed that this difference in somatic cross-sectional area between the RNm of 
the two sides was significant for all lesioned monkeys (Fig. 4 A, B). In contrast, the 
percentage difference of median values of somatic cross sectional area between the two 
RNm on each side ranged from 1.1% to -9.4% in intact animals and none was statistically 
significant. The relationship between the values of cross-sectional area difference and the 
extent of the lesion was not straightforward. For instance, the lowest percentage difference 
of somatic cross-sectional area (-13.6%, Mk-CH) was found in an animal with complete 
transection of the RS/CS tracts, whereas in this animal the cell number difference between 
the two RNm was relatively high (-35.3%). In general, the poor correlation with parameters 
such as lesion extent and survival time is due to an individual variability, representing a 
major aspect of the impact of axotomy at cervical level. This variability is also reflected in 
the literature by the divergent results reported with respect to cell death and cell body 
shrinkage. 
Anti-Nogo-A antibody treatment 
Anti-Nogo-A antibody treatment applied at the level of the spinal cord lesion did 
influence neither the number nor cross-sectional-somatic area of SMI positive neurons in 
the contralesional RNm. In other words, the treatment did not have a measurable impact 
on RS cell body survival or maintenance. Such a protective effect may have been 
expected as an indirect consequence of the increased number of synaptic boutons which 
is associated with the sprouting and/or regeneration which is commonly induced by the 
neutralization of Nogo-A. Indeed, new synapses could provide additional sources of 
neurotrophic substances and thus help neurons to respond to the damaging effects of 
axotomy. As no study has yet investigated whether the neutralization of Nogo-A promotes 
sprouting and/or regeneration of RS neurons in the non-human primate, the question 
remains as to whether the absence of effects reported here indicates that these neurons 
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do not generate new synapses in response to the treatment. This view is however rather 
unlikely, because no effect on the number or volume of SMI-32 neurons was observed for 
axotomized CS neurons (Beaud and others, 2006). For these neurons, the mechanisms 
mentioned above should have then entered in action, as the neutralization of Nogo-A has 
been shown to promote CS axonal sprouting after cervical spinal cord lesion in rats 
(Bregman et al., 1995; Schwab, 2004; Liebscher et al., 2005), marmoset monkeys (Fouad 
et al., 2004) and macaque monkeys (Freund and others, 2006; Freund and others, 2007). 
Nevertheless, the issue of whether anti-Nogo-A antibody treatment enhances sprouting of 
the RS tract in non-human primates remains an open question that will require future 
attention.  
Experimental procedure 
All animals included in the present study belong to a long-term research project on 
spinal cord lesion from which post-lesion changes in the CS system were described earlier 
(Schmidlin et al., 2004; Schmidlin et al., 2005; Wannier and others, 2005a; Freund and 
others, 2006; Freund and others, 2007). To assess the number of RS neurons in this 
model, midbrain sections including the red nucleus were obtained from 15 adult (3-8 years 
old) macaque monkeys (Macaca m ulatta or Macaca fa scicularis). All experiments were 
conducted in accordance with the Guide for the care and Use of Laboratory animals (ISBN 
0-309-05377-3; 1996) and approved by the local (Swiss) veterinary authority. Following an 
initial period of 2-3 months during which the animals were trained to perform several 
manual dexterity tasks until they reached a stable level of performance, 11 of these 15 
monkeys were subjected to hemisection of the cervical spinal cord. The lesion consisted of 
a unilateral transection performed at the C7/C8 border. The manual dexterity 
performances were assessed for several months post-lesion, until the animals reached a 
plateau reflecting a stable level of manual dexterity. The behavioural, electrophysiological 
and neuroanatomical tracing data related to the CS tract derived from these animals were 
described in previous reports (Schmidlin and others, 2004; Schmidlin and others, 2005; 
Wannier and others, 2005a; Wannier et al., 2005b; Freund and others, 2006; Freund and 
others, 2007). The present report is focussed on anatomical aspects dealing specifically 
with the issue of fate of RS neurons after unilateral cervical section. Therefore, only the 
methods relevant to this specific issue will be described in detail below. In addition, the 
anatomical data derived from the 11 lesioned monkeys were compared with data derived 
from 4 intact monkeys. 
Surgical procedures 
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The surgical procedures for the unilateral spinal cord lesion at C7/C8 level have been 
described in detail in previous reports; (Schmidlin and others, 2004; Wannier and others, 
2005a; Freund and others, 2006; Freund and others, 2007). Briefly, the animal was 
anesthetized by intramuscular (i.m.) injection of ketamine (Ketalar®; Parke-Davis, 5 mg/kg, 
i.m.). Before surgery, atropine was injected i.m. (0.05 mg/kg) to reduce bronchial 
secretions and the animal was treated with the analgesic Carprofen (Rymadil®, 4 mg/kg, 
s.c.). To assure and monitor deep anesthesia, a catheter was placed in the femoral vein 
for continuous perfusion with a mixture of propofol 1% (Fresenius ®) and a 4% glucose 
solution (1 volume of Propofol and 2 volumes of glucose solution). The animal was placed 
in a ventral decubitus position, with his head kept in a flexed position ventrally to expose 
the posterior cervical region. Under sterile conditions, a complete C6 laminectomy and an 
upper C7 hemi-laminectomy were performed to expose the spinal cord. Next, the dura 
mater was incised longitudinally. To perform the unilateral section of the spinal cord at the 
C7/C8 border, the dorsal root entry zone, identified under the microscope, was taken as 
the most medial landmark. From this target, a surgical blade (no 11, Paragon®) was 
inserted 4 mm in depth perpendicularly to the spinal cord, and the section was prolonged 
laterally to completely transect the dorsolateral funiculus. The rostro-caudal levels were 
the dorsal rootlets entering respectively the 7th and the 8th cervical spinal segments. This 
region corresponds to the rostral zone of the spinal portion covered by the 6th cervical 
lamina. The muscles and the skin were sutured and the animal recovered from 
anaesthesia in about half of an hour. After the spinal lesion, the animal was kept alone in a 
separate cage for a few days, to allow best conditions for recovery. Then, the usual 
housing in groups with other monkeys was restored. To assess the effect of a regenerative 
treatment, an osmotic pump (Alzet®, 2ML2, flow: 5 µl/h) delivering either a monoclonal 
mouse IgG or an antibody neutralizing Nogo-A was inserted subcutaneously between the 
shoulder blades and changed once after 2 weeks. In order to deliver the antibody in close 
proximity of the lesion, the free tip of a polyethylene tube attached to the pump was fixed 
under the dura few mm rostrally to the cervical lesion. 
Anti-Nogo-A antibodies 
Two monoclonal antibodies (mAbs) against different sites of Nogo-A were employed: 
the mouse mAb 11C7 was raised against a 18 amino acid sequence of rat Nogo-A (aa623 
– 640) close to the most inhibitory region of the Nogo-A protein (Oertle et al., 2003). The 
second antibody used, mAb hNogo-A recognized the Nogo-A specific region of the human 
Nogo-A sequence. Both antibodies identify primate Nogo-A monospecifically on Western 
blots (Oertle and others, 2003; Weinmann et al., 2006; Freund and others, 2006; Freund 
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and others, 2007). The antibodies were purified as IgGs and concentrated to 3.7-10 mg/ml 
in PBS (Freund and others, 2007). 
 
Control antibodies 
Purified IgG of a mouse mAb directed against wheat auxin (AMS Biotechnology, 
Oxon/UK) was used as control antibody (concentration: 3.7-10 mg/ml). 
Histology 
Monkeys were sacrificed at different time points (days) post-lesion (Table 1). For 
sacrifice, the animal was first sedated with ketamine and subsequently deeply 
anaesthetized by an intraperitoneal injection of a lethal dose of pentobarbital (90 mg/kg). 
Monkeys were perfused transcardially with 0.4 litre of 0.9% saline, followed by 4 litres of 
fixative (4% solution of paraformaldehyde in 0.1 M phosphate buffer, pH=7.6). This fixative 
was followed by 3 solutions of sucrose of increasing concentration (10% in fixative, 20 and 
30 % in phosphate buffer) to prepare the tissue for cryoprotection. For this purpose, after 
dissection the brain and the spinal cord were additionally stored in a 30% sucrose solution 
for 1-2 days. Frozen sections of the brain comprising both sides of the midbrain at the level 
of the RN were cut in the coronal plane at a thickness of 50 µm. The sections were 
distributed into eight series. The lesion site was reconstructed from camera lucida 
drawings of individual paralongitudinal consecutive Nissl-stained sections of the cervical 
spinal cord. The drawings were then aligned to allow reconstruction of the location and 
extent of the lesion on a transverse view of the spinal cord (Fig. 1), as previously 
described (Schmidlin and others, 2004; Wannier and others, 2005a). In one monkey (Mk-
AT, table 1) the size of the lesion could not be estimated due to poor quality of the spinal 
cord tissue after histological processing. 
A series of brain sections was stained immunocytochemically with a monoclonal SMI-
32 antibody (Sternberger Monoclonals, Covance Antibodies, USA). The epitope 
recognised by the SMI-32 antibody lies on non-phosphorylated regions of the 
neurofilament protein and is only expressed by particular categories of neurons (Campbell 
and Morrison, 1989; Tsang et al., 2000). Standard immunohistochemical procedures were 
used as previously described (Liu et al., 2002). Comparison of adjacent series of sections 
stained either for Nissl or with the SMI-32 antibody indicated that virtually all neurons in the 
RNm were labelled by this antibody (see results). As the brain was cut into 8 series (see 
above), sections stained with the SMI-32 antibody and including entire rostro-caudal extent 
of the RNm were usually six to nine. For every animal, all sections were included in the 
analysis. 
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To evaluate the effect of the lesion on RS neurons, we analysed the series of coronal 
sections stained for SMI-32 through the midbrain and we identified the position and the 
extent of the RNm close to the roots of the oculomotor cranial nerve (Fig. 2A) (Paxinos et 
al., 2000). Well stained SMI-32 positive RNm cells were easily identifiable even using low 
magnification (x40). In lesioned animals, RNm neurons on the contralesional side were 
smaller and somewhat more faintly stained than ipsilaterally, and therefore some of them 
may have escaped detection at low magnification. To circumvent the problem, the 
quantitative analysis was conducted at higher magnification (x400) for better 
discrimination. The number of SMI-32 stained RNm cells and the projected surface of their 
cell body was obtained from digitised photomicrographs using appropriate software 
(Neurolucida®). The neurons included in this analysis were SMI-32 positive and had a 
visible nucleus (Fig. 2B). The possibility of sampling the RNm neurons as required by 
stereological methods appeared not applicable here as the number of neurons responding 
to the criteria listed above was relatively small. Instead, all RNm neurons filling the above 
criteria were counted on each individual section. In addition, our aim was not to establish 
the absolute total number of cells in the RNm but to compare the number and size of 
neurons in the RNm on each side. This method was shown to be reliable in the motor 
cortex for the CS neurons (Wannier and others, 2005a). Furthermore, in six animals (data 
not shown) the cross-sectional area of the nucleus of all neurons included in the counting 
was calculated. The derived maximal value of the diameter ranged from 8.5 to 20.8 
microns. These values were far below the section thickness of 50 µm. Thus, the possibility 
of introducing significant counting errors by including fractions of the cells is unlikely.  Only 
the soma without the numerous dendritic ramifications was underlined to determine the 
cell body cross-sectional area. Because of the presence of large dendritic ramifications 
(Fig. 2B) the cell body contour was in some cases difficult to delineate. Therefore, we 
considered that, along these large processes, the soma ended at a distance of 20 µm from 
the nucleus, thus corresponding to the same procedure as used for CS neurons (Wannier 
and others, 2005a). For comparison, brain sections from four intact animals, which had 
been included in previous tracing studies (Liu and others, 2002), were used as control 
material for the SMI-32 analysis of RNm neurons. Counts of SMI-32 positive RNm neurons 
and measurements of their somatic cross-sectional area were performed for each monkey 
on both right and left brain side on coronal sections, separated by 400 µm each. The 
rostro-caudal dimensions of the RNm thus analysed was consistent with the calculated 
dimensions of the RNm as derived from the atlas of the macaque brain (Paxinos and 
others, 2000). Each section comprised both the right and left side of the brain (except for 
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Mk-AS). When cutting the midbrain, care was taken to position the bloc parallel to the 
coronal plane so that for each section the two RNm were at a similar level. As shown 
already for the cerebral cortex (Wannier and others, 2005a), althought the sections shrank 
to some degree, the shrinkage was very similar for the two brain sides on a given section. 
In other words, cell counts and somatic cross-sectional area measurements were 
performed on brain halves of comparable thickness for each section analyzed. 
Consequently, the quantitative comparisons regarding the number of RNm neurons and 
their somatic cross-sectional area have been conducted on comparable volumes of tissue 
in RNm. Data were then analysed with the SPSS software for statistical evaluation of the 
significance of cell number difference and cross-sectional area difference between the 
RNm neurons on the two sides of midbrain. Statistical analysis on the cell number was 
conducted by comparing the number of cells in each histological section and on the RNm 
of each brain side. The data obtained were analysed by means of the Wilcoxon signed-
rank, 1-tailed test. In one monkey (Mk-AS) this analysis could not be performed as the two 
brain sides were processed separately and it was not possible to compare equivalent 
levels of the RNm for each side. The statistical analysis concerning the cross sectional 
somatic area was performed by using the non-parametric Mann and Whitney test (see 
results).  
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Table 1: List of cervical cord lesioned and intact monkeys included in the present study with identification code 
(same as in Freund et al., 2006 for the lesioned animals). 
 
 
 
 
Mk-AG Mk -
AT* 
Mk-
AF 
Mk-
AP 
Mk-AC Mk -
AM 
Mk-
AS 
Mk-
CS 
Mk-
CB 
Mk-
CG 
Mk-
CH 
Mk-
IR 
Mk- 
IE 
Mk- 
IZ 
MkIRh 
Species fasc. fasc.  mul. fasc. fasc. f asc. f asc. mul. fasc. f asc. fasc. m ul. mul. fasc. mul. 
Treatment Anti-
Nogo-A 
(hNogo) 
Anti-
Nogo-A 
(hNogo) 
Anti-
Nogo-
A 
(11C7
) 
Anti-
Nogo-
A 
(11C7
) 
Anti-
Nogo-A 
(hNogo) 
Anti-
Nogo-A 
(hNogo) 
Anti-
Nogo-
A 
(11C7
) 
Contr. Contr. C ontr. Contr. Inta ct Intact Intact Intact 
Proportion o f 
hemi-section 
extent (%) 
78    - 56 58 85 80 41 63 75 51 90 0 0 0 0 
Lateral 
funiculus 
lesion e xtent 
(%) 
100     - 73.4 100 100 10 0 48.2 87 93.4 70 100 0 0 0 0 
Functional 
Recovery (%) 
100 ( 100) 57 99 100 96 100 22 78 90 53 - - - - 
Completeness 
of CS /RS 
section 
Yes 
 
- 
 
No 
 
Yes 
 
Yes 
 
Yes 
 
No Yes 
 
Yes 
 
No 
 
Yes 
 
- - - - 
Survival t ime 
after le sion 
(days) 
112 97 144 160 135 13 8 282 198 225 140 138 - - - - 
Age at  
sacrifice 
(years) 
3.5 3.75 6.25 6.5 ~ 4 ~ 4 6.25 4.5 5 ~ 4 ~ 4 5 ~ 5 7.75 6.5 
 
At the ti me of the experiment, the monkeys had different  names, not indicating whether the animal was 
infused with the control or the anti-Nogo-A antibody or was an intact animal. New names were assigned 
to t he monkeys during the writi ng of the  manuscript to improve its readab ility, in consistency w ith 
Freund et al., 2006. 
 
Under species, "mul." is for macaca mulatta while "fasc." is for macaca fascicularis. 
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The seven anti-Nogo-A antibody treated monkeys are in th e sev en leftm ost colu mns ("Anti-Nogo-A") 
with indication of w hich of the 2 an tibodies was used (mAb 11C7 or mAb hNogo-A), whereas the four 
control antibody treated monkeys ("Contr.") are in the next four columns. The four intact monkeys are in 
the four rightmost columns. 
 
Proportion of hemi-section extent was calculated as the percentage of corresponding he micord affected 
by the lesion on the frontal reconstruction of the cervical cord. 
 
To tentatively determine more precisely the extent of the lesion affecting the RS and CS tracts, the lateral 
funiculus in the white matter was outli ned go ing from the dorsa l t o the ventral rootle t zone. This was 
indicated as lateral funiculus lesion extent.  
 
 
Mk-AG Mk -AT Mk -AF Mk -
AP 
Mk-AC Mk -
AM 
Mk-
AS 
Mk-
CS 
Mk-
CB 
Mk-
CG 
Mk-
CH 
Mk-IR Mk -IE Mk -
IZ 
M
Antibody 
Treatment 
Anti-
Nogo-A 
(hNogo) 
Anti-
Nogo-A 
(hNogo) 
Anti-
Nogo-A 
(11C7) 
Anti-
Nogo-
A 
(11C7) 
Anti-
Nogo-A 
(hNogo) 
Anti-
Nogo-A 
(hNogo) 
Anti-
Nogo-
A 
(11C7) 
Contr. C ontr. C ontr. Contr. Intact Intact Intact I
Lateral 
funiculus 
lesion ex tent 
(%) 
 
 
100 
   
 
    * 
 
 
  73.4 
 
 
  100 
 
 
  100 
 
 
  100 
 
 
  48.2 
 
 
  87 
 
 
  93.4 
 
 
  70 
 
 
  100 
 
 
     0 
 
 
     0 
 
 
     0 
Number o f 
SMI cells  
contralesional 
88 10
0 
        59 
(53) 
66 71  55 91 81 
(82) 
39 56  88 1 51 91 1
17 
Number o f 
SMI cells  
ipsilesional 
 
       
       
124 
 
       
       
144 
 
       
       115   
(117) 
 
       
       
116 
 
        
       
116 
 
         
         
87 
 
          
         
99 
 
        
       
166 
(158) 
 
         
         
82 
 
          
         
89 
 
       
       
136 
 
        
       174 
 
        
       
114 
 
        
       
93 
% d ifference 
in cell 
number 
 
-29.0% 
 
-30.6% 
 
-48.7% 
 
-
43.1% 
 
-38.8% 
 
-36.8% 
 
-8.1% 
 
-
51.2% 
 
-
52.4% 
 
-
37.1% 
 
-
35.3% 
 
-13.2% 
 
-
20.2% 
 
25.8
% 
-
Median cel l 
size 
contralesional 
(µm2) 
548.19 510.67 607.3 520.11 413 415.83 441.6 787.53 5 02.87  
 
 
556.28 
 
 
 
494.03 
 
 
 
1223.79 
 
 
 
879.19 
 
 
 
601 7
Median cel l 
size 
ipsilesional 
(µm2) 
750.08 806.18 744.95 66 1.1 56 3.28 526.41 623.6 1023.6 626.31  
 
 
728.75 
 
 
 
571.9 
 
 
 
1268.43 
 
 
 
862.36 
 
 
 
663 7
% d ifference 
in me dian 
 
-26.9% 
 
-36.7% 
 
-18.5% 
 
-
 
-26.7% 
 
-21.0% 
 
-
 
-
 
-
 
-
 
-
 
-3.5% 
 
2% 
 
-
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Functional recovery was assessed here for manual dexterity based on the "modified Brinkman board" task 
(see Freund et al., 2006), by giving in percent the ratio of the post-lesion score to the pre-lesion score. 
 
In the  row “co mpleteness of RS se ction”, “No” and “Yes” indicate w hether th e RS trans ection w as 
considered as partial or as complete, respectively (for further explanation see text). 
 
Survival time: number of days separating the cervical cord hemisection and the sacrifice of the animal. 
 
Age of the animal a t sacrifice: for five an imals the ag e was not pre cisely de termined when they were 
received in our animal facility. Thus, their c alculated age at sacrifice is the estimation according to t he 
age attributed at arrival in the animal facility (~).  
 
* In this an imal the proportion of hemisection extent and consequently also the RS and CS  extent could 
not be d etermined for tec hnical reasons (poor quality of his tology). In addition, in thi s same animal the 
lesion was too caudal and thus the 100% functional recovery cannot be interpreted. 
 
cell size 21.3% 29.2
% 
23.1% 19 .7% 23 .7% 13.6% 9.4% 
Average c ell 
number 
ipsilesional 
                     
                                                 114 + 17 
 
                          118 + 21 
 
                          125 + 42 
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Table 2: Summary of differences in cell number and somatic size in RNm on each side in the monkeys 
included in the present study. 
 
 
As in Table 1, the seven anti-Nogo-A antibody treated monkeys are in the seven leftmost columns ("Anti-
Nogo-A") with indication of which of t he 2 antibodies was u sed (mAb11C7 or mAb hNogoA), whereas 
the four control an tibody treated monkeys ("Contr.") are in the nex t four colum ns. Th e four intact  
monkeys are in the four rightmost columns. In lesioned animals the term “contralesional” indicates the 
RNm opposite to the spinal cord hemisection, whereas “ipsilesional” the RNm situated on th e same side 
of the cervical cord section. In intact animals the contralesional RNm is to be intended as on the right side 
and the ipsilesional as on the left side. 
In Mk-AF and Mk-CS the nu mber o f cel ls in paren theses indicates th e nu mber of cell s counted in 
adjacent Nissl stained sections. 
 
* In  this  a nimal th e total lesion extent and consequently also the RS and CS  ex tent could not  b e 
determined for technical reasons (poor histological quality). 
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Chapter 6 
 
 
Does anti-Nogo-A antibody 
treatment prevent cell body 
shrinkage in the motor cortex in 
adult monkeys subjected to 
unilateral cervical cord lesion? 
 
 
 
    This chapter has been adapted from an article originally published 
in BMC Neurosience (M.-L. Beaud,*, E. Schmidlin,*, T. Wannier*, 
P. Freund, J. Bloch, A. Mir, M.E. Schwab and E.M. Rouiller; 2008 
Jan 14; 9(1):5) 
 
* The first three authors contributed equally to the study. 
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1.1 Abstract 
 
Background: After unilateral cervical cord lesion at the C7/C8 border 
interrupting the dorsolateral funiculus in adult monkeys, neutralization of Nogo-A 
using a specific monoclonal antibody promoted sprouting of corticospinal (CS) 
axons rostral and caudal to the lesion and, in parallel, improved functional 
recovery. In monkeys lesioned but not treated with the anti-Nogo-A antibody, the 
CS neurons in the contralesional primary motor cortex (M1) survived to the 
axotomy, but their soma shrank. Because the anti-Nogo-A treatment induces 
regeneration and/or sprouting of CS axons, it may improve access to 
neurotrophic factors. The question therefore arises as to whether anti-Nogo-A 
treatment prevents the soma shrinkage observed in the contralesional M1? 
Results: Using the marker SMI-32, a quantitative and qualitative anatomical 
assessment of the pyramidal neurons in the layer V (thus including the CS cells) 
in M1 was performed and compared across three groups of animals: intact 
monkeys (n=5); monkeys subjected to the cervical cord lesion and treated with a 
control antibody (n=4); monkeys with the cervical lesion and treated with anti-
Nogo-A antibody (n=5). SMI-32 positive neurons on the side contralateral to the 
lesion were generally less well stained than those on the ipsilesional hemisphere, 
suggesting that they expressed less neurofilaments. Nevertheless, in all three 
groups of monkeys, the amount of SMI-32 positive neurons in both hemispheres 
was generally comparable, confirming the notion that most axotomized CS 
neurons survived. However, shrinkage of CS cell body area was observed in the 
contralesional hemisphere in the two groups of lesioned monkeys. The cell 
surface shrinkage was found to be of the same magnitude in the monkeys 
treated with the anti-Nogo-A antibody as in the control antibody treated monkeys. 
Conclusion: the anti-Nogo-A antibody treatment did not preserve the 
axotomized CS cells from soma shrinkage, indicating that the anti-Nogo-A 
treatment affects morphologically the axotomized CS neurons mainly at distal 
levels, especially the axon collateralization in the cervical cord, and little or not at 
all at the level of their soma. 
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1.2 Background 
 
The motor deficits associated with interruption of the CS tract at a segmental 
level in monkeys were assessed in several studies (Aoki and Mori 1979;Darian-
Smith, Cheema, Darian-Smith, Galea, and Ratcliffe 1990;Denny-Brown 
1966;Freund et al. 2006;Galea and Darian-Smith 1997a;Galea and Darian-Smith 
1997b;Holmes and May 1909;Mettler 1944;Sasaki et al. 2004b;Schmidlin, 
Wannier, Bloch, and Rouiller 2004)}. More precisely, a surprisingly good and 
rapid recovery of dexterous finger movements of the ipsilateral hand took place 
after hemi-section at C3 level in either newborn and juvenile monkeys (Galea 
and Darian-Smith 1997a,b), or in adult monkeys after hemi-section at C4/C5 
(Sasaki et al. 2004)  or C7/C8 level (Freund et al. 2006; Schmidlin et al., 2004).  
Immediately after the cervical hemi-section and later on during the recovery, 
there was a dramatic reduction of the CS projection to the hemi-cord caudal to 
the lesion (Galea and Darian-Smith 1997a),indicating that the spontaneous 
recovery of manual dexterity was not due to a substantial reconstruction of the 
lesioned projection but rather to enhancement of the transmission of information 
from cortex to spinal cord in a reduced number of CS and/or corticobulbospinal 
projections together with a contribution of a more effective use of spinal circuits. 
As far as the fate of the axotomized CS neurons is concerned, some 
controversy can be found in the literature. Some earlier anatomical studies 
suggested that pyramidotomy (Pernet and Hepp-Reymond 1975;Wohlfarth 1932) 
or cervical cord lesion(Holmes and May 1909;Levin and Bradford 1938) induced 
the death of a substantial part of the large CS neurons in the contralateral 
primary motor cortex (M1), amounting up to 70% loss (Pernet and Hepp-
Reymond 1975;Wohlfarth 1932). In sharp contrast, other authors concluded that 
there was no retrograde degeneration with breakdown and loss of neurons after 
section of the CS tract (Davison 1937; Lassek 1942;Tower 1940). In a recent 
study (Wannier, Schmidlin, Bloch, and Rouiller 2005b) ,the issue of the fate of 
axotomized CS neurons was re-examined in two monkeys using SMI-32 as a 
specific marker for pyramidal neurons. We found that, after unilateral lesion of 
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the dorsolateral funiculus at cervical level (C7-C8), the CS neurons in the 
contralesional primary motor cortex (M1) survived the axotomy, but their soma 
shrank (Wannier et al., 2005b). 
In a recent report, evidence was provided in monkeys that the functional 
recovery from unilateral cervical cord lesion and CS axonal sprouting can be 
enhanced by an antibody treatment neutralizing the neurite growth inhibitor 
Nogo-A (Freund et al. 2006) extending to the primates previous results obtained 
in the rat (e.g. Bregman et al., 1995; Liebscher et al. 2005; Schwab 2004). 
Indeed, several functional readouts of manual dexterity showed a faster and 
more complete recovery of manual dexterity in a group of six anti-Nogo-A 
antibody treated monkeys subjected to cervical hemi-section than in a group of 
six monkeys subjected to a comparable lesion but treated with a control antibody 
(Freund et al. 2006). Such enhancement of manual dexterity promoted by anti-
Nogo-A antibody treatment was associated with an axonal sprouting of CS axons 
in the cervical cord rostral and caudal to the lesion (Freund et al. 2006). These 
new fibers could provide the axotomized CS neurons an augmented access to 
neurotrophic factors compared to that available to the axotomized CS neurons in 
control antibody treated animals. The goal of the present study was thus to 
investigate whether the anti-Nogo-A antibody treatment also exert an effect on 
the CS neurons at the level of their soma in the contralesional motor cortex, for 
instance by preventing the cell soma shrinkage occurring in the monkeys 
subjected to cervical lesion and treated with a control antibody (Wannier et al., 
2005a). This hypothesis is plausible because, although the anti-Nogo-A antibody 
was delivered intrathecally in the cervical cord close to the lesion, the antibody 
was shown to reach the entire brain through the CSF circulation (Weinmann et 
al. 2006) and, therefore, it may have affected the CS cell bodies in the cerebral 
cortex as well. 
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1.3 Results 
 
1. Cervical cord lesion 
For the animals subjected to the unilateral spinal cord section, the extent of 
the lesion was assessed by reconstructing the incision site from histological 
sections (Fig. 1A). In most monkeys, the lesion completely transected the 
dorsolateral funiculus, thus corresponding to a complete transection of the CS 
axons originating from the contralesional hemisphere (as checked with BDA 
labeling of CS axons in most monkeys; see (Freund et al. 2006). In one monkey 
(asterisk in Fig. 1A), the dorsolateral funiculus was not completely transected and 
therefore a few CS axons as well as RS axons were spared by the lesion. The 
other seven monkeys had a complete transection of the dorsolateral funiculus on 
the lesioned hemi-cord (Table 1), thus corresponding to a complete interruption 
of the main CS tract originating from the opposite hemisphere (as discussed in 
detail earlier in (Freund et al. 2006). The monkeys Mk-AF and Mk-CC clearly had 
an incomplete lesion of the RS tract, whereas monkeys Mk-CS and Mk-CB 
possibly had an incomplete lesion of the RS tract (though transected at 95% at 
least). The RS tract transection was complete in the other four monkeys with 
complete lesion of the dorsolateral funiculus(Mk-AG, Mk-AC, Mk-AM and Mk-
CH). 
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Figure 1: Spinal cord lesion and number of py ramidal neurons in layer V of 
the motor cortex 
A: Reconstruction from paralongitudinal sections of the lesion performed in eight 
monkeys at cervical level C7/C8. The lesion area is indicated in red for the anti-
Nogo-A antibody treated monkeys and in blue for the control antibody treated 
monkeys. The gray zone in the center corresponds to the gray matter. In one 
monkey (Mk-AT), the tissue was damaged in the zone of the cervical cord lesion 
and it was not possible to precisely assess the position and extent of the lesion. 
The lesions have already been shown in recent reports (Freund et al., 2006; 
2007). Although some lesions (hemi-sections) were on the left side and others on 
the right side, for simplification they were all represented here as a left side 
lesion. 
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B: Photomicrograph showing the part of M1 corresponding to the hindlimb 
representation on both hemispheres and stained with SMI-32. On both sides, 
SMI-32 typically labeled the pyramidal cells in the layers III and V. However, 
typically at such low magnification, the layer V appears more densely stained on 
the ipsilesional hemisphere than on the contralesional one (see text). The 
hindlimb area in M1 was thus visible on the same section for the two 
hemispheres and the observer could thus delineate roughly equally long portions 
of the layer V in each hemisphere on which the counts were performed (dashed 
line), as explained in detail earlier (Wannier et al 2005). The length of the portion 
of layer V in which counts were made (l in mm) was determined for data 
normalization. CIN = cingulate sulcus. 
C: Bar graph indicating the mean number of SMI-32 positive neurons per unit 
length (and SD) counted in layer V of the hindlimb area in M1 of each 
hemisphere, on the sample of sections examined in the three groups of monkeys 
(green is for intact monkeys). * is for p<=0.05; n.s. is for p>0.05 (t-test for small 
samples as explained in the methods section). 
D: A portion of the hindlimb area in M1, on which morphometric measurements 
were conducted, is shown at higher magnification, for a typical contralesional 
hemisphere (left photomicrograph). At low magnification (panel C), due to lighter 
SMI-32 staining than in the ipsilesional hemisphere, very few SMI-32 positive 
neurons were visible in layer V. At this magnification (left photomicrograph), 
some SMI-32 positive neurons appear. The observer then identified at high 
magnification and at different planes of focus all SMI-32 positive neurons with a 
visible nucleus in layer V (neurons highlighted on top of a yellow background), as 
shown on the right photomicrograph. In general, it turned out that, in spite of a 
lighter SMI-32 staining, the positive neurons with a visible nucleus were on 
average as numerous as in the ipsilesional hemisphere. In each 
photomicrograph, the cortical surface is on top and white matter on bottom. The 
SMI-32 positive neurons are typically found in layer III and layer V. 
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2. Do some axotomized CS neurons degenerate? 
In a recent paper, we reported that the number of SMI-32 positive pyramidal 
neurons in layer V in M1 was comparable in the contralesional and in the 
ipsilesional hemispheres in two monkeys subjected to an unilateral cervical 
lesion (treated with a control antibody), and amounted to a comparable figure as 
in two intact animals(Wannier, Schmidlin, Bloch, and Rouiller 2005a). In the 
present study, these data were extended to a total of four monkeys subjected to 
the cervical lesion (treated with a control antibody) and five intact monkeys (Fig. 
1C; blue and green bars, respectively). In the group of intact monkeys, as 
expected the majority (four out of five) of animals did not show a statistically 
significant difference of SMI-32 positive neurons between the two hemispheres 
(p>0.05, n.s. in Fig. 1C). However, in one intact monkey (Mk-IU), the number of 
SMI-32 positive neurons per unit length was significantly higher (p<0.05) in the 
right than in the left hemisphere (Fig. 1C), indicating that even in intact monkeys 
there may be cases in which the density of SMI-32 positive neurons in layer V of 
M1 differs between the two hemispheres. Accordingly, there was also one 
monkey (Mk-CS) in the group of lesioned monkeys treated with the control 
antibody (blue bars in Fig. 1C) exhibiting an inter-hemispheric difference of the 
number of SMI-32 positive neurons per unit length (p<0.05), whereas in the other 
three monkeys the difference was not statistically significant. However, still in the 
group of lesioned monkeys treated with the control antibody (blue bars in Fig. 
1C), there was no systematic trend with respect to the side of the lesion. These 
data thus confirm the notion that axotomy of the crossed CS tract at cervical level 
in macaque monkeys treated with a control antibody does not lead to significant 
neuronal loss. As anticipated, the same conclusion applies to the group of five 
monkeys subjected to cervical cord lesion and treated with anti-Nogo-A antibody 
(Fig. 1C; red bars): in two monkeys there were slightly more SMI-32 positive 
neurons in the contralesional hemisphere whereas in the other three monkeys 
the ipsilesional hemisphere had more SMI-32 positive neurons (in two of them, 
the difference was statistically significant, but to a similar extent as in the case 
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observed in each of the other two groups of monkeys). Overall, the unsystematic 
inter-hemispheric differences in the two groups of lesioned monkeys were 
generally in the same order of magnitude as those observed in the group of intact 
monkeys. 
 
3. Does anti-Nogo-A treatment prevent shrinkage of CS neurons after axotomy? 
In our recent study (Wannier et al 2005), the two monkeys subjected to the 
cervical lesion and treated with the control antibody exhibited shrinkage of their 
soma as a result of the CS axotomy at cervical level. This observation is 
confirmed here on a larger pool of four control-antibody treated monkeys (Fig. 
2A; blue bars): in three of the four monkeys, the SMI-32 positive neurons of layer 
V were significantly smaller in the contralesional hemisphere than in the 
ipsilesional one. In the fourth monkey (Mk-CH), no somatic size difference was 
found, but in this particular animal the quality of the SMI-32 immunostaining was 
poor, which may in part explain this result. In contrast to the majority of control 
antibody treated monkeys, the intact monkeys did not show a statistically 
significant difference in the distribution of somatic area of layer V pyramidal 
neurons between the two hemispheres (Fig. 2A; green bars). It can be concluded 
that CS axotomy induced shrinkage of somatic area of the corresponding CS 
neurons in the lesioned monkeys treated with the control antibody. 
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Figure 2: Somatic size of py ramidal neurons in lay er V of the motor cortex 
and inter-hemispheric differences 
A: Box and whisker plots showing the distribution of somatic cross-sectional 
areas of SMI-32 positive neurons in layer V in M1 for the three groups of 
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monkeys. In the box and whisker plots, the thick horizontal line in the box 
corresponds to the median value, whereas the top and bottom of the box are for 
the 75 and 25 percentile values respectively. The top and bottom extremities of 
the vertical lines on each side of the box are for the 90 and 10 percentile values, 
respectively. All but one lesioned monkey (red and blue bars) exhibited a 
significant inter-hemispheric difference of cross-sectional soma area (*=p<0.05; 
**=p<0.001; ***=p<0.0001; Mann and Whitney test), whereas in the intact 
monkeys the difference was not statistically significant (n.s.=p>0.05; Mann and 
Whitney test). 
B: Inter-hemispheric percent difference in the number of SMI-32 positive neurons 
per unit length in layer V in M1 for the same three groups of monkeys as in 
Figure 1C (same color code), plotted as a function of the lesion extent (percent of 
the territory corresponding to the CS and RS tracts affected by the lesion). Note 
that the differences are not systematic with respect to the side of the lesion in the 
two groups of lesioned animals (red squares and blue circles for the anti-Nogo-A 
and control antibody treated monkeys, respectively). In the percent comparison, 
100% is for the number of SMI-32 positive neurons per unit length on the 
ipsilesional side (on the left side for the intact monkeys). The green triangles are 
for the intact monkeys. As the lesion extent could not be determined for Mk-AT 
(see Table 1), its corresponding percent value was represented by an horizontal 
dashed line. 
C: Inter-hemispheric percent difference of the median value of the cross-
sectional soma area of SMI-32 positive neurons in layer V in M1 for the same 
three groups of monkeys as in panel A, plotted as a function of the lesion extent 
(percent of the territory corresponding to the CS and RS tracts affected by the 
lesion). Note that the difference is small for the intact monkeys (green symbols), 
but it is more prominent and systematic with respect to the side of the lesion for 
most lesioned monkeys, with considerable overlap between the two groups of 
lesioned monkeys. Same conventions as in panel B. 
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To address the issue whether anti-Nogo-A antibody treatment, in addition to 
enhanced sprouting in the cervical cord near the lesion (Freund et al. 2006;  
2007),also prevents shrinkage of the soma of the CS axotomized neurons, the 
same analysis was conducted here in the group of five anti-Nogo-A antibody 
treated monkeys. In all five monkeys (Fig. 2A; red bars), the soma cross-
sectional areas of SMI-32 positive layer V pyramidal neurons were significantly 
reduced in the contralesional hemisphere as compared to the ipsilesional one, 
indicating that the CS axotomized neurons shrank. Moreover, the extent of 
shrinkage is generally comparable in the anti-Nogo-A antibody treated and 
control antibody treated monkeys (Fig. 2C). In other words, the anti-Nogo-A 
antibody treatment did not prevent or reduce shrinkage of the soma of 
axotomized CS neurons. 
The data of the present study are summarized in Figures 2B and 2C, where 
the inter-hemispheric difference (in percent) of the number of SMI-32 positive 
neurons per unit length in the layer V of M1 and of the median of their cross-
sectional soma area were plotted as a function of the extent of the lesion, 
estimated in percent of the lateral spinal cord. For the three groups of monkeys, 
there was no systematic inter-hemispheric difference for the number of SMI-32 
positive neurons per unit length in layer V of M1 (Fig. 2B), indicating that the 
unilateral axotomy of the CS tract did not produce a substantial cell loss in the 
contralesional hemisphere. Indeed, in the two groups of lesioned monkeys, the 
inter-hemispheric cell number difference was in the same range as in intact 
monkeys. On the other hand, as compared to intact monkeys, the cervical hemi-
section led to a significant shrinkage of SMI-32 positive cells in layer V of the 
contralesional M1, irrespective of whether the monkey was treated with a control 
antibody or an anti-Nogo-A antibody (Fig. 2C). 
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1.4 Discussio n 
 
Based on a substantially increased number of animals, the present study 
confirms preliminary data (Wannier, Schmidlin, Bloch, and Rouiller 2005b)  
indicating that unilateral cervical lesion is not followed by a significant elimination 
of axotomized CS neurons. This conclusion thus adds a new piece of evidence to 
the long debated issue of whether CS neurons die after axotomy in monkeys 
(see introduction). The present data are in line with previous reports claiming that 
there is no extensive CS cell loss after spinal cord lesion in monkeys (Davison 
1937; Lassek 1942; Tower 1940). As compared to the studies which previously 
addressed this question, the present investigation is based on a specific staining 
of pyramidal neurons in layer V (SMI-32), allowing better focus on the neurons of 
interest (CS neurons) than for instance in Nissl staining, as used in most cases 
previously. Although SMI-32 stains pyramidal cells in layer V in general and not 
only the CS neurons, the measurements conducted in the present study are thus 
somewhat more directed towards the subpopulation of CS neurons than 
measurements conducted for instance in Nissl material, where a much larger 
population of neurons would be involved. As a consequence, a difference 
between the two hemispheres affecting the CS neurons after a unilateral cervical 
lesion is detected with more sensitivity in SMI-32 than in Nissl material. Our 
measurements thus include the large pyramidal neurons of layer V in the motor 
cortex, which may possibly be the neurons preferentially expressing Nogo-A, as 
it was recently reported in the primary somatosensory (barrel) cortex of the rat 
(Shin, Shim, Hwang, Jung, Park, and Sohn 2006). Whether this is also true in 
primates and in the motor cortex remains an open question. 
To investigate whether cell death occurred in layer V in the contralesional 
hemisphere, we counted the number of SMI-32 positive neurons in layer V in M1 
territories of roughly comparable size delineated on the same section in the two 
hemispheres. Moreover, the data were normalized with respect to the length of 
the layer V territory in which the measurements were conducted. Our goal here 
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was not to establish the absolute number of SMI-32 positive neurons in a given 
cortical area but rather to compare between the two hemispheres their relative 
numbers. Furthermore, because the number of SMI-32 stained neurons in the 
delineated territory of interest was relatively low, we did not use a stereological 
probe to estimate their number, rather we counted all of them exhibiting their 
nucleus. This approach is considered as adequate as all samples were analyzed 
using the same procedure (Lavenex et al 2002; Geuna et al., 2000 ;Benes et al., 
2001). More precisely, in a recent morphometrical study in the hippocampus 
(Lavenex et al 2002) the authors used a true stereological approach to estimate 
the volume of the structure of interest as well as the total absolute number of 
neurons. In contrast, to estimate the number of BrdU immunoreactive neurons, 
the authors did not use a stereological probe because “of the low number of 
BrdU-labelled cells” (Lavenex et al 2002). In the present case, the number of 
SMI-32 positive neurons with a visible nucleus in the restricted zone of interest of 
M1 (layer V) was also very low, thus preventing the use of stereological probe. 
Furthermore, the data and their reproducibility obtained in the five intact monkeys 
strongly support the validity of the method used here to establish the number of 
SMI-32 positive neurons and their cross-sectional somatic area. Indeed, in all five 
intact monkeys, there was no statistically significant inter-hemispheric difference 
for their soma area. Furthermore, the number of SMI-32 positive cells did not 
show substantial inter-hemispheric difference in four out of five intact monkeys. 
In contrast, the somatic area difference observed in the two groups of lesioned 
monkeys was considerable and systematic with respect to the side of the lesion 
(except in one animal, Mk-CH). The morphometrical measurements were 
conducted in the hindlimb area of M1 and not in the hand area because the latter 
zone was subjected, in some animals, to extensive intracortical microstimulation 
(Sasaki et al. 2004a); see also Table 1) and, in all animals, to the injection of an 
anterograde tracer to label the CS tract (Freund et al. 2006). The hand area in 
M1 was thus not suitable for an optimal detection of SMI-32 positive neurons as 
they may be obscured by the presence of the reaction product corresponding to 
the injection site. The hindlimb area, also affected by the cervical lesion, was 
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thus more appropriate to conduct the anatomical analysis and we believe that the 
present data derived from the CS neurons of the hindlimb area is very likely to 
apply also to the CS neurons of the hand representation. 
As shown in Figure 1C, there was no systematic inter-hemispheric 
difference in the number of SMI-32 positive neurons in the three groups of 
monkeys, thus supporting the conclusion that the cervical cord hemi-section did 
not provoque substantial loss of axotomized CS neurons. Considering the results 
in Figure 1C for the two groups of monkeys subjected to the cervical cord hemi-
section (red and blue bar graphs), surprisingly three monkeys (Mk-AT, Mk-AC 
and Mk-CS) exhibited a higher number of SMI-32 labeled neurons on the 
contralesional hemisphere. In the first two monkeys, this difference was however 
not statistically significant, reflecting in part the variability of the method. For the 
third monkey (Mk-CS), the significant difference may reflect an episodic 
interhemispheric difference in a minority of monkeys, as actually observed in one 
intact monkey (Mk-IU in Fig. 1C) out of five intact animals. Nevertheless, the 
presence of some lesioned monkeys with more SMI-32 positive neurons on the 
contralesional hemisphere reinforces the conclusion of an absence of elimination 
of CS axotomized neurons after cervical cord hemi-section. Overall, as shown in 
Figure 1C, the number of SMI-32 positive neurons varied across animals, most 
likely reflecting individual variability both in the number of large layer V pyramidal 
neurons and in the intensity of SMI-32 staining. 
 
The observation that there was no substantial loss of axotomized CS 
neuron after cervical hemi-section represents a quite favorable outcome for 
functional recovery. Indeed, the axons that have been severed, although they 
retract some distance from the lesion (Freund et al., 2007) are still present and 
potentially in position to regenerate or give rise to collateral sprouting. In other 
words, the functional recovery does not depend only on CS neurons spared by 
the lesion or on other preserved descending tracts. In recent reports, we 
demonstrated that the severed CS axons indeed can give rise to spontaneous 
axonal sprouting in absence of treatment, but only to a very limited extent 
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(Freund et al., 2006; 2007). In contrast, an anti-Nogo-A antibody treatment 
substantially enhanced CS axonal sprouting from the severed axons, as 
manifested by an increase of axonal arbors rostral to the lesion as well as axonal 
arbors and swellings caudal to the lesion (Freund et al., 2006; 2007). 
 
As a result of cervical cord hemi-section, the axotomized CS neurons in the 
contralesional hemisphere exhibit shrinkage of their soma (Fig. 2A, blue bar 
graphs). Neuron atrophy in response to axotomy is very well known and widely 
observed, including for cortical neurons. Neuronal metabolism depends on 
continuous retrograde trophic signals from the targets, which are absent or 
reduced in case of axotomy. As the normal intact axonal arborization may be 
much larger than the “spontaneously” newly formed arbor of the few sprouting 
neurons in the control antibody treated monkeys, the decrease of retrogradely 
transported trophic signals would thus contribute to the soma shrinkage. In the 
anti-Nogo-A antibody treated monkeys, although sprouting was enhanced 
(Freund et al., 2007), the quality and amount of trophic signals may be still 
insufficient to completely reverse the atrophy. Furthermore, the number of CS 
axons that successfully sprout and re-establish an axonal arbor with contacts is 
not precisely known. It is likely that only a relatively limited proportion of 
axotomized CS neurons managed to re-establish a large axonal arbor and to 
obtain enough trophic signals to prevent or reverse the atrophy. These few 
neurons indeed appear in the upper extreme of the soma size distribution 
(largest cells in Fig. 2A) but, in the anti-Nogo-A antibody treated monkeys, their 
number is not sufficient to compensate for the large number of shrunk neurons. 
Finally, the time course has to be taken into consideration. Shortly after the 
lesion, sprouting neurons are not in an atrophic state and this is true for the initial 
few weeks after the injury when sprouting takes place. The present morphometric 
measurements were conducted in our monkeys many months post-lesion at a 
time point when sprouting was completed. However, as the newly formed axonal 
arbors may not be as large as intact ones, the total amount of trophic support 
they receive may still not be enough to maintain their full soma size. 
Chapter 6: Does anti-Nogo-A treatment affect CS cell bodies after SCI?          194 
 
As far as the basic molecular/cellular mechanisms are concerned, it is 
known that somatic responses to an injury depend upon the intracellular levels of 
cyclic AMP and activation of transcription factors such as CREB (cAMP 
responsive element-binding protein; see for reviews(Oertle et al. 2003;Schmidlin 
et al. 2005). Thus, by increasing the cAMP levels, the neuronal regenerative 
capacity can be enhanced. 
 
The present study provides evidence that the anti-Nogo-A antibody 
treatment limits its action on the distal part of the axotomized CS neurons, 
namely by enhancing axonal sprouting close to the lesion itself, but does not 
prevent changes taking place at the level of the CS cell body, at least as far as 
soma size shrinkage is concerned. This conclusion applies to the present 
experimental conditions and it cannot be excluded that soma shrinkage of 
axotomized CS neurons could have been better prevented, at least to some 
extent, if the dose of the anti-Nogo-A antibody would have been higher or if it 
would have been delivered not only near the cervical lesion but also at cortical 
level. Indeed, although the anti-Nogo-A antibody delivered intrathecally near the 
lesion site penetrates into the CNS, the penetration was less complete in the 
brain than in the spinal cord (Weinmann et al. 2006; Liu et al., 2002).  
To our knowledge, the issue of CS neurons elimination after spinal cord 
lesion and treatment with anti-Nogo-A antibody has not been investigated before, 
even in rodents and therefore the present observation of an absence of anti-
Nogo-A antibody treatment effect on the shrinkage of axotomized CS neurons is 
original. The issue of whether the anti-Nogo-A antibody treatment can contribute 
to rescue cells from elimination after axotomy could not be addressed here as 
there was no CS neuron loss, even in the control antibody treated monkeys. The 
absence of CS cell loss after cervical lesion contrasts with the number of RS 
neurons detected in the contralesional magnocellular red nucleus (RNm), which 
was up to 30% lower than in the ipsilesional RNm (Liu et al., 2002). However, in 
the latter study conducted on the same groups of lesioned monkeys, it was 
observed that the anti-Nogo-A treatment did not impact on the RS neurons, as 
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the number of detected RS neurons was comparable in the anti-Nogo-A antibody 
and in the control antibody treated monkeys. 
 
 
 
 
1.5 Methods 
 
The present data have been derived from a long-term protocol, described 
earlier in detail(Freund et al. 2006;Schmidlin, Wannier, Bloch, Belhaj-Saïf, Wyss, 
and Rouiller 2005;Schmidlin, Wannier, Bloch, and Rouiller 2004;Wannier, 
Schmidlin, Bloch, and Rouiller 2005a) ,conducted on monkeys subjected to 
unilateral cervical cord lesion at the C7/C8 border, in accordance with the Guide 
for the Care and Use of Laboratory Animals (ISBN 0-309-05377-3; 1996) and 
approved by local (Swiss) veterinary authorities. The present study aimed at 
comparing three groups of monkeys (Table 1): (i) Intact monkeys (n=5); (ii) 
Monkeys subjected to the cervical hemi-section and treated with anti-Nogo-A 
antibody (n=5); (iii) Monkeys subjected to the cervical hemi-section and treated 
with a control antibody (n=4).  
Two monoclonal antibodies (mAbs) against different sites of the neurite 
inhibitor protein Nogo-A were employed (Table 1; see also (Freund et al. 2007) 
for more detail on the antibodies) in the group of anti-Nogo-A antibody treated 
monkeys: the mouse mAB 11C7 was raised against a 18 amino acid sequence of 
rat Nogo-A (aa623 – 640) close to the most inhibitory region of the Nogo-A 
protein (Oertle et al. 2003). The second antibody used, mAb hNogo-A recognized 
the Nogo-A specific region of the human Nogo-A sequence. Both antibodies 
identify primate Nogo-A monospecifically on Western blots (Campbell and 
Morrison 1989;Weinmann et al. 2006). The antibodies were purified as IgGs and 
concentrated to 3.7-10 mg/ml in PBS. In the control antibody treated monkeys, 
purified IgG of a mouse mAb directed against wheat auxin (AMS Biotechnology, 
Oxon/UK) was used as control antibody (concentration: 3.7-10 mg/ml). 
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Briefly, the main steps of the protocol conducted on the lesioned monkeys 
were the following. First, an intensive pre-lesion training was initially performed in 
order to establish a stable behavioral score in manual dexterity tasks involving 
both hands (Freund et al. 2006). A unilateral lesion was performed at the C7/C8 
border (see Wannier et al. 2005; Freund et al. 2006) and the antibody (either 
control or anti-Nogo-A) was administered intrathecally a couple of mm rostral to 
the lesion. The manual dexterity tests were conducted at regular intervals for 
several months post-lesion, until the animals reached a plateau reflecting a 
stable level of functional recovery. Anterograde tracers were injected mainly in 
the hand representation of the primary motor cortex (M1) bilaterally to label the 
CS tract (Freund et al. 2006; 2007). The monkeys were sacrificed under deep 
anesthesia and perfused transcardially with fixatives (Wannier et al. 
2005).Frozen sections comprising each of the two hemispheres were cut in the 
coronal plane at a thickness of 50 m. The spinal cord was cut in the 
paralongitudinal plane at the site of the lesion and transversally at the level of the 
first cervical segments as well as of thoracic segments caudal to the lesion. The 
lesion was reconstructed using SMI-32 stained material in all monkeys as 
previously reported (Wannier et al. 2005; Freund et al. 2006) and its extent was 
expressed quantitatively by the percent of the territory delimited by two lines 
starting from the central channel and extending to the dorsal and ventral rootlets, 
thus covering completely the lateral funiculus and hence the zone occupied by 
the main CS and rubrospinal (RS) tracts. A series of brain and spinal cord 
sections was treated immunocytochemically with SMI-32 antibody in order to 
visualize in the cerebral cortex the layers III and V pyramidal neurons (Fig. 1B), 
as recently described in detail(Tsang, Chiong, Kuznetsov, Kasarskis, and Geula 
2006). The epitope recognised by the SMI-32 antibody lies on non-
phosphorylated regions of neurofilament protein and is only expressed by 
specific categories of neurons (Campbell & Morrison, 1989; Tsang et al., 2006). 
SMI-32 positive neurons (only those exhibiting the nucleus) in the primary 
motor cortex (M1) on both hemispheres were counted under the microscope at 
high magnification (400x), in a territory including layer V at the same dorso-
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ventral location and defined of roughly equal length on both hemispheres (zone 
delineated with a dashed line in Fig. 1B). The typical appearance of SMI-32 
positive neurons in layer V of M1 was illustrated in a recent report (see Figure 3 
in Wannier et al., 2005). At low magnification, as staining was stronger on the 
ipsilesional hemisphere, the number of SMI-32 positive neurons seems to be 
lower on the contralesional side (Fig. 1B). This is however a wrong impression 
as, at higher magnification (Fig. 1D), several SMI-32 positive neurons appear on 
the contralesional hemisphere (Fig. 1D): at high magnification, even lightly 
stained SMI-32 positive neurons can reliably be detected. On each section and 
separately for each hemisphere, the total number of SMI-32 positive neurons 
was divided by the length (in mm) of the territory in which the analysis was 
conducted (l in mm in Fig. 1B). Moreover, the somatic cross-sectional silhouette 
area of these SMI-32 positive neurons in layer V was determined, as described in 
detail earlier [17]. In each monkey, four to six coronal histological sections were 
taken along the rostrocaudal extent of M1 (separated by 800 m each) in which 
the analysis of SMI-32 positive neurons in layer V was conducted. 
The number of SMI-32 positive neurons per unit length (mm) obtained in a 
given section was averaged across the sections analyzed in each monkey, 
separately for the two hemispheres, and a standard deviation was obtained 
reflecting the variability from one section to the next (Fig. 1C). The statistical 
comparison of the number of SMI-32 positive neurons per unit length between 
the two hemispheres was based on a paired t-test for small samples applied on 
the four to six sections analyzed in each monkey. A statistically significant 
difference of the number of SMI-32 positive neurons in layer V between the two 
hemispheres was obtained for a t value corresponding to p<=0.05 (df=3 to 5 for 4 
to 6 sections analyzed, respectively). The soma areas did not follow a normal 
distribution (wider dispersion for large somatic areas than small ones) and 
therefore they were graphically represented in the form of box and whisker plots 
(putting emphasis on the median value rather than the mean value; Fig. 2A). 
Accordingly, the statistical comparison of soma areas of SMI-32 positive neurons 
between the two hemispheres was conducted for each animal using the non-
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parametric unpaired Mann and Whitney test (Fig. 2A), with a significance level of 
p<=0.05. 
 
 
 
 
 
 
1.6 List of abbreviations 
 
CS = corticospinal 
M1 = primary motor cortex 
Mk = monkey 
RNm = magnocellular red nucleus 
RS = rubrospinal 
SCI = spinal cord injury 
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Table 1: List of cervical cord lesioned and intact monkeys included in the present study with identification code (same as in [10]). 
 
 
 
 
Mk-
AG 
Mk-
AT 
Mk-
AF 
Mk-
AC 
Mk-
AM 
Mk-
CS 
Mk-
CB 
Mk-
CC 
Mk-
CH 
Mk-
IR 
Mk-IE Mk-IZ Mk-
IRh 
Mk-
IG 
species fasc. fasc. mul. fasc. fasc. mul. fasc. fasc. fasc. mul. mul. fasc. mul. mul 
Antibody 
Treatment 
Anti-
Nogo
-A 
(hNo
go) 
Anti-
Nogo
-A 
(hNo
go) 
Anti-
Nogo
-A 
(11C
7) 
Anti-
Nogo
-A 
(hNo
go) 
Anti-
Nogo
-A 
(hNo
go) 
Contr
. 
Contr
. 
Contr
. 
Contr
. 
- - - - - 
Hemi-section 
total 
extent (%) 
78    * 56 85 80 63 75 38 90 - - - - - 
Completenes
s of 
dorsolateral 
funiculus 
section 
Yes    * Yes Yes Yes Yes Yes No Yes - - - - - 
RS and CS 
lesion extent 
(%) 
100     * 73 100 100 87 93 61 100 - - - - - 
Functional 
Recovery (%) 
100 (100)
* 
57 100 96 22 78 83 53 - - - - - 
Completenes
s of CS/RS 
section 
Yes 
 
   * No 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
No 
 
Yes 
 
- - - - - 
Survival time 
after lesion (in 
days) 
112 97 144 135 138 198 225 105 138 - - - - - 
ICMS no no yes no no yes no yes no no no no no no 
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At the time of the experiment, the lesioned monkeys had different names, not indicating whether the animal was infused with the control or the anti-
Nogo-A antibody, corresponding to a double blind procedure (except Mk-AF, Mk-CS and Mk-CC). New names were assigned to the monkeys during 
the writing of the manuscript to improve its readability, in consistency with (Freund et al. 2006). 
 
Under species, "mul." is for macaca mulatta while "fasc." is for macaca fascicularis. 
 
The five anti-Nogo-A antibody treated monkeys are in the five leftmost columns ("Anti-Nogo-A") with indication of which of the two antibodies was 
used (mAB11C7 or mAB hNogo-A), whereas the four control antibody treated monkeys ("Contr.") are in the next four columns. The five intact 
monkeys are in the five rightmost columns. 
 
Total hemi-section extent was calculated as the percentage of corresponding hemi-cord affected by the lesion on the frontal reconstruction of the 
cervical cord. 
 
To tentatively determine more precisely the extent of the RS and CS lesions a quadrant of the lateral funiculus in the white matter was outlined going 
from the dorsal to the ventral rootlet zone. This was indicated as RS and CS lesion extent.  
 
Functional recovery was assessed here for manual dexterity based on the "modified Brinkman board" task (see Freund et al. 2006) by giving in 
percent the ratio of the post-lesion score to the pre-lesion score. 
 
In the row “completeness of RS section”, “No” and “Yes” indicates whether the RS transection was considered as partial or as complete, respectively 
(for further explanation see text). 
 
Survival time: number of days separating the cord hemi-section from the sacrifice of the animal. 
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* In this animal the total hemi-section extent and consequently also the RS and CS extent could not be calculated for technical reasons (poor quality 
of histology). In addition in this same animal the lesion was too caudal and thus the 100% functional recovery cannot be interpreted. 
 
ICMS is for intracortical microstimulation. “Yes” means that the corresponding monkeys were subjected to extensive ICMS both pre- and post-lesion in 
order to study the change of motor maps (somatotopy) in relation to the lesion (see Schmidlin et al. 2004; 2005). 
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1.1 Neutralizing Nogo-A in SCI macaque monkeys: Summary 
The present investigation aimed at assessing the effects on nerve fiber plasticity 
and the amount and time course of spontaneous recovery when neutralizing 
antibodies against Nogo-A were infused intrathecally after a unilateral cervical 
spinal cord lesion in adult primates. The understanding of such mechanisms in 
the non-human primate is of strategic significance in the context of ongoing 
research leading to translational attempts to treat SCI patients. In particular, such 
knowledge derived from the non-human primate model is crucial, because of the 
potential difficulties in translating work in the rat model of spinal cord injury to the 
human condition (Courtine et al., 2007). In macaque monkeys, we used skilled 
tasks, such as the prehension of objects with the precision grip, the ballistic arm 
movement test and food grasping to test functional recovery of manual dexterity 
in control and anti- Nogo-A antibody treated monkeys.   
We found that neutralization of Nogo-A promoted regenerative sprouting of CS 
(and possibly other) axons around the lesion and into the denervated spinal cord 
in macaque monkeys (Freund et al., 2006; Freund et al., 2007), in line with 
previous observation in marmoset (Fouad et al., 2004).  
In particular, anti-Nogo-A antibody treatment decreased the normally occurring 
retrograde degeneration of the axotomized CS axons: the number of terminal 
retraction bulbs formed by the axotomized CS axons was smaller in the group of 
anti-Nogo-A antibody treated monkeys than in the group of control antibody 
treated monkeys and the terminal retraction bulbs were closer to the lesion 
(Chapter 4 : Fig. 2). Thus, anti-Nogo-A antibody treatment reduced axonal 
dieback. More CS axons grew into the lesion scar, but their regeneration through 
the scar tissue remained unsuccessful. Scar associated growth inhibition factors 
mainly account for this blockade of regeneration (Rhodes and Fawcett, 2004). 
The anti-Nogo-A antibody treatment enhanced the presence of CS axon arbors 
in the grey matter rostral to the lesion, the number of CS axon arbors (possibly 
corresponding to CS axon collaterals) passing from the white to the grey matter 
and, finally, the number of CS fibers crossing the segmental midline at C5 level 
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(Freund et al. 2007). These measurements show that axonal sprouting was 
induced by neutralizing the neurite outgrowth inhibitor Nogo-A after a cervical 
lesion, and that some CS collaterals were in a position to grow around the lesion 
in order to re-innervate the spinal cord territory caudal to the lesion deprived of 
CS input.  
We believe that these axons sprouting around the lesion make an important 
contribution to the incomplete but significantly enhanced reconstruction of the CS 
fiber plexus caudal to the lesion in the anti-Nogo-A antibody treated monkeys 
(Freund et al., 2006), more so than the fibers attempting to regenerate and to re-
enter the lesion itself.  
For the first time we report that nearly full recovery in a specific behavioural task 
measuring manual dexterity (Freund et al 2006, 2007b) parallels the 
reorganization of the CS tract in anti-Nogo-A antibody treated monkeys. Thus the 
enhanced growth of the CST may be part of a neural substrate for promoting 
better and faster recovery of manual dexterity as compared to control antibody 
treated monkeys.  
However, axotomized CS and RN neurons exhibited in control and anti-Nogo-A 
antibody treated monkeys a similar shrinkage of their cell soma (Beaud et al. 
2007). In contrast to CS neurons where the number of SMI-32 positive neurons 
remains similar in both hemispheres, a reduced number of positive stained RN 
neurons were found in the contralesional RNm (Wannier-Morino et al. 2007). In 
conclusion, the anti-Nogo-A antibody treatment did not preserve the axotomized 
CS and RN cells from soma shrinkage, indicating that in our experimental 
conditions the anti-Nogo-A antibody treatment affects morphologically the 
axotomized CS neurons mainly at distal levels, especially the axon 
collateralization in the cervical cord, and little or not at all at the level of their 
soma. 
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1.2 Lesion variability 
 
Spinal cord injuries are well-known to trigger a cascade of secondary tissue 
reactions due to bleeding, ischemia and inflammation, which lead to substantial 
variability within groups of animals and remain a crucial concern in the context 
studies investigating behavioral recovery.  
In the present investigation thirteen monkeys were subjected to a unilateral 
partial section of the spinal cord aiming at completely interrupting the decussated 
component of the CST which runs in the dorsolateral funiculus (Rouiller et al., 
1996; Lacroix et al., 2004). Histological reconstructions demonstrated a 
considerable variability in the extent of the lesion. In some animals the lesion 
covered an area of 45% of the total surface of the hemicord, whereas in others it 
affected up to 90%.  
However, in an experimental injury situation, the key prerequisite for studying 
regeneration is the completeness of the transection of the studied fiber tract. In 
our investigation, the crucial criterion for a complete lesion was not only the 
extent of the lesion as it appears in reconstructed cross sections for each 
monkey, but the full interruption of the corticospinal (CS) tract as assessed by 
anterograde transport of the tracer BDA from the hand area of motor cortex. 
Based on our criteria, 9 out of 13 monkeys had a complete lesion of the CS tract 
in the dorsolateral funiculus. Furthermore, among the animals considered for the 
tracing analysis of axonal arbors caudal to the lesion, only a single animal, Mk-
CP, had an incomplete CS lesion, as shown by the presence of a few BDA-
labeled CS axons not transected at the level of the lesion. 
 
The extensive functional recovery of manual dexterity which depends on lesion 
size may be due to pathways others then the CST. However, to what extent the 
variability of the lesions affected the degree of recovery, by involving other 
descending tracts such as the rubrospinal, reticulospinal, tectospinal and 
vestibulospinal tracts was not addressed in the present investigation at least at 
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the anatomical level (Hashimoto and Fukuda, 1991; Schucht et al., 2002; Fouad 
et al., 2005). Without doubt, the functional roles of these different descending 
tracts are not independent and, to address the impact of a lesion to one of them 
would require the comparison of several monkeys with the same lesion of the RS 
and CS tracts and assess the effects of lesions of graded extent aimed at the 
ventral column for instance. Due to restrictions in the use of non-human primates, 
the contribution to manual deficits of damage to separate territories of the 
cervical cord could not be addressed in the present study. 
However, the mean of the extent of the ventral column lesions in the control 
antibody treated monkeys (28.5%) was almost identical to that of the anti-Nogo-A 
antibody treated monkeys (28%; Table 2 of Chapter 2). This remains true if one 
considers separately the subgroup of monkeys retained for the statistics of 
functional recovery (treated: 33.6 %; control: 30.5%). Note also that the only 
animal, Mk-AC, which had a full section of both the dorsolateral and ventral 
funiculi was treated and recovered better than anyone of the control antibody 
treated animals, which all had some portion of their ventral funiculus remaining 
intact (Fig. 1 in Chapter 2). 
 
An additional important aspect of inter-animal variability is due to processes of 
scar formation and inflammation. CNS scars are well-known to contain a variety 
of neurite inhibitory factors other than the CNS myelin and neuron associated 
Nogo-A (Moon and Fawcett, 2001; Rhodes et al., 2003; Rhodes and Fawcett, 
2004). Inflammatory cells, on the other hand, are known to secrete cytokines and 
growth factors in CNS injury situations; some of these factors are effective 
neurite growth promoters (Schnell et al., 1994). Because complete serial sections 
series were prepared for the reconstruction of BDA-labeled CS fibers in our 
study, we had no control over the detailed anatomy of scar formation and 
inflammation. The variability in the extent of regenerative sprouting, growth of 
fibers around the injury site and elongation into the caudal spinal cord may well 
be influenced by these very complex tissue reactions.  
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1.3 Time course of manual dexterity recovery 
 
After injury at spinal level, ascending as well as descending pathways are 
affected. In a complete lesion situation a transmission of information below the 
lesion is completely abolished whereas, in an incomplete SCI, information can 
bypass the lesion using intact or partially intact pathways. In any case sensory as 
well as motor deficits are the consequence. The motor deficits associated to 
interruption of the CS tract at a segmental level in monkeys were assessed in 
several studies (Aoki and Mori 1979; Cheema, 1990; Denny-Brown 1966; Freund 
et al. 2006; Galea and Darian-Smith 1997a; Galea and Darian-Smith 1997b; 
Holmes and May 1909; Mettler 1944; Sasaki et al. 2004; Schmidlin, et al., 2004). 
A surprisingly good and rapid recovery of dexterous finger movements of the 
ipsilateral hand took place after hemi-section at C3 level in either newborn and 
juvenile monkeys (Galea and Darian-Smith 1997a,b), or in adult monkeys after 
hemi-section at C4/C5 (Sasaki et al. 2004) or C7/C8 level (Freund et al. 2006; 
Schmidlin et al., 2004).  
The above mentioned authors report persisting deficits of manual dexterity, in line 
with our data demonstrating that the recovery of manual dexterity is incomplete in 
a control situation (Fig. 1). In contrast, neutralization of Nogo-A by specific 
antibodies infused intrathecally leads to impressive functional manual dexterity 
recovery and enhanced regenerative CS sprouting and elongation in adult 
primates. The absence of detectable malfunctions such as allodynia supports the 
present view that the newly formed connections of sprouting axons reached 
meaningful targets. The extent of sprouting was not sufficient to reach the lumbar 
segment and may explain partially the absence of functional recovery of grasping 
with the hindlimb in anti-Nogo-A antibody treated monkeys. 
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In the context of spontaneous vs. anti-Nogo-A antibody enhanced recovery a 
critical issue remains the lesion level at C7/C8. In the macaque monkey a lesion 
introduced at this level reflects an incomplete lesion for fine finger controlled 
hand manipulation. CS neurons from the hand area terminate mainly in spinal 
segments from C5 down to Th2 and the main afferent input to the hand from the 
opposing fingers (thumb and index) enter the spinal cord at C5-C7. Whereas the 
anti-Nogo-A antibody treated monkeys show an enhanced recovery, the 
variability of the lesion level which can amount up to some mm, has to be taken 
into consideration as a contributing factor to functional recovery. 
 
 
1.4 Scar formation, regeneration and regenerative sprouting 
 
In the context of the fiber tract lesions, the term regeneration is clearly defined as 
re-growth of injured axons. The initial outgrowth over short distances has been 
called “regenerative sprouting” by Ramon y Cajal; elongation of these fibers over 
longer distances is often simply referred to as “regeneration”. Following anti-
Nogo-A antibody treatment in the rodent model of SCI true regeneration across 
and around the glia scar was observed (Schnell and Schwab, 1990; Schnell and 
Schwab, 1993; Liebscher et al., 2005). When Nogo-A was neutralized in 
monkeys the phenomena of regeneration in the sense of elongation from the 
axon stump was observed, but remained very limited and the elongating axons 
never crossed successfully the scar tissue. Rather regenerative sprouting of the 
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injured CST occurred. Most important, histological reconstructions showed that 
caudal to the lesion, the anti-Nogo-A antibody treated monkeys had longer 
cumulated axonal arbor lengths than the control antibody treated monkeys 
(Figure 3 in Chapter 2). These fibers were analyzed many months after the injury 
following antibody treatment; they had a healthy appearance and had 
characteristic typical varicosities and terminal buttons. Due to the long standing 
injury, there is no reason to assume that these fibers would be degenerating 
rather they represent newly grown fibers.  
It appears that in the context of fiber elongation the enhanced reconstruction of 
the CST tract in anti-Nogo-A antibody treated monkeys was successful because 
spared tissue served as a bridge to circumvent the lesion, thus limiting the 
approach at least in the context of SCI to incomplete SCI patients. However, 
incomplete SCI patients represent up to 70% of the whole injury population and 
therefore will, if successful in the clinical trial, address the majority of SCI 
patients. 
 
The BDA injections were targeted mainly to the hand area of M1 and therefore 
most labeled fibers are mainly directed to spinal levels C7-Th2, in other words 
one to three spinal segments below the lesion.  
In the first two monkeys (Mk-CC, Mk-CS), the survival time after BDA injection 
was set to three weeks, as used before in intact monkeys. However the tracer did 
not reach the cervical segments suggesting that the cervical lesion substantially 
slowed down the anterograde axonal transport of BDA. These animals were not 
considered further for the anatomical analysis (see Table 1 of Chapter 2 ). In 
contrast, a much longer survival time (60 days) allowed transport of BDA up to 
thoracic level in the other ten monkeys (see Table 1 of Chapter 2). 
The number of CS labeled axons observed at C5 level on transverse 
sections (up to 2282; see Table 1 of Chapter 2) appears low considering that the 
total number of CS axons was estimated to be 400'000 and that the number of 
CS neurons retrogradely labeled after tracer injection in the upper spinal cord 
amounted up to 72'000 in the entire frontal lobe (Dum and Strick, 1991). A few 
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explanations may account for this. First of all, only 50% of the precentral CS 
axons originate from M1 (Dum and Strick, 1991; He et al., 1993; He et al., 1995). 
Secondly, the BDA injections formed patchy territories leaving in between zones 
where there was no or less uptake. Thirdly, the BDA injections did not cover the 
entire M1; instead they were focused to the hand (forelimb) representation. 
Fourthly, a contingent of CS axons terminates above C5. In addition, BDA 
infusion was limited to the rostral bank of the central sulcus and therefore the 
whole rostral part of M1 was not injected. Furthermore, as compared to other 
anterograde tracers such as WGA-HRP for instance, the uptake of BDA appears 
less prominent. However, to explain the surprisingly low number of CS axons 
labeled with BDA in the present study, one may consider the likely possibility that 
the very fine axons making the majority of the CS tract are not labeled or 
escaped detection at light microscopy level, as suggested by our observation 
that most BDA labeled CS axons visible in our material at C5 level are relatively 
large in diameter. In this context, for the same reason, one cannot exclude that 
some fine CS axons unlabeled with BDA or undetected at light microscopic level 
were spared by the lesion. 
 
The quantitative analysis of the presence of BDA-labeled CS axon arbors below 
the lesion was limited to a distance of 3 mm, because it is the area where one 
expects most of the arborisation and where the motoneurons involved in the 
control of manual dexterity tested in our behavioral assessment are located. 
A systematic quantitative evaluation of the maximal distance at which BDA-
labeled CS axons are present caudal to the lesion would make sense only if the 
tracer BDA would have been injected not mainly in the hand area but also 
massively in cortical areas projecting to the hindlimb, which was not the case in 
the present study. In other words, as our data are focused on the hand 
representation, the true potential of the anti-Nogo-A antibody treatment in term of 
maximal distance of regeneration remains unknown in macaque monkeys, and 
would require further experiments. 
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In the present study, young adult monkeys (3.5 – 6.9 years old at time of 
sacrifice) were subjected to the spinal cord lesion (Table 1). It cannot be 
excluded that some of the axonal sprouting (although limited) observed in the 
control antibody treated monkeys occurred due to the relatively juvenile state of 
some of the animals and would not have taken place in older animals. Similarly, 
it is not established whether the enhancement of sprouting due to the anti-Nogo-
A treatment would have reached the same extent in older animals. Nevertheless, 
our animals had an age at the time of the lesion of 3.5 years or more, at which 
the myelination of the CS tract reached the adult stage, as full myelination was 
reported to last as long as 36 months (Olivier et al., 1997). As far as the CS tract 
is concerned, the animals included in the present study can thus be considered 
as adult monkeys. 
 
 
1.5 Problem of statistics with a small population 
 
The statistical analysis for the validation of our data remains an important point.  
An intrinsic difficulty of lesion studies on humans and monkeys is the inevitable 
variability in lesion location and extent between individuals. The impact being 
even more substantial on our nonhuman primate model of SCI for which ethical 
considerations drastically limit the number of animals. Moreover, the monkeys 
motivational and attentional states vary from day to day thus influencing strongly 
the readout of the behavioural test. 
In rodents, the inter-individual variability is dealt with in part by increasing the 
number of animals included in the treated and control groups. In the present 
investigation, in order to reduce the inter-animal variability, we paired monkeys 
for behavioural evaluation that were conducted by one experimenter in the same 
conditions. However, statistical analysis was performed by treatment group and 
not by pairs. Six control antibody treated monkeys and seven anti-Nogo-A 
antibodies treated were assessed for functional recovery whereas only eight 
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monkeys fulfilled the inclusion criteria for the anatomical tracing data (see 
paragraph 1.4).  
The statistical test indicating a significant functional recovery as reported in 
Chapter 2 was based on a single parameter: the percentage of manual dexterity 
recovery between the individual groups. Yet, Figure 1 indicates an inverse 
relationship of functional recovery to lesion size and thus needs to be taken into 
consideration for statistical examination. Therefore, in a second report extending 
the behavioural data, the variability related to the lesion extent was taken into 
account statistically, by introducing a non-parametric statistical test comparing 
the anti-Nogo-A antibody treated and control antibody treated monkeys with 
assessment of both the percent of recovery and lesion extent. More importantly, 
a new parameter was introduced for the same task, namely the “contact time”, 
defined as the time required grasping the first food pellet aimed by the monkey. 
This new parameter demonstrates more accurately the manual dexterity as it 
focuses on the precision grip between thumb and index finger, a prerogative of 
primates including humans (Lemon and Griffiths, 2005). The difference of 
functional recovery were statistically significant (P<0.05; two dimensional Mann-
and Whitney test) for parameters, the contact time and the score. 
 
 
1.6 Fate of CS and RS neurons after spinal cord injury 
The debate whether axotomized CS neurons die after axotomy remains 
controversial. On the one side a substantial loss of CS neurons was detected 
after pyramidotomy (Pernet and Hepp-Reymond, 1975) or cervical lesion 
(Holmes and May, 1909) but others did not observe any retrograde degeneration 
with breakdown and loss of neurons after section of the CS tract (Tower, 1940). 
Moreover, in primates the effect of axotomy on RS neurons is not known in 
contrast to the rat where cell shrinkage is observed (Novikova et al., 2000). In the 
present investigation we used a specific staining of a subpopulation of neurons in 
layer V, the pyramidal neurons and RS neurons of the RNm allowing a better 
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focus on the neurons of interest than for instance in Nissl staining that stains a 
much larger population of neurons. As a consequence, a difference between the 
two hemispheres and red nuclei affecting the CS and RS neurons after a 
unilateral cervical lesion is detected with more sensitivity in SMI-32 than in Nissl 
material. 
Our findings show that CS and RNm neurons shrink and that anti-Nogo-A 
antibody treatment does not prevent cell shrinkage. Despite the wide diffusion of 
the antibody reaching also the brain through the CSF circulation (Weinmann et 
al., 2006) this may seem surprising. 
However, normal neuronal functioning depends on the neurotrophic 
substances acquired via the numerous synapses. Hence after injury enhanced 
sprouting, as observed in the anti-Nogo-A antibody treated monkeys (Freund and 
others, 2006; Freund and others, 2007) should lead to enhanced synapse 
formation and thus could provide the neuron with more neurotrophic support as 
not sprouting neurons after injury. However, if one considers that the number of 
sprouting CS and RNm neurons after injury may be limited to a small population 
and that the newly formed axonal arbors may not be as large as intact axons the 
amount of neurotrophic support would not be sufficient to maintain their full soma 
size. Moreover, such minor difference between the cell sizes may not be 
detectable by the methods used in this investigations.  
Because the number of SMI-32 stained neurons is relatively low in both 
cortical layer and red nucleus, we did not use a stereological probe to estimate 
their number but we counted all visible nuclei of the labelled cells on the analyzed 
sections. This approach is considered as adequate as all samples were analyzed 
using the same procedure and the number of cells is low (Geuna, 2000; Lavenex 
et al., 2000; Benes and Lange, 2001). In the present case, in addition, the validity 
of the method is supported a posteriori  by the absence of overlap between 
lesioned and intact monkeys in a large group of animals.  
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1.7 Reconstruction of the injured CST, a mechanism of recovery? 
 
During recovery after CNS lesion, extensive plastic re-organization of 
neuronal networks at cortical level as well as spinal level have been observed in 
rodents (Bareyre et al., 2004), non-human primates (Schmidlin et al., 2004) and 
humans (Dietz, 1992; Ward et al., 2003). In the case of incomplete SCI spared 
tissue functions as a bridge for regenerating fibers. In addition the spared tissue 
conserves pathways that can takeover function after injury and thus may 
represent the substrate for compensatory mechanism. 
In the present study, reflecting an incomplete SCI situation, a substantial 
reorganization of the injured CST tract was observed in anti-Nogo-A antibody and 
limited in control antibody treated monkeys. As compared to control antibody 
treated monkeys, the anti-Nogo-A antibody treated monkeys exhibited an 
increased cumulated axon arbor length and a higher number of axon arbors 
going in the medial direction from the white to the grey matter. Higher in the 
cervical cord (at C5 level), the anti-Nogo-A treatment enhanced the number of 
corticospinal fibers crossing the midline, suggesting axonal sprouting. In 
conclusion, the anti-Nogo-A antibody treatment enhanced axonal sprouting 
rostral to the cervical lesion (Freund et al 2007); some of these fibers grew 
around the lesion and into the caudal spinal segments (Freund et al. 2006). 
Among the possible mechanisms leading to the partial reconstruction of the CS 
tract caudal to the lesion, sprouting from the CS tract that originates from the 
ipsilesional hemisphere can be ruled out, at least in control antibody treated 
monkeys. After reversible inactivation using the GABA antagonist muscimol 
(brown syringes in Fig 2) of the ipsilesional motor cortex the recovered manual 
dexterity score was not affected (Schmidlin and others, 2004; Schmidlin et al., 
2005). On the other hand, reversible inactivation of the contralesional motor 
cortex reduced the ability of the ipsilesional hand to obtain the recovered manual 
dexterity score (Schmidlin et al., 2005), indicating that the spontaneous 
reconstruction of the CS tract caudal to the lesion occurs from axons originating 
from the contralesional hemisphere in the form of sprouting of the transected CS 
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axons (green solid lines in Fig. 2) and/or sprouting of the undecussated CS 
projection not affected by the lesion, crossing the midline below the lesion (yellow 
solid lines in Fig. 2).  
After injection of an anterograde tracers into the hand area of M1 90 % of 
the CS projection run in the contralateral dorsolateral funiculus (90%) whereas 
the other 10 % do not decussate and thus remain unaffected by the cervical 
lesion (Rouiller et al. 1996; Lacroix et al. 2004). However, the present study did 
not address the possibility that some CS axon arbors observed caudal to the 
lesion (Chapter 2 ) could result from sprouting arising from these undecussated 
CS axons (Fig. 2). In rats subjected to a spinal cord lesion interrupting the main 
CS tract, axon sprouting from the intact ventral CS tract was indeed found to play 
an important role in the spontaneous post-lesion recovery (Weidner et al., 2001). 
CS fibers from the intact side have been seen to cross the spinal cord midline in 
rats after unilateral pyramidotomy and anti-Nogo-A antibody application 
(Thallmair et al., 1998).  
Descending tracts other than the CS projection were not labeled in the 
present investigation and therefore it remains uncertain how much they were 
affected by the lesion, as well as to what extent the anti-Nogo-A antibody 
treatment enhanced sprouting of the rubrospinal, reticulospinal, tectospinal and 
vestibulospinal tracts for instance as observed in the rat (Thallmair et al., 1998; 
Raineteau et al., 2001). 
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1.8 Takeover of indirect pathways   
 
To recover from an injury to the CNS injured fiber tracts can respond in terms 
of regeneration and/or regenerative sprouting (Schwab, 2002). The latter 
mechanism can also be observed from fiber tracts not directly affected by the 
lesion (Thallmair and others, 1998; Raineteau et al., 2002; Cafferty and 
Strittmatter, 2006).  
In non-human primates subjected to a unilateral section of the CST the 
ipsilateral descending portion of the CST responded to injury by compensatory 
sprouting. However, as these animals were mature, the effect of CST sprouting 
remained very limited and may not play a significant role for the recovery of 
manual dexterity (Galea and Darian-Smith, 1997a; Galea and Darian-Smith, 
1997b). It was observed that both CS as well as RN atrophy and therefore cannot 
solely contribute to functional recovery to the extent as observed in the 
hemisected primates (Galea and Darian-Smith, 1997a; Galea and Darian-Smith, 
1997b). At least in the cat, reticulospinal tract neurons do not atrophy after 
cervical hemisection. This may offer a neural substrate for descending inputs 
onto ipsilateral motoneurons in form of commissural axons sprouting rostral and 
caudal to lesion to reconnect to pre-existing spinal circuits. In the recovery weeks 
these connections could be reinforced by increasing crosstalk through 
corticocortical connections between the different corticospinal populations. In the 
latter study on primate hemisection of the cervical cord, Galea and Darian-Smith 
attributed a substantial part of the functional recovery of the precision grip in the 
lesioned monkeys to the remaining fibres of the reticulospinal tract spared by 
their model of lesion (Galea and Darian-Smith, 1997a; Galea and Darian-Smith, 
1997b), though no direct evidence supports this hypothesis in macaque 
monkeys. 
 
Another possible neural adaptation mechanism promoting functional recovery is 
the use and exploitation of intrinsic circuits of the spinal cord. It was shown that 
spontaneous sprouting of lesioned axons can contribute to recovery in absence 
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of long distance regeneration via collaterals that connect to long distance 
propriospinal fibers themselves forming a new circuit caudal to lesion (Bareyre et 
al. 2004). These networks are called ‘detour circuit’ that allow spinal interneural 
circuits to take over new functions in order to compensate for the deprived input 
(Galea and Darian Smith 1997; Bareyre et al. 2004).  
In addition, further intraspinal reorganization has been observed following mid- 
thoracic hemisection in rodents: After a recovery time of eight weeks the number 
of direct contacts between long propriospinal axon terminals and lumbar 
motoneurons is doubled. This two fold increase demonstrates that neural 
population not directly affected by the lesion respond to injury and create novel 
axonal circuits (Bareyre and others, 2004). 
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Figure 2 : Schematic representation of the macaque monkey corticospinal (CS) 
projection originating from the right primary motor cortex (M1) as seen at cervical cord 
level, as a result of BDA injection (empty syringe) in the right motor cortex. At C5 level, 
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on a frontal section of the cervical cord, green dots indicate the location and distribution 
of the CS axons, forming the dorsolateral funiculus (dlf) contralateral to the injection site 
and the uncrossed CS axons, present in the dorsolateral and ventral funiculi ipsilateral 
to the injection site. At C7/C8 level, the ensemble of black oblique lines represents the 
cervical lesion performed in the present study. Rostral to the lesion, parallel green thick 
lines represent CS axons in the dorsolateral funiculus, interrupted by the lesion. Axonal 
sprouting is represented by thinner lines arising from the thick green lines above, into 
and around the lesion. 
The brown syringe is for pharmacological reversible inactivation experiments of the 
contralesional primary motor cortex (M1), (Schmidlin and others, 2004). The thick 
vertical dashed line represents midline, whereas the thin vertical dashed line 
represents the boundary between the white (wm) and the grey (gm) matter. 
 
 
 
1.9 Adaptive strategies to compensate for loss of function  
 
In an incomplete SCI condition, the large information normally projected to the 
spinal cord via the CST for reach and grasp movements is greatly reduced and 
remains a “bottleneck” situation. The decreased transmission rates from the 
cortex to the cervical cord may influence the animal to adopt new strategies to 
achieve its intention with simpler and slower actions which nevertheless are still 
effective. It is known that in SCI patients as well as in experimentally induced SCI 
animals the use of adaptive strategies for the recovery of limb function is 
important. In cats this has been observed for grasping after high cervical lesions 
(Alstermark et al., 1987) and in rats for walking by involving axial movements 
(Giszter et al., 1998). Such change in strategy has also been observed in 
monkeys for a precision grip task after cervical dorsal rhizotomy (Darian-Smith 
and Ciferri, 2005) and locomotion in thoracical hemisected monkeys (Courtine et 
al., 2005). 
In the present investigation it was observed that especially control antibody 
treated monkeys made use of new adaptive strategies. In particular, during the 
Chapter 7: Discussion                                                                                               226 
 
modified “Brinkman Board task” the monkeys tucked their thumb into the palm of 
the hand. As a consequence the opposed thumb served as an opposing platform 
for the index finger in order to achieve a successful retrieve.  
In anti-Nogo-A antibody treated monkeys adaptive strategies at least during 
the dexterity test were rarely observed. A question then arises to what extent the 
limited sprouting of the CST tract in control antibody treated monkeys implies the 
need for such adaptation mechanism? Due to the limited number of control 
monkeys the question is difficult to answer. However the comparison of the 
sprouting occurring rostral to the lesion with the numbers of axonal swellings 
caudal to lesion indicates a correlation between the rostral and caudal occurring 
anatomical reorganization (Fig 4 E, Chapter 4 ); supporting the notion that the 
contingent of CS axons growing around the lesion in the grey matter is an 
anatomical correlate of the functional recovery observed in the anti-Nogo-A 
antibody treated animals. 
 
 
1.10  Perspectives:  
Combined anti-Nogo-A / BDNF treatment: Neutrophic support? 
 
In the present investigation we revealed that axotomized CS and RN neurons 
exhibited significant shrinkage of their cell soma size after a unilateral cervical 
lesion (Beaud et al. 2007; Wannier-Morino et al. 2007). In addition, positive SMI-
32 stained RS neurons were less numerous on the contralateral side of injury, 
possibly indicating cell loss. Infusion of anti-Nogo-A antibodies did not prevent 
atrophy of the axotomized CS and RS neurons. Rather its effect was at the distal 
end of the axotomized axons leading to regenerative CS sprouting (Freund and 
others, 2006; Freund and others, 2007).  
Neuronal metabolism depends on continuous retrograde trophic signals from 
the targets, which are absent or reduced in case of axotomy. As the normal intact 
axonal arborization may be much larger than the “spontaneously” newly formed 
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arbors of the few sprouting neurons the decrease of retrogradely transported 
trophic signals may in part explain soma shrinkage. Although in the anti-Nogo-A 
antibody treated monkeys sprouting was enhanced (Freund and others, 2006; 
Freund and others, 2007), the quality and amount of neurotrophic signals may 
still not be sufficient to reverse atrophy completely. 
 
In line with our data, adult rats subjected to cervical axotomy undergo a 
marked atrophy of rubrospinal neurons (RSNs) within the first month together 
with a decline in expression of regeneration-associated genes such as GAP-43 
and Tα1-tubulin (Bregman et al., 1998; Broude et al., 1999). Can this be 
attributed in part to the lack of neutrophic factors? 
The neutrophin factor family comprises the nerve growth factor (NGF), the 
brain derived brain growth factor (BDNF) (Leibrock et al. 1998), neutrophin-3 
(NT-3) and neutrophin-4/5 (NT-4/5). All known members bind to two different 
types of receptors, the trk tyrosine kinases and the neurotrophin receptor p75. 
Neutrophins mediate via these receptors neuronal survival, neural differentiation 
during development, maintenance of neural phenotype and modulation of 
synaptic efficacy in the adult CNS (Bonhoeffer, 1996). 
In consequent studies using a battery of administration techniques to supply 
neutrophic factors such as BDNF, NT-3 and NT-4/5 showed that axotomized 
RSNs and other supraspinal neurons in adult rats after cervical lesion did not 
atrophy, in contrast to untreated (Bregman and others, 1998; Liu et al., 2002). 
Following BDNF and NT-4/5 administration in the vicinity of RSNs neurons GAP-
43 and Tα1-tubulin gene expression was increased. In addition, infusion of BDNF 
enhanced the numbers of RSNs axons regenerating into a sciatic nerve 
implanted into the cervical cord at the level of injury (Kobayashi et al., 1997) 
Moreover, following BDNF administration at CS cell bodies after SCI in adult rats, 
CS neurons established new connections onto spared descending interneurons 
(Vavrek et al., 2006) and collateral sprouting (Coumans et al., 2001; Hiebert et 
al., 2002). The restoration of anatomical connections was associated with 
recovery of locomotor function (Coumans and others, 2001).  
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In conclusion, the aforementioned studies add up evidence that indeed lack of 
neutrophic factors leads to cell soma atrophy; itself a detrimental process to 
functional recovery. In contrast, exogenous administration of neutrophins, such 
as BDNF, can prevent neural atrophy, stimulate axonal sprouting and promotes 
functional recovery.  
As the anti-Nogo-A antibody treatment did not prevent cell body shrinkage of 
CS and RS neurons (Beaud et al., 2007; Morino-Wannier et al. 2007), we 
hypothesized that a combination of anti-Nogo-A antibodies and BDNF infusion 
could prevent cell atrophy of these neurons. In addition, BDNF infusion could 
contribute to the restoration of anatomical connections, making the reconstruction 
of the CST as observed when neutralizing Nogo-A (Freund and others, 2006; 
Freund and others, 2007) more beneficial in supporting functional recovery. 
In ongoing investigations three monkeys received a combination of anti-Nogo-
A and BDNF being intrathecally infused. Despite a complete hemisection, these 
animals recovered manual dexterity to a greater extend then control antibody 
treated animals, in line with the anti-Nogo-A antibody treatment. In the ongoing 
anatomical investigation we have found that at least in two of the three treated 
animals cell soma atrophy of RN neurons was more limited then in control and 
anti-Nogo-A antibody treated animals. 
 
Measuring grip and load force to monitor forelimb recovery? 
 
Tasks that have been commonly used to gain insights into control and recovery 
of manual dexterity usually involve a monkey removing food pellets from wells in 
a “Klüver” or “Brinkman board” task using the precision grip, the opposition of 
thumb and index finger (Nudo and Milliken, 1996; Friel and Nudo, 1998; Liu and 
Rouiller, 1999; Freund and others, 2006). The success and temporal measures 
are the most commonly recorded parameters. However, dexterous manipulation 
of objects requires also a precise control of the forces applied to objects held 
between two or more digits. 
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This precise control over the digit forces is important for successful completion of 
complex daily tasks, such as writing and food preparation. Measuring forces 
applied by the hand and digits during a task should provide a sensitive measure 
to monitor recovery reflecting the level of coordination of several joints and 
muscles. In order to measure these deficits and to monitor its recovery in the 
nonhuman primate we developed a so-called “Drawer Pulling task”: This device 
allows analyzing the recovery of the grip force exerted by the fingers on the 
drawer knob, the load force exerted to pull the drawer, the time to pull the drawer 
open and the time required to pick a food reward out of the drawer. A torque 
motor allows generating a force of chosen constant amplitude to oppose the 
pulling force.  
So far, we have investigated the recovery of four adult macaque monkeys 
performing the task. The macaques were either treated with a control antibody 
(N=2) or with a combination of BDNF and of an antibody neutralizing Nogo-A 
(N=2). During the pre-lesion period the strength of the grip force and load force 
covaried. However, immediately after the lesion the hand homolateral to the 
lesion was impaired and, during the first trials depending on the resistance 
amplitude tested, pulling time increased. A control antibody treated monkey with 
an incomplete lesion of the corticospinal tract (CST) exhibited a persistent 
significant loss of grip and load forces at the highest resistance amplitude (6.5 N) 
and an increase in pulling time for the lowest resistance amplitude (0.5 N). In 
contrast an anti-Nogo-A / BDNF treated monkey with a complete CST lesion 
recovered fully its grip force, load force and pulling time under the same 
conditions for this specific task. Picking time returned for both monkeys to pre-
lesion level. The recovery profile of one of the two remaining animals 
corresponds to that of the control antibody treated animal, whereas that of the 
second animal corresponds to that of the combined anti-Nogo-A / BDNF treated 
animal. However, the experimenter is presently blind to the treatment of the two 
other monkeys, and to the size of their lesion. These data suggests that the 
unimanual drawer-pulling task is a useful tool to detect a motor deficit after a 
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unilateral spinal cord lesion and to monitor the time course and extent of 
recovery. 
 
Repair of neural pathways by olfactory ensheathing cells 
After injury to the spinal cord, axons first attempt to regenerate but fail because of 
the myelin inhibitory environment and the lack of proper glia pathways that nerve 
fibres require for their elongation. Transplantation of olfactory ensheathing cells 
into the lesion site is being investigated as a procedure to re-establish glia 
pathways. 
The failure of injured axons to regenerate within the adult CNS does not apply to 
the olfactory bulb containing the olfactore ensheathing glia cells. During 
development the olfactory ensheathing cells develop from a placode on the 
surface of the body (Raisman, 1985; Raisman and Li, 2007) and therefore need 
to tunnel their way through intervening mesenchym to reach the olfactory bulb. 
Electron microscopy studies show that these cells consist of a thin cytoplasmic 
sheet that is curved over to enclose a tunnel-like space. Through this tunnel 
approximately 1000 olfactory fibres make their way to the olfactory bulb (Field et 
al., 2003). It was shown that by transplanting such cells into the lesion site, 
analogous to the reasoning of the experiments conducted by David and Aaguyo 
(David and Aguayo, 1981), the property of axons to re-enter the astrocytic 
environment could be translated. The transplanted cells appear to migrate with 
regenerating axons through the nonpermissive astrocytic environment towards 
specific denervated spinal cord laminae (Li and Raisman, 1993; Ramon-Cueto 
and Nieto-Sampedro, 1994). Most important, the enhanced long distance 
regeneration was shown to lead to impressive functional recovery of rats with 
injured CST(Li et al., 1997; Ramon-Cueto et al., 2000). 
Clinical demonstration of the effectiveness of transplanting the olfactory 
ensheating cells would open a door to treating a wide variety of currently 
incurable injuries of the brain and the spinal cord. At present two neurosurgical 
groups (Dobkin et al., 2006; Lima et al., 2006a) have adopted transplantation of 
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olfactory tissue as a clinical approach to treat spinal cord injuries and one reports 
preliminary data of enhanced functional recovery(Lima et al., 2006b).  
 
 
 
1.11 Conclusion 
The present thesis demonstrates a remarkable functional recovery of manual 
dexterity when Nogo-A is neutralized in adult non-human monkeys subjected to a 
cervical spinal cord lesion. CS sprouting into and around the lesion paralleled the 
observed functional recovery of manual dexterity. We believe that this enhanced 
anatomical reorganization may in part contribute to the observed enhanced 
functional recovery of manual dexterity. This result is a further promising step 
towards clinical application.  
The demonstration of nerve fiber plasticity within the mature spinal cord, a 
process being paralleled by significant functional recovery opens exiting 
perspectives for therapeutic approaches after SCI in humans. However, for an 
optimal future treatment aiming at restoring function after SCI, a combination of 
different approaches to overcome the barrier and inhibitory constitutes will be 
required (Thuret and Moon, 2006). In this line one could imagine to combine the 
anti-Nogo-A antibody treatment with the auto transplantation of olfactory 
ensheathing cells. This double treatment would allow neutralizing the inhibitory 
myelin and in addition provide the regenerating axons a proper glia pathways. 
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